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Abstract
What is the evidence for the effectiveness, appropriateness
and feasibility of group clinics for patients with chronic
conditions? A systematic review
Andrew Booth,* Anna Cantrell, Louise Preston, Duncan Chambers
and Elizabeth Goyder
School for Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK
*Corresponding author a.booth@sheffield.ac.uk
Background: Group clinics are a form of delivering specialist-led care in groups rather than in
individual consultations.
Objective: To examine the evidence for the use of group clinics for patients with chronic health conditions.
Design: A systematic review of evidence from randomised controlled trials (RCTs) supplemented by
qualitative studies, cost studies and UK initiatives.
Data sources: We searched MEDLINE, EMBASE, The Cochrane Library, Web of Science and Cumulative
Index to Nursing and Allied Health Literature from 1999 to 2014. Systematic reviews and RCTs were
eligible for inclusion. Additional searches were performed to identify qualitative studies, studies reporting
costs and evidence specific to UK settings.
Review methods: Data were extracted for all included systematic reviews, RCTs and qualitative studies
using a standardised form. Quality assessment was performed for systematic reviews, RCTs and qualitative
studies. UK studies were included regardless of the quality or level of reporting. Tabulation of the extracted
data informed a narrative synthesis. We did not attempt to synthesise quantitative data through formal
meta-analysis. However, given the predominance of studies of group clinics for diabetes, using common
biomedical outcomes, this subset was subject to quantitative analysis.
Results: Thirteen systematic reviews and 22 RCT studies met the inclusion criteria. These were supplemented
by 12 qualitative papers (10 studies), four surveys and eight papers examining costs. Thirteen papers
reported on 12 UK initiatives. With 82 papers covering 69 different studies, this constituted the most
comprehensive coverage of the evidence base to date. Disease-specific outcomes – the large majority of
RCTs examined group clinic approaches to diabetes. Other conditions included hypertension/heart failure
and neuromuscular conditions. The most commonly measured outcomes for diabetes were glycated
haemoglobin A1c (HbA1c), blood pressure and cholesterol. Group clinic approaches improved HbA1c and
improved systolic blood pressure but did not improve low-density lipoprotein cholesterol. A significant effect
was found for disease-specific quality of life in a few studies. No other outcome measure showed a
consistent effect in favour of group clinics. Recent RCTs largely confirm previous findings. Health services
outcomes – the evidence on costs and feasibility was equivocal. No rigorous evaluation of group clinics has
been conducted in a UK setting. A good-quality qualitative study from the UK highlighted factors such as the
physical space and a flexible appointment system as being important to patients. The views and attitudes of
those who dislike group clinic provision are poorly represented. Little attention has been directed at the
needs of people from ethnic minorities. The review team identified significant weaknesses in the included
research. Potential selection bias limits the generalisability of the results. Many patients who could potentially
be included do not consent to the group approach. Attendance is often interpreted liberally.
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Limitations: This telescoped review, conducted within half the time period of a conventional systematic
review, sought breadth in covering feasibility, appropriateness and meaningfulness in addition to
effectiveness and cost-effectiveness and utilised several rapid-review methods. It focused on the
contribution of recently published evidence from RCTs to the existing evidence base. It did not reanalyse
trials covered in previous reviews. Following rapid review methods, we did not perform independent
double data extraction and quality assessment.
Conclusions: Although there is consistent and promising evidence for an effect of group clinics for some
biomedical measures, this effect does not extend across all outcomes. Much of the evidence was derived
from the USA. It is important to engage with UK stakeholders to identify NHS considerations relating to
the implementation of group clinic approaches.
Future work: The review team identified three research priorities: (1) more UK-centred evaluations using
rigorous research designs and economic models with robust components; (2) clearer delineation of
individual components within different models of group clinic delivery; and (3) clarification of the
circumstances under which group clinics present an appropriate alternative to an individual consultation.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Plain English summary
G roup clinics deliver care to small groups of patients with the same condition at the same time ratherthan each patient meeting a doctor on a one-to-one basis. We wanted to find out whether or
not group clinics worked better and were a better use of resources than one-to-one appointments.
We also wanted to find out what patients and health professionals thought about group clinics.
We have assembled the largest number of relevant studies to date (82 papers reporting 69 research
projects). We looked at research about people with long-term conditions only (e.g. diabetes or heart
disease). We focused on how people manage their condition and not on using a group setting
for teaching.
Most research focused on people with diabetes. We found that group clinics were better than individual
appointments for improving some measures of how well diabetes is controlled. Group clinics also improved
the quality of life of patients. However, we did not find any other improvements for patients. Patients and
health professionals tend to view group clinics positively. However, the research did not tell us much about
the views of people who disliked group clinics. Several studies looked at whether or not group clinics save
money but the results were unclear. Although we were interested in group clinics as an alternative to
one-to-one appointments, most studies combined group approaches with an individual consultation. Most
studies took place in the USA. More research is needed to see whether or not group clinics are acceptable
and good value for money in the NHS.
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Scientific summary
Background
Group clinics are a form of delivering specialist-led care in groups rather than in individual consultations.
They may include aspects of clinical management as well as patient education and support. Group clinics
have been suggested as a way to replace individual patient consultations with a group session focused on
the management of an ongoing condition and advice. Synonyms for group clinics include group medical
appointments, drop-in group medical appointments, shared medical appointments, group visits and cluster
visits. In the UK, interest in group clinics is linked to a wider concern about modernising outpatient
services, which account for over 90 million episodes every year and increase year on year.
Theoretical considerations
We found supporting evidence for many candidate programme theories to explain how and why patients
might benefit by attending group clinics. Particularly influential high-level theories reflected in the
published accounts included social cognitive theory, social comparison theory and social learning theory.
Of particular value to understanding group clinic dynamics were theories relating to the core components of
chronic disease self-management developed by Corbin and Strauss and the five core self-management skills
identified by Lorig and Holman: problem-solving, decision-making, appropriate resource utilisation, forming
a partnership with a health-care provider and taking necessary actions. Opportunities for a partnership of
clinician and patient to use all of these skills are evidenced in the standard group clinic format.
In the UK, there is little published evidence on the impact and a lack of good-quality information on the
range and scale of group clinic activity in different specialties. A systematic review is needed to combine
published evidence of different types, including descriptive or qualitative studies, with grey literature.
Objective
To examine the evidence for the use of group clinics in patients who have chronic health conditions.
The review question is:
l What is the current evidence for the feasibility, appropriateness, meaningfulness, clinical effectiveness
and cost-effectiveness of group clinics/group medical visits (GMVs) for patients with chronic conditions?
Specifically:
l What different models of group clinic exist (in the UK and internationally)?
l What evidence exists about the outcomes and cost-effectiveness of these clinics?
l What evidence exists about patient experience of these clinics?
l What are the possible explanatory mechanisms for any reported improvements in outcomes?
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Methods
Data sources
We searched MEDLINE, EMBASE, The Cochrane Library, Web of Science and Cumulative Index to Nursing
and Allied Health Literature from 1999 to 2014. Systematic reviews and randomised controlled trials (RCTs)
were eligible for inclusion. Additional searches were performed to identify qualitative studies, studies
reporting on costs and evidence specific to UK settings. UK studies were included regardless of the
quality or level of reporting.
Study selection
We sought to differentiate a group clinic from group educational interventions that are common in chronic
disease management. To define inclusion in our review we required that a participating clinician do more
than simply fill an educational or a facilitative role. Our focus on chronic disease meant that we excluded
numerous studies of group clinics for pregnant women and for smoking cessation. We included group
clinics for inherited metabolic disease because of their long-term disease management implications.
Detailed inclusion and exclusion criteria for the review were as follows.
Population
Adults and/or children receiving health-care services for one or more chronic health condition. We
excluded visits for healthy patient groups (i.e. those without an indication related to a chronic health
condition). This exclusion covers pregnant women and women planning a pregnancy (unless they
also had a chronic health condition such as diabetes), as well as smoking cessation and other health
promotion clinics.
Intervention
Delivery of one or more services to a small group of patients (typically 8–10 patients) simultaneously.
Only studies including the delivery of the intervention by one or more specialist health-care professionals
met the inclusion criteria of the review. We excluded delivery of intervention by peers or non-specialist
health-care professionals. We also excluded peer-facilitated support groups, as the intervention in these
cases is not principally delivered by health-care professionals (although they may contribute).
Comparison
Other methods of organisation of treatment (with the exception of qualitative research and surveys, only
studies with a comparator group are included).
Outcomes
Patient outcomes, health services outcomes, patient and carer satisfaction, and resource use.
Search results were sifted and studies were selected for inclusion by one reviewer. Where there was doubt
about inclusion, a second reviewer independently examined the full text.
Data extraction
Formal data extraction was employed for all included systematic reviews, RCTs and qualitative studies.
Data extraction was undertaken by three reviewers using a standardised form. Quality assessment was
performed for RCTs and qualitative studies. For the RCTs we used the Critical Appraisal Skills Programme
(CASP) checklist for RCTs and the Cochrane risk of bias tables, and for the qualitative research we used
the CASP checklist for qualitative studies. Assessment of the limitations of included studies was also
undertaken using the limitations reported by study authors in the included studies.
SCIENTIFIC SUMMARY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
xxiv
Data synthesis
Data were extracted and tabulated. This tabulation was used to inform a narrative synthesis. There was no
attempt to synthesise quantitative data through formal meta-analysis given the heterogeneity of disease
conditions and models of service delivery for group clinics. However, given the predominance of studies of
group clinics in the context of diabetes and the use of common biomedical outcomes, this large group of
studies was subject to quantitative analysis. For literature that made a conceptual contribution, a method
known as best-fit framework synthesis was used, which involved the extraction of data against a
pre-existing framework. The review provides an analysis of the quality of evidence and the strength of
conclusions that can be drawn from existing studies.
Results
Effectiveness
A total of 13 systematic reviews and 22 RCTs (32 papers) met the inclusion criteria. This evidence base was
supplemented by 12 qualitative studies, four surveys and eight papers examining costs and other economic
issues. Thirteen papers reported on 12 UK initiatives.
Thirteen systematic reviews reported on multiple variations of GMVs. Twelve reviews were analysed in
detail and one was available only in summary form. One further review is only at the protocol stage. The
majority of reviews were disease specific, primarily with a focus on diabetes. Most included studies were
performed in the USA. Reviews of diabetes reported a consistent effect of group clinics in improving
glycated haemoglobin A1c (HbA1c) and systolic blood pressure. A significant effect was also found for
disease-specific quality of life in a few studies. No other outcome measure showed a significant and
consistent effect in favour of group clinics. Many reviews commented that the heterogeneity of group
clinic interventions made it problematic to classify such initiatives, to isolate the effects of specific
intervention components and, consequently, to evaluate the intervention’s effects.
Recent RCTs supplementing published systematic reviews largely confirm previous findings. Eight reports of
seven RCTs have been published between 2012 and 2014 to add to 15 RCTs (24 reports) previously
available in existing reviews, making this the largest review to date focused on group clinics. Three of these
reports supplement existing meta-analyses. Two of these reports confirm previous findings of a significant
effect for improved HbA1c and systolic blood pressure associated with the use of group clinics in diabetes.
One new trial found a significant effect for total cholesterol and low-density lipoprotein cholesterol but
this was not consistent with previous meta-analyses and unlikely to overturn the finding of no overall
significant effect.
Qualitative studies
Qualitative research found that patients appreciate many of the features of group clinics, including
socialisation, normalisation and information sharing. Clinicians appreciated the opportunity to informally
monitor patients and to gain a better understanding of practical threats to treatment adherence. Again,
studies from the USA were dominant, with other studies being conducted in Canada, the Netherlands and
the UK (one study, two papers). Generally, the qualitative studies were of low quality, with only 5 of the
12 studies using recognised methods of both qualitative data collection and analysis.
Costs and cost-effectiveness
Of the eight papers that provided evidence on costs, seven reported studies performed in the USA and one
reported on a study in Italy. The conditions covered were diabetes, comorbid diabetes with hypertension
and complex behavioural health and medical needs. This heterogeneous set of studies showed mixed
effects of group clinic interventions on costs. Furthermore, certain costs were not explicitly identified in the
included studies. For example, it is likely that a group clinic intervention may require specialist training of
health-care staff, particularly in relation to facilitation skills.
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Evidence from the UK
Of the 13 papers describing group clinic initiatives in the UK, none represented evidence from rigorously
conducted experimental studies. Descriptions of several initiatives were available only as abstracts. One study
found that acceptability of group clinics was high among patients undergoing acupuncture for knee
osteoarthritis. However, the sensitivity of health and lifestyle topics is not a key issue for this particular
population. Even in this context there was an expressed demand for single-sex sessions, including in a
Muslim population.
A good-quality qualitative study from the UK highlighted the importance of factors such as physical space
and a flexible appointment system. The views and attitudes of those who feel that group clinic provision is
unacceptable, inappropriate or not feasible were relatively poorly represented and little attention has been
directed at the specific needs of those patients from ethnic minorities. Patients for whom group clinic
sessions may not be appropriate include those with complex conditions and those with severe pain.
Conclusions
Although there is consistent and promising evidence for an effect of group clinics for some biomedical
measures, this evidence does not extend to other measures such as control of cholesterol. Disease-specific
quality of life improved significantly in a small number of studies but the effects were less marked for
generic health-related quality of life. Much of the evidence was derived from the USA and it will be
important to engage with UK stakeholders and identify specific NHS considerations when considering
issues relating to the implementation of the group clinic model.
Recommendations for research
A full economic evaluation of group clinics is recommended. This should accommodate data such as the
type of clinician delivering the intervention and how long each clinic lasts to derive a richer picture of
the costs of group clinics. Primary research that gathers information on the running of group clinics and
potential cost savings in the UK NHS context would be particularly valuable.
Funding
Funding for this study was provided by the Health Services and Delivery Research programme of the
National Institute for Health Research.
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Chapter 1 Background
Chronic disease in the UK
Chronic conditions and diseases are the leading causes of mortality and morbidity in Europe. Complex
conditions such as diabetes and depression continue to impose an ever-increasing health burden on societies
across Europe. The World Health Organization’s ‘Global Burden of Disease’ study estimated that, as of 2002,
chronic or non-communicable conditions accounted for 87% of deaths in high-income countries.1
More than 15.4 million people in England are living with one or more long-term conditions.2 Research by The
King’s Fund estimates that the average cost per year of treatment for a person with a single long-term
condition in the health and social care system is £1000, and this rises to £3000 and £8000 for those with two
or three conditions respectively.3 By 2018 the number of people with three or more long-term conditions is
predicted to rise from 1.9 million (2008) to 2.9 million (2018).3 People with long-term conditions account for
50% of all general practitioner appointments, 64% of outpatient appointments and 70% of all inpatient
bed-days.3 In total, around 70% of the total health and care spend in England (£7 out of every £10) is
attributed to caring for people with long-term conditions. The prevalence, morbidity and mortality from
chronic diseases are expected to rise, especially in countries with rapidly ageing populations.4
Patients with chronic diseases require intense patient education, counselling, lifestyle modification and
complicated pharmacological management, all of which consume a significant amount of service delivery
time. These interventions are difficult to achieve in the current health-care system, where less time per
patient visit is a result of increasing numbers of patients seen per day. Historically, the medical model is
focused on the treatment of acute episodic health problems, and hospital facilities are correspondingly
poorer equipped to handle chronically ill patients who require complex services.5
Chronic care was explicitly recognised as a priority in 2004 in the NHS Improvement Plan.6 The plan set out
the government’s priority to improve care for people with long-term conditions by moving from reactive
care towards a systematic, patient-centred approach.
Supporting People with Long-Term Conditions in 2005 outlined a new NHS and social care model for the
care of people with long-term conditions.7 It aimed to match support with need, providing personalised yet
systematic health and social care to people with chronic conditions. The model categorised patients
according to their level of need:
l supported self-care for the 80% of patients with a long-term condition who, given sufficient support,
can care for themselves and their condition effectively
l disease-specific care management for patients with a complex single need or multiple conditions
which require responsive, specialist services using multidisciplinary teams and disease-specific protocols
and pathways
l case management for the most vulnerable people, who have highly complex, multiple long-term
conditions and who require co-ordinated health and social care provision.
What are group clinic approaches?
Group clinics are a form of delivering specialist-led care in groups rather than in individual consultations.
They may include aspects of clinical management (e.g. adjusting medication in the light of health status
information) as well as patient education and support. The innovative nature of group clinics, particularly as a
potential vehicle for improving the maintenance and care of patients with chronic conditions (e.g. diabetes,
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asthma, urological conditions and coronary disease), coupled with a need to use available resources more
efficiently and the perception that the organisation of group clinics requires only modest scale redesign,8 has
stimulated much evaluation activity. Over the past decade, several models for group medical visits (GMVs)
have emerged, mainly in managed care environments. Some of these models originated in the care of the
frail elderly, a population that suffers from many chronic illnesses and comorbidities. These models have
been widely used in the USA, largely for people with long-term conditions. Early findings suggested potential
for considerable cost savings, equivalent or improved outcomes and higher levels of patient/staff satisfaction.
Later studies have not always replicated these effects. The terminology of group clinic approaches includes
‘group visits’, ‘shared medical appointments’ (SMAs), ‘cluster visits’ and ‘problem-solving DIGMA’ (drop-in
group medical appointments).9,10 The four principal conceptual models of group clinic approaches are
reviewed later in this chapter, alongside a variety of terms and variants.
Although the literature reflects considerable variation, both in what is understood by a ‘group clinic’ and in
the terminology associated with such initiatives, the following vignette (Box 1) seeks to broadly characterise
how group clinics are depicted in the professional literature.
BOX 1 Vignette characterising group clinic approaches
For a group clinic approach, between 3 and 20 patients with a chronic medical condition get together with one
or more clinicians to share information about how to manage their disease. Typically led by a physician and/or a
specialist nurse, group clinics are often supported by the involvement of a medical assistant or nurse. Other
participating professionals may include a social worker, a pharmacist or a mental health professional. Patients
typically learn together, so, for example, diabetics could learn together how to conduct a foot check correctly
and heart patients might take their own blood pressure readings. Educational sessions may follow a set session
schedule or may be offered in response to previously identified needs as expressed by the group. Typically
there is an opportunity to review current medication. Patients often have the additional opportunity to meet
individually with a consultant for a one-to-one consultation. Patients thus feel that they are receiving
appropriate care and attention within the group appointment setting. In turn, nurses value the chance to spend
more time with their patients and the apparent efficiency of being able to reach several patients at once.
A typical group clinic session lasts somewhere between 60 and 150 minutes.
Most group clinic approaches include an element of between-visit care co-ordination and case management,
typically provided by a nurse or nurse practitioner. Setting up a limited element of care co-ordination for attendees
of group visits may trigger distal benefits in relation to improved record-keeping and co-ordination of care.
Group clinic approaches may either replace or supplement usual one-on-one care. Group clinic approaches
should be distinguished from more narrowly defined group education classes, which address self-management
skills, exercise and nutrition but do not provide medical evaluation, medication adjustment or the co-ordination
and delivery of preventative services. Group clinic approaches typically include group education, shared
problem-solving, focused private or semiprivate medical evaluations that allow individualised medication
adjustment, and ordering of preventative services and referrals. One attraction for patients lies in the potential
for group visits to improve access, interaction with clinicians, between-patient learning and self-efficacy.
A group clinic appointment, therefore, differs from an individual consultation in that some information giving,
which would typically take place within the consultation, is activated within a group setting. In addition, the
group context may facilitate collective problem-solving, peer support and the identification of positive, or at the
very least realistic, role models. Peer support may be instrumental (in providing practical tips and resources),
cognitive (in addressing individual uncertainties) and/or affective (in providing reassurance and a sense of
solidarity and mutual support).
Based on Davis et al.8
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The vignette in Box 2 embodies several assumptions, articulated in the literature, that are to be tested within
this review, most notably in relation to patient and staff satisfaction and efficiency. The attractiveness of group
clinics as a viable service delivery option is also founded on implicit assumptions of acceptability and feasibility.
Potential drivers for group clinics
We have identified four principal drivers for the introduction of group clinic-type interventions:
l A substitution argument maintains that group clinics may be used to mitigate the supply of and
demand for individual consultations without compromising continuity of care.
l A quality of care argument claims that group clinics result in better self-management behaviours,
particularly with regard to the management of chronic symptoms.
l An acceptability argument affirms that patients are at least as likely to be satisfied with care provided
via group clinic arrangements as they would be with individualised consultations.
l An enhancement model rehearses the benefits of integrating group clinic-type approaches into
existing group educational provision for chronic disease where this is currently taking place.
Group clinics are used to replace either an individual patient consultation or, more commonly, pre-identified
components of the consultation such as education and information giving, with a group session, focused
on the management of an ongoing condition and advice. Much outpatient activity centres on the
monitoring and management of people with long-term conditions such as arthritis or diabetes. Questions
have been raised concerning the appropriateness of outpatient appointments. Two-thirds of missed
appointments are for follow-up appointments, suggesting that there is scope for improved efficiency. The
group clinic represents one suggested initiative to improve efficiency and enhance patient satisfaction.
In the UK, there is little published evidence on impact and a lack of good-quality information on the range
and scale of group clinic activity in different specialties. A systematic review is needed to combine the
published evidence of different types, including descriptive or qualitative studies, with grey literature.
For the potential of group clinic-type interventions to be explored fully, with a view to their possible
increased utilisation within a UK NHS context, requires a systematic investigation of research evaluating
their usefulness and costs, not only financially but in terms of professional training, patient satisfaction
and clinical and health service outcomes.
Hypotheses tested in the review (review questions)
Purpose of review
The purpose of this systematic review is to examine the available evidence for use of group clinics with
patients who have chronic health conditions.
Review question
The review question is as follows:
l What is the current evidence for the feasibility, appropriateness, meaningfulness, effectiveness (FAME)
and cost-effectiveness of group clinics/GMVs for patients with chronic conditions?
Specifically:
l What different models of group clinic exist (in the UK and internationally)?
l What evidence exists about the outcomes and cost-effectiveness of these clinics?
l What evidence exists about patient experience of these clinics?
l What are the possible explanatory mechanisms for any reported improvements in outcomes?
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Objectives
The primary objective of this review is:
l To identify evidence of effectiveness, or likely effectiveness, of group clinics and, where this is
identified, to review evidence of impact, in particular cost-effectiveness of group clinics. This might
include measures of efficiencies and clinic/staff time, use of services (hospitalisation rates), patient
outcome (and surrogate clinical measures), behaviour, self-efficacy, quality of life and other patient
and staff satisfaction indices.
Additional objectives were:
l to understand how group clinics have been conceptualised and to identify different models of use from
a review of academic and grey literature
l to relate emerging findings on what works to current practice
l to identify research gaps for funding bodies and researchers.
Scope
This review covers all group clinics which include a component of clinical advice and management, as well
as peer learning and support, for chronic health conditions. Terms (largely US) include ‘group medical
visits’, ‘cluster visits’, ‘shared medical appointments’ and ‘co-operative health-care clinics’. The focus is on
specialist-led services (i.e. replacing hospital outpatient appointments). Patient education and support
groups (including expert patient groups) focused on self-management with no clinical advice or input are
not the main focus of this review, although there may be some overlap in activity (see Chapter 2 for
inclusion and exclusion criteria).
In seeking to inform the review from as holistic a perspective as possible, the team decided to examine the
available evidence against the FAME framework. FAME is a mnemonic for the aspects of feasibility,
appropriateness, meaningfulness and effectiveness and was devised at the Joanna Briggs Institute.11
Appendix 1 sets out the FAME framework as used to guide the review process. This framework allows us to:
1. define the scope of the search strategy
2. define inclusion and exclusion criteria to specify types of studies to be included in the final report
3. construct summary tables of all included studies to present key information and findings
4. synthesise the evidence from the included studies.
It should be noted, however, that the FAME framework was selected principally to facilitate the synthesis
process. In the interests of brevity we have subsumed considerations of feasibility, appropriateness and
meaningfulness elsewhere under ‘appropriateness’ as an umbrella term, as in the report title.
What are the existing models of group clinics?
This section starts with a brief consideration of the main models of group clinic and attempts to outline
a workable typology with which to inform the subsequent analysis. Essentially, there are four principal
models of group clinic approaches:
1. the co-operative health-care clinic (CHCC) model
2. the specialty CHCC model
3. the DIGMA model
4. the SMA model.
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The co-operative health-care clinic model
Overview
The CHCC model, developed by Kaiser Permanente in 1990, is designed to provide physicians with
adequate time to deliver quality care.
Designed for
Generally used to provide care to patients over the age of 65 years with chronic conditions or who frequently
utilise medical resources. The main objective of the CHCC model is to facilitate the self-management of
patients’ chronic condition(s) through enhanced education, encouragement of self-care, peer and
professional support, and attention to the psychosocial aspects of living with chronic disease.12 Specific to
the CHCC model are regular scheduled visits with the same group cohort over extended periods of time.
Duration
Co-operative health-care clinics generally last from 2 to 2.5 hours and comprise no more than 20 patients
at a time.
Content
Individualised medical care usually takes place in a private room near the meeting site. A physician
encounters patients individually, allowing up to 5 minutes per patient, while a nurse takes vital signs and
other measurements for the rest of the participants. Approximately 30 minutes is allocated for collecting
patient data and conducting individual sessions; the rest of the time is spent addressing group concerns,
providing educational material and answering participants’ questions.13 Groups may meet monthly or
quarterly, according to need. Group time is structured and includes set intervals of socialising, education
and medical interaction. Medical interaction may include an overview of the patient’s medications,
laboratory results, immunisation or any other primary care need identified at the time of meeting.14
The specialty co-operative health-care clinic model
Overview
The specialty CHCC model is similar to the regular CHCC model from which it later evolved, but it focuses
on a specific disease. A later variation of this model, the high-risk cohort model, targets patients of all ages
with similar chronic problems, such as diabetes or coronary artery disease.13
Designed for
Offering a foundation on which to base high-risk patient population management programmes (e.g.
diabetes, hypertension, hyperlipidaemia, depression, etc.), thereby assisting patients and care providers to
follow clinical-based practice guidelines.
The drop-in-group medical appointment model
Overview
The DIGMA model was created in 1996 to improve access to care and enable physicians to better manage
their large patient panels.
Designed for
Drop-in group medical appointments are composed of different patients from meeting to meeting, who
‘drop in’ when they have a specific medical need. These groups may focus on a specific diagnosis or they
may target all chronically ill patients within a given practice. DIGMAs are customised to the needs, goals,
practice style and patient panel constituency of the individual physician.14 DIGMAs have been utilised in a
variety of specialties, including oncology, rheumatology and neurology.15 DIGMAs can be designed as
heterogeneous, mixed or homogeneous; typically, they are heterogeneous in terms of age, sex, diagnosis,
marital status, race and utilisation behaviour.
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In a heterogeneous DIGMA, patients with any diagnosis can attend the group session, and patients may
vary by age and sex. In the mixed DIGMA model, the physician will choose a different health concern or
disease each week. Those attending will vary according to the topic. For example, the physician may hold a
DIGMA on chronic pain one week and then focus on hypertension and diet at the next weekly session.
Different patients may attend their physician’s DIGMA depending on their questions, needs or diagnosis.15
Duration
Drop-in group medical appointments typically last for 90 minutes and involve 10 to 15 patients.
Content
Drop-in group medical appointments often include a behaviourist who facilitates group processes and
addresses each patient’s psychosocial concerns. The physician conducts individual medical sessions within
the group setting instead of in a separate space and often engages the group in providing solutions to
patient problems; by doing so, the physician provides education throughout the visit rather than a formal
lecture. After the educational session, patients who need to see their doctor privately can do so.
The shared medical appointment model
Overview
The SMA was conceived by Noffsinger in 200216 as an effective and efficient method for physicians and
specialists to increase their efficiency at providing physical examinations. Noffsinger identified that the
majority of time spent performing a physical examination was devoted to answering questions and
exchanging information.16 Noffsinger coined the term ‘shared medical appointment’ to describe models
where several patients meet with the same physician at the same time.16 SMAs have been described ‘as a
form of medical appointment with varying medical staff and patient populations and have been utilised for
patients with chronic illnesses for whom education, self-management, and problem-solving skills are
essential’.17 SMAs, a subgroup of GMVs, may also be called group visits, cluster visits or chronic health-care
clinics. However, unlike group visits, SMAs are not intended to substitute for an individual consultation.
Designed for
‘Groups of patients meeting over time for comprehensive care, usually involving a practitioner with
prescribing privileges, for a defining chronic condition or health care state’.18 Most SMAs are homogeneous
in terms of age and sex.
Duration
Shared medical appointments are regularly scheduled and typically last 90 minutes.
Content
In the SMA, physical examinations are provided privately, but have a group component whereby an
interactive group discussion answers patient questions and provides patients with information. Two weeks
prior to the session, patients receive an information package that includes history forms, laboratory
requisitions, screening tests and handouts. Patients complete the required procedures before the SMA.
Individual examinations occur during the first 30–45 minutes of the session, with the remaining time
reserved for group discussion. Questions that do not lend themselves to group discussion are addressed
during a private examination. Components of SMAs include educational and/or self-management
enhancement strategies, paired with medication management, in an effort to achieve improved disease
outcomes. The prescriber usually performs the medication changes, often in one-on-one ‘breakouts’.
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Additional terminology and definitions
Additional terms are encountered throughout the relevant literature, adding to the terminological
confusion and further dissipating the distinctiveness of individual models of group clinic. Existing
definitions are reproduced below for the sake of completeness.
Chronic care clinics are based on a chronic disease approach to illness that recognises the need for active
patient participation and supports patients’ confidence and skills in managing their illness.19 Chronic care
clinic visits involve approximately eight patients at a time. They consist of a standardised assessment and
individual (not group) appointments with the primary care physician, nurse and clinical pharmacist,
followed by group education and support. Typically, the chronic care clinic replaces a formal educational
component with interactive discussions related to patient self-management.12
Cluster visits are monthly 2-hour group visits with a multidisciplinary team led by a nurse educator and
including a dietitian, a pharmacist and a behavioural therapist.20 Cluster visits typically involve
10–18 patients.
Group clinics are a potential method of integrating self-management support with routine clinical care.
The term is sometimes used synonymously with ‘shared medical appointment’. Group clinics are an
alternative model of care to one-to-one clinic appointments, having a higher ratio of patients to health
professionals and a longer duration than one-to-one appointments.
Group medical appointments (GMAs) are a series of one-to-one patient–clinician contacts in the
presence of a group of at least two voluntary attending patients. Usually the clinician is supported by a
group facilitator. A GMA generally takes 1–2 hours and is a substitute for a clinician’s individual
appointments with the attending patients at a primary care clinic, specialty clinic or hospital outpatient
setting. The same items the clinician attends to in a one-to-one appointment are attended to during
the GMA. Patients can ask questions of their fellow patients, and patients and clinicians can learn from the
other attending patients and their carers.21
Group medical visits are defined as multiple patients seen together while in the same clinical setting.
Group visits include not only group education and interaction but also most elements of an individual
patient visit, such as the collection of vital signs, history taking and physical examination. As Weinger
acknowledges, ‘Some confusion exists regarding the term “group medical visit.” Currently, no single
definition of a group medical appointment is universally accepted’.22 This confusion exists among the other
related terminologies. She highlights how most group medical visit models include a group education
component taught by a nurse, psychologist or other health professional. In her view the main difference
among models is that ‘some include only individual visits with the physician, whereas others include group
visits through which several patients meet with the same physician at the same time. The latter typically
allowed for individual appointments if necessary or if requested by a patient’.22
Jaber et al. define group visits as a cohort visit of 20 patients who meet monthly or quarterly during a
2-hour multidisciplinary session that includes individual provider time, data collection similar to an
individual visit, and group discussion or education to foster self-management.23 Clinicians are able to
answer questions and meet the medical needs of patients who need the same education and assistance
with lifestyle issues. Patients have improved access to their clinician and are able to share experiences with
other patients through peer support. Two models of group visit are a scheduled high-needs group (see The
specialty co-operative health-care clinic model) and a drop-in arrangement (see The drop-in-group medical
appointment model).23 Scheduled high-needs groups comprise patients with similar medical conditions
who commit to meet regularly over time. Drop-in models allow patients to schedule in advance for a
group appointment. They typically include fewer patients and are shorter in duration. These models were
developed to improve patient access by offering education and support.
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The above descriptions reveal considerable overlap between the purpose and content of the different
models. Indeed, several models share common origins in the writings of Noffsinger.9,14,15 Typical duration
across the models is somewhere in the region of 90–120 minutes (Table 1). Several models have social,
medical and behavioural components. At the same time there is considerable variation in terms of group
size, composition and target group. The driver for several models is improved efficiency, and claims for
improved patient and provider satisfaction are common. These claims are examined through the remainder
of this report.
TABLE 1 Typical configurations of different group clinic approaches
Model Duration
Number of
patients Consultation type Other components
CHCC model 120–150 minutes 15–20 Individual Socialisation
Group discussion
Education
Question answering
Specialty CHCC
model
120–150 minutes 15–20 Individual Socialisation
Group discussion
Education
Question answering
DIGMA 90 minutes 10–15 Individual (but
conducted in group
setting)
Problem-solving
Education
Private follow-up if required
SMA 90 minutes 4–8 Individual Education
Self-management
Medication management
Chronic care clinic 60 minutes Approximately 8 Individual Peer support
Interactive group education
Cluster visit 120 minutes 10–18 Group with individual
on request
Behavioural sessions
Medication review
Group education
Group clinic 60 minutes
(plus 10-minute
individual sessions)
5–7 Group followed by
individual session
Goal setting
Self-management
Support
GMA 60–120 minutes At least 2 Group Peer support
Group discussion
Question answering
GMV 90 minutes 12–15 Group/individual by
appointment
Group education
Group visit 120 minutes 20 Individual Group discussion
Group education
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Towards a theoretical understanding of how group clinics work
The team began by examining explicit pre-existing theory relating to the group clinic/SMA/GMV approach.
This not only provides a backdrop against which the systematic reviews, randomised controlled trials (RCTs)
and qualitative research studies may be considered but also acts as preparation for the subsequent realist
synthesis phase (see Chapter 3, Realist synthesis).
The review team’s initial conceptual framework centred on four principal drivers for the group clinic model:
1. perceived and actual benefits and disadvantages of a group consultation when compared with an
individual consultation
2. the value of group education
3. the value of synchronicity of clinical and group activities
4. the value of multiprofessional approaches resulting from simultaneous clinical involvement.
A conceptual model of group medical appointments
In order to initiate thinking around the elements of group clinics the team accessed a conceptual framework
from the Cochrane GMA protocol21 (Table 2). This identified key structural elements for consideration within
any group clinic-based intervention. This conceptual framework helped to identify key differences with regard
to the intensity of the intervention (number of GMAs × frequency interval × duration) plus the qualitative
consideration of the number of patients per GMA (and by implication the staff-to-patient ratio). The issue of
continuity helped to distinguish between drop-in type appointments, those with a cohort of members
progressing together and those with more fluid membership. Linked to this is the issue of heterogeneity as
explored in issues relating to age, gender, ethnicity and experience of the condition. As our review addresses
only chronic conditions, the chronic versus non-chronic was not pertinent except in considering why chronic
diseases might be more amenable to a group clinic approach. The children/adults/elderly distinction served as
a reminder that, typically for children and adolescents and occasionally for adults and older people, the
perspective of family members (e.g. parents or carers) may be an additional factor in assessing the
acceptability of group clinics. Finally, the team considerations from the Cochrane GMA conceptual framework
highlight the requirement for group facilitation and team training as a resource issue.
High-level theory relating to social support
In order to bridge the often-reported dislocation of empirical intervention studies from their underlying or
implicit theory, we conducted a brief literature survey to identify the prevalence of high-level theory in
relation to group clinics. Particularly influential high-level theories reflected in the published accounts
included social cognitive theory, social comparison theory, social learning theory24 and social support
theory (Table 3). In addition, from the perspective of staff delivering the intervention, SMAs may access
theories in relation to shared learning and interprofessional working.27 When introducing group clinics,
therefore, attention should be directed to the impact of the programme on staff interaction and
interprofessional learning.
TABLE 2 Conceptual framework for GMAs (from the Cochrane GMA protocol)21
Design Patient group Team
Number of GMA offered Continuity vs. non-continuity Type of clinician
Time between successive GMA Heterogeneous vs. homogeneous Presence of group facilitator
Duration of GMA Chronic vs. non-chronic Training of team
Number of patients per GMA Children, adults, elderly
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Theory relating to group interventions
Hoddinott et al. offer a useful generic framework against which to examine group interventions.26
Interventions delivered to patient groups are addressed by their framework, which includes:
l the place, setting and context of the intervention
l the design of the intervention, the theory underlying the choice of intervention, the target population
and choosing the relevant behavioural outcome to measure
l membership of the group
l how the group will influence people
l intended health outcomes and target populations
l what happens within the group.
Theory relating to chronic disease self-management
Theories relating to the core components of chronic disease self-management, namely the tasks of
medical, role and emotional management,28 are particularly pertinent to the operation of group clinic
approaches. These are highlighted in the rapid review, A rapid synthesis of the evidence on interventions
supporting self management for people with long-term conditions, commissioned by the Health Services
and Delivery Research (HSDR) programme.29 In their review the authors29 highlight the key role of
self-efficacy in relation to self-management behaviours.30 This resonates with Knowles’ theory of
andragogy, cited in the trial by Yehle et al.,31 which proposes that adults are self-directed and that they
expect to take responsibility for decisions.
Lorig and Holman32 identify five core self-management skills which can be seen to be accessed within a
group clinic approach: (1) problem-solving; (2) decision-making; (3) appropriate resource utilisation;
(4) forming a partnership with a healthcare provider; and (5) taking necessary actions. The standard group
clinic format may be seen as an opportunity for the clinician and patient to harness all of these skills as
targeted by individual components of the intervention.
TABLE 3 Theories relevant to group clinic interventions
Theory Brief explanation
Patient
Social cognitive theory Highlights importance of self efficacy – the belief of an individual that they are able to
achieve something such as a change in health behaviour, including self management25
Social comparison theory Proposes that ‘conformity within a group is dependent on three main motivations:
(1) dependence on others for information to self-evaluate; (2) achieving group goals and
the need for approval; and (3) a desire not to seem different’26
Social learning theory Emphasises ‘learning through observation and modelling behaviour’ and is particularly
relevant to ‘behaviours involving action or performing’26
Social support theory Proposes that ‘information is disseminated more effectively between networks of people
with strong social ties and this confers health benefits’26
Staff
Social identity theory Argues that the social group to which someone belongs at times determines both
relationships and interactions between individuals. May result in changed perceptions and
challenge of stereotypes27
Social practice theory Highlights the importance of situated learning and practice on identity and includes an
enhanced appreciation for the perspective of others27
BACKGROUND
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Theory relating to monitoring
Finally, as highlighted by Taylor et al.,29 we can better understand the role of regular group clinic meetings
by examining the complementary and evolving roles of periodic professional reviews and ongoing patient
self-monitoring.33 Group clinics could be conceived as a forum for juxtaposing, bringing these two roles
in a potentially helpful synergy.
A symbolic role for group clinics?
Group clinic approaches may also fulfil a symbolic or emblematic role by instilling in the patients a hope
and belief in the treatments being offered.34 Social interchange in a group setting may emphasise the
universality of the condition along with recognition that one is not alone in suffering or healing.
Instrumentally, the group clinic setting offers an opportunity both to impart information through
instruction or dialogue and to clarify any distorted or misleading information.34 A sense of community may
develop over time, with individuals beginning to display altruism and to derive a sense of usefulness from
contributing to the group.
The group may provide patients with potential role models in the form of other group members who are
better able to manage their condition and, thus, to function more effectively.34 This may in turn stimulate
imitative behaviour. Socialisation may offer potential catharsis through sharing and the destigmatising of
chronic medical conditions as well as fulfilling a more pragmatic role as a source of direct advice and the
sharing of coping strategies.34 As a forum for interpersonal learning the group may encourage the sharing
of experiences with others and problem-solving as a group. These resources may be more plentiful and
more creative than may be offered by an individual clinician with no direct experience of living with a
chronic condition. Peer pressure, in its positive sense and as an antidote to the unequal clinician–patient
relationship, may encourage patients to become more empowered and, thus, more involved in their care.34
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Chapter 2 Review methods
This systematic review was conducted within an abbreviated (7-month) time scale and, therefore, did notattempt to identify all relevant evidence or to search exhaustively for all evidence that met the inclusion
criteria; instead, the search approach sought to identify the key evidence of most relevance to the review
question by focusing on RCT designs. Relevance may be interpreted in multiple ways; in this particular
context we sought to address a narrow and tightly defined question, as captured by an appropriate
population–intervention–comparison–outcome (PICO) formulation. The PICO formulation is an accepted
mechanism used in systematic reviews to frame a review question about an intervention programme, in this
case group clinic approaches.35 Outlining inclusion and exclusion criteria in terms of the PICO format helps
to operationalise systematic and consistent approaches to selection of items for inclusion independent of
either the direction or nature of results or factors empirically known to influence the direction or
interpretation of results (e.g. sample size, funding source, etc.).
For logistic reasons this review examined the evidence through the ‘lens’ of evidence from existing
systematic reviews and RCTs. Data extraction and quality assessment was performed on the RCTs and
interventions demonstrated as actually, or potentially, effective were then investigated in further detail with
regard to feasibility, acceptability, meaningfulness and cost-effectiveness. In addition, where gaps in the
RCT evidence were specifically identified, we examined indicative evidence from qualitative research and
cost studies to indicate the extent to which candidate interventions were likely to be feasible, appropriate
and meaningful if subsequently demonstrated to be effective by future trial evidence.
Protocol development
The protocol for the review was developed iteratively between the School for Health and Related Research
(ScHARR) and the National Institute for Health Research HSDR programme. A copy of the study protocol
is available on the project website (see www.nets.nihr.ac.uk/projects/hsdr/130512).
Literature searching
The review incorporated a range of search methods, as outlined below, to identify evidence to address the
review research questions:
l stage 1 – search for reviews on group clinics
l stage 2 – search of health and medical databases
l stage 3 – search for qualitative studies
l stage 4 – search for cost studies
l stage 5 – search for UK studies.
The search process was undertaken with reference to the protocol.
Stage 1: search for reviews on group clinics
Our initial approach was to scope the literature around group clinics by searching for recent relevant
reviews. All studies included in reviews were then scrutinised for inclusion in the review. Relevant terms for
the search were found during the scoping exercise. Systematic reviews were identified from the following
sources: PubMed Clinical Queries, Epistemonikos (Santiago, Chile; www.epistemonikos.org/), The
Cochrane Library, Database of Abstracts of Reviews of Effects (DARE) and Google Scholar (GoogleTM,
Mountain View, CA, USA; https://scholar.google.co.uk), combining ‘systematic review’ with terms relating
to group clinics, SMAs, etc. (see Appendix 2).
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Stage 2: search of health and medical databases
The search strategy used a combination of free text and medical subject headings (MeSHs) and can be
found in Appendix 2.
We searched MEDLINE and EMBASE via OVID SP, Cochrane Library via Wiley Interscience, Web of Science
via Web of Knowledge and Cumulative Index to Nursing and Allied Health Literature (CINAHL) via
EBSCOhost. MEDLINE, EMBASE, CINAHL and The Cochrane Library are commonly considered the core
databases for identifying evidence relating to clinical topics.
The search strategy was limited to 1999–2014. Bibliometric analysis identified the sudden appearance of
group visit studies at around 2000. Evidence was included if it was published between 1999 and 2014 and
written in English.
The search results were downloaded into Reference Manager version 12 (Thomson ResearchSoft,
San Francisco, CA, USA) where duplicates were removed before sifting for inclusion in the review
was undertaken.
Stage 3: search for qualitative studies
A three-part search strategy was used to identify papers reporting qualitative research, as follows:
l Stage 1 – during screening and data extraction, any papers that were relevant and included qualitative
data were tagged accordingly in Reference Manager.
l Stage 2 – a search of our Reference Manager database for relevant studies was undertaken using the
keywords ‘qualitative’, ‘interview*’ or ‘findings’ in the title and abstract of the records. These terms
have been found to have acceptable sensitivity for retrieval of qualitative research.36,37
l Stage 3 – cited records for all included trials were searched on Google Scholar using the keywords
‘qualitative’, ‘interview*’ or ‘findings’ using the ‘search within citing articles’ check-box function. This
would enable the retrieval of ‘sibling’ studies associated with the trials as well as more distant ‘kinship’
studies citing those trials for reasons of topical relevance.38
Stage 4: search for costs studies
Three separate methods were used to identify studies for the assessment of costs and feasibility,
as follows:
l Stage 1 – during screening and data extraction, any papers that were relevant and included costs data
were tagged accordingly in Reference Manager.
l Stage 2 – a search of our Reference Manager database for the study was undertaken using the
keywords cost*, economic*, charg*, expens*, reimburse* in the title and abstract of the records.
l Stage 3 – a targeted search of MEDLINE and EMBASE was undertaken, with no date or language
restrictions, using the following search strategy: ((((shared or group) adj medical adj (visit or
appointment or clinic or care)) OR (group adj (visit or appointment or clinic or care))) AND
(economic* or cost* or charg* or expens* or reimburs*)).ti,ab.
Stage 5: search for UK studies
Studies conducted in the UK were identified in two ways:
1. Geographical terms for ‘united kingdom’, ‘uk’, ‘britain’, ‘England’, ‘Scotland’, Wales, Ireland were used
to retrieve records from the Reference Manager database.
2. Similarly, geographical terms for ‘united kingdom’, ‘uk’, ‘britain’, ‘England’, ‘Scotland’, Wales, Ireland
were used to retrieve items from Google Scholar in conjunction with the most common terms used
for the intervention, that is, ‘shared medical appointments’, ‘group medical clinic’, ‘group medical visit’
and ‘group visit’. This search approach harnessed full-text retrieval and so added value over the
title-and-abstract-based approach listed above.
REVIEW METHODS
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Sifting
References identified from stages 1 and 2 were downloaded into Reference Manager to be sifted for
inclusion in the review. A total of 4176 of the potential titles were examined for inclusion by one reviewer.
Any titles that did not meet the inclusion criteria were excluded. Following the title sift, any remaining
references were scrutinised at abstract level. For any references where possible inclusion was unclear, a
second reviewer independently examined the corresponding full text.
Progressive fractions method
Following the sifting of 4176 titles and abstracts a further 1212 search results were scrutinised using a
method of ‘progressive fractions’. Progressive fractions is a method developed in-house by the ScHARR
team for undertaking systematic reviews within a time-constrained period. Essentially, it involves
conducting a sensitive search strategy in order to populate a project reference management database.
This database then becomes the data set that is progressively ‘mined’ for articles for potential inclusion.
Essentially, titles and abstracts are reviewed in decreasing relevance order until no further unique relevant
references are retrieved. This method also minimises the likelihood of relevant references being missed
through being submerged by excessive quantities of irrelevant noise (Table 4).
Instead of the ‘big bang’ approach that typifies systematic review methods and which conflates terms of
low specificity alongside terms of high specificity, the progressive fractions method involves using single
string strategies (e.g. ‘group medical visit*’) in decreasing likelihood of unique retrieval, with the team
evaluating retrieval results at each point. As each progressive fraction is executed attention is focused on
the identification of unique results. When an additional relevant reference is retrieved this yields additional
search terms. Quantitative results for the new search terms are used to evaluate whether or not it will be
time effective to sift new results, taking into account the number of relevant studies already identified by
the combined search strategy and the number of additional records to be sifted. Progressive fractions
allows a review team to make iterative and informed judgements about the optimal sensitivity for a
systematic review search. After precise search terms were used we had scanned 11% of our sensitive
database and retrieved 89.7% of our randomised trials. The remaining four trial citations were identified
by citation searching and checking existing systematic reviews. The same precise search sets were also
scanned for qualitative studies.
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Inclusion/exclusion criteria
The inclusion of studies in the review was as according to Table 5.
Setting of intervention
Interventions are not initially excluded on the basis of the setting for the group intervention, given the
potential for very similar interventions to be delivered in the community or primary care setting as well as
in hospital/outpatient settings. Although the review team has justifiable concerns about the additional
literature likely to be identified if group approaches in primary care are included within the review scope
we cannot identify a sound justification for excluding such studies on conceptual grounds particularly
given that the setting for interventions and definitions of ‘specialist’ care may cover a wide range of
different settings.
TABLE 5 Inclusion and exclusion criteria
Criteria Inclusion Exclusion
Population Adults and/or children receiving health-care
services for one or more chronic health
condition
Group visits for healthy patient groups (i.e. those
without an indication related to a chronic health
condition) This exclusion covers:
1. pregnant women or those planning a
pregnancy (unless they also have a chronic
health condition such as diabetes)
2. smoking cessation and other health
promotion clinics
Intervention Delivery of one or more services to a small
group of patients (typically 8–10 patients)
simultaneously. Only studies including the
delivery of the intervention by one or more
specialist health-care professionals met the
inclusion criteria of the review
Delivery of intervention by peers or non-specialist
health-care professionals: we also exclude
peer-facilitated support groups as the intervention
is not principally delivered by health-care
professionals (although they may contribute)
Outcome Patient outcomes; health services outcomes;
patient and carer satisfaction; resource use
Comparison Other methods of organisation of treatment
(with the exception of qualitative research and
surveys, only studies with a comparator group
are included)
Date Cut-off date limit of 1999–2014 was applied
in recognition of the distribution of the
literature as identified from the scoping
searches (see above)
Language Only studies written in English were included
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Data extraction including development of the data
extraction tool
Formal data extraction was employed for all included systematic reviews, RCTs and qualitative studies. Data
extraction was undertaken by one of three reviewers (AB, AC and LP). Owing to the time constraints of the
review a model of single data extraction with verification by a second reviewer was used for all included
studies (see Chapter 6, Strengths and limitations of this review). Empirical evidence demonstrates that single
data extraction results in an acceptably low rate of additional errors, when compared with optimal double
data extraction. In particular, the likelihood of error relating to primary outcomes, as opposed to minor data
inconsistencies, has been found to be low.39
A standardised data extraction form was designed using Google Forms to capture relevant information
from the studies on a broad range of factors related to group clinics and their outcomes. The form
was piloted by all three reviewers and then minor changes were made before full data extraction was
undertaken. The output from Google Forms (Google Inc., Mountain View, CA, USA) was imported into
Microsoft Excel® (Microsoft Corporation, Redmond, WA, USA) to facilitate manipulation and production
of tables.
For literature that made a conceptual contribution a method known as best-fit framework synthesis40,41
was used, which involved extraction of data against a pre-existing framework. Any data not explained by
the initial framework were then coded inductively. We identified a framework from a review entitled
Group Visits Focusing on Education for the Management of Chronic Conditions in Adults: A Systematic
Review.42 This review was intended as a ‘companion piece’ to a SMA review conducted by the Durham
Evidence-based Synthesis Program led by Edelman.18 The SMA review focuses on visits led by a physician
or other prescribing provider during which individual-level changes in management plan can be made and,
thus, fully corresponds to the scope of our own review. In contrast the review from which we derived the
best-fit framework ‘focuses exclusively on literature that tests the effectiveness of group visits that have an
emphasis on health education and are led by facilitators, including but not limited to non-prescribing
health professionals such as nurses, dietitians, and physical therapists’.42 Nevertheless, it fulfils the forgiving
selection criterion for identifying a conceptual framework as specified by the ‘best fit’ method. A sample
data extraction form is available in Appendix 3. Cost data were extracted into a separate purpose-created
Microsoft Word® (Microsoft Corporation, Redmond, WA, USA) document.
Quality assessment
Systematic reviews
Systematic reviews were appraised using the guidelines employed by the Centre for Reviews and
Dissemination (CRD) when populating their DARE.43 This method was employed to ensure consistency of
approach between our assessments and existing assessments of published reviews.
Randomised controlled trials
Randomised controlled trials were formally assessed for quality using questions from the Critical Appraisal
Skills Programme (CASP) checklist 11 questions to help you make sense of a trial44 in order to explore
study limitations qualitatively and the Cochrane risk of bias tables in order to identify likely sources of
bias.45 Assessment of the limitations of included studies was also undertaken using the limitations reported
by study authors in the included studies.
Qualitative research
Qualitative studies were formally assessed for quality using questions from the CASP 10 questions to help
you make sense of qualitative research checklist.46 Surveys were not formally appraised and, therefore,
were used only to validate findings from qualitative research.
REVIEW METHODS
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Costs
We undertook an assessment of relevance of evidence to the study objectives by answering three
questions about each paper: the currency of the data, the quality of the data sources and the relevance to
a UK setting.
UK initiatives
Research studies reporting UK initiatives were not formally assessed given the heterogeneity of study types,
making comparability problematic. Nevertheless, all reports of initiatives were reviewed for any identifiable
or acknowledged limitations.
Synthesis
Data were extracted and tabulated. This tabulation was used to inform the narrative synthesis in
Chapter 3. There was no attempt to synthesise quantitative data through formal meta-analysis, given the
heterogeneity of disease conditions and models of service delivery for group clinics. However, where
previous review teams had attempted to undertake meta-analysis these analyses were used as a frame of
reference when assessing the likely contribution of newly appeared evidence. The review provides an
analysis of the quality of evidence and the strength of conclusions that can be drawn from existing studies.
Involvement of clinical advisers
As it emerged that there were no trials from a UK context, and the UK studies correspondingly lacked
rigour, the review team identified a need to access contextual data to aid translation to a NHS context.
The review was not resourced to conduct a rigorous consensus process, nor were there sufficient numbers
and diversity of informants. The clinical advisers were selected on the basis of their knowledge of group
approaches within a diabetes context (the most frequently researched condition) or because of their
experience of running group clinic approaches.
It was recognised that this was neither a representative nor a valid sample. The review team, therefore,
put in place various protections to ensure that the review findings were not overly influenced by these
otherwise valuable clinical opinions. Clinical advisers were presented with a summary of the review
findings and so had no influence on the selection of studies or outcomes. Their comments were elicited
around a series of prespecified questions independently identified by the review team. In this way their
contribution was ‘ring-fenced’ from overly influencing the review but was considered invaluable,
particularly given the absence of ‘hard’ data relevant to the UK.
Five potential informants were initially identified: three from a group clinic setting and two from diabetes.
Owing to resource and timing constraints only four informants were interviewed (via telephone and/or
e-mail). These constituted two representing diabetes and two from group clinic approaches.
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Chapter 3 Results
Overview of studies included in the review
This review comprises six principal components informed by five different types of data (Table 6). The
realist synthesis was populated by data from the systematic reviews, RCTs, qualitative studies and UK
initiatives. Figure 1 shows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) flow chart for all included studies.
Systematic reviews
Literature searches retrieved 13 systematic reviews and one review protocol. This evidence was reviewed in
Results of the review of reviews.
Randomised controlled trials
We retrieved 32 papers representing 22 different RCTs. These trials are reviewed in Results of the review
of effectiveness.
Qualitative studies and surveys
We identified 12 qualitative papers reporting 10 different qualitative studies. In addition, we identified four
surveys that were used to triangulate qualitative research findings. These qualitative studies and surveys are
explored in Results of the qualitative synthesis.
TABLE 6 Summary of included studies
Study type Number of papers Number of studies Other items
Systematic reviews 13 13 One review protocol
RCTs 32 22
Qualitative studies 12 10
Surveys 4 4
UK initiatives 15 12 Conference abstracts
Cost studies 8 8
Total 82 69
Realist synthesis includes four study
types (excluding surveys and cost
studies) above
84 57
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UK initiatives
We identified 15 papers reporting 12 UK group clinic initiatives. This review of current practice is examined
in Results of the review of UK evidence.
Realist synthesis
Data from the 13 systematic reviews, 22 different RCTs, 10 qualitative studies and 12 UK initiatives (a total
of 75 papers) were used to inform Chapter 4.
Cost studies
We identified eight cost studies either nested within RCTs or reported as separate cost-effectiveness or
cost–utilisation analyses. These cost studies are analysed in Chapter 5.
From Table 7 it can be seen that group clinics is the most frequently mentioned model, in 19 of the
84 papers. Other frequently used labels are SMAs (n= 12) and CHCCs (n= 10). A further nine labels are
used in the 84 papers included in this review, with even greater variation in the non-empirical literature.
Records identified through
database searches
(n = 12,819 )
Records screened (n = 4176) plus
progressive fractions approach (n = 1212)
Total = 5388
Full-text articles assessed for eligibility
(n = 132)
Included: 13 systematic reviews; 32 RCT papers,
12 qualitative papers, 4 surveys, 8 cost studies
and 15 UK papers (84 papers)
Records excluded
(n = 5256)
Studies included in narrative synthesis
(n = 69 studies)
Studies included in quantitative synthesis
(n = 22 trials, 32 papers)
Additional records identified through
searches for relevant systematic reviews
(n = 60)
Records after duplicates removed
(n = 11,000 )
Full-text articles excluded,
with reasons
(n = 48)
• Not RCT, n = 31
• Intervention, education only, n = 4
• Unable to obtain paper, n = 3
• Intervention, no clinician 
   involvement, n = 2
• Intervention, not patient care, n = 2
• RCT protocol, n = 2
• Methods paper, n = 1
• Article in other language, n = 1
• Precedes inclusion date, n = 1
• Not original study, evidence
   digest, n = 1
FIGURE 1 The PRISMA flow chart for all included studies.
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Results of the review of reviews
The team started by identifying existing reviews that had examined aspects of the review question. No
single existing review offered a complete match to the scope covered by this systematic review. Reasons
for this were that the review focused on a single condition, the review included only RCT evidence, the
review included general group care, the review included group education, etc. A summary of the congruity
of this review with other published reviews is given below.
A total of 13 reviews involving a total of 92 trials (including duplicates) were identified for inclusion in the
review (Table 8). No unpublished relevant reviews were obtained. However, we identified one review
protocol for a Cochrane review in progress.21
Table 8 shows coverage of studies by the existing reviews. The main contribution of our review would be
to provide unique coverage of trials published over the period 2012–14. Ultimately we would be including
32 papers, whereas the previous most comprehensive review covered either 18 papers through secondary
analysis or 16 studies in primary analysis (see Table 8).
Review characteristics and review strategy
As a precursor to our own review of group clinics the review team identified 13 reviews that either
matched or overlapped the scope of the planned review. Another review, The effectiveness of group visits
for patients with heart failure on knowledge, quality of life, self-care, and readmissions: a systematic
review,54 is available only on private subscription from the Joanna Briggs Institute Library and so a
summary, commissioned on request from the CRD, was used in assessing the evidence. One Cochrane
review entitled Group medical appointments for people with physical illness is currently in progress.21
TABLE 7 Models of group clinics as represented by the retrieved literature
Model
Effectiveness review
Qualitative
review
Economic
studies UK studies
Total
papers
Number
of studies
Number
of papers
Number
of papers
Number
of papers
Number
of studies
Number
of papers
Group clinic 3 5 2 1 9 11 19
SMA 5 6 5 0 1 1 12
CHCC model 6 10 0 0 0 0 10
GMV 3 4 4 1 0 0 9
Group visit 3 5 0 4 0 0 9
DIGMA 0 0 2 1 0 0 3
Chronic care clinic 1 1 0 1 0 0 2
Group medical
appointment
0 0 2 0 0 0 2
Cluster visit 1 1 0 0 0 0 1
Shared medical visit 1 1 0 0 0 0 1
Specialty CHCC model 0 0 0 0 0 0 0
Other models 1 1 0 0 1 1 2
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Characteristics of previous reviews
An initial task was to seek to characterise existing reviews in terms of their congruity, or otherwise, with
regard to the population-intervention-study type elements. In Table 9 total congruity with a particular
element is indicated by a +++ notation. Close congruity is correspondingly indicated by ++, while a
narrow specific focus is assigned a + notation. In this way, the key reviews with the greatest potential to
inform our review question are clearly identified.
Only one18 of the 13 reviews was congruous with our review when matched against both population and
intervention (see Table 9). We therefore decided to undertake our review as a more comprehensive update
of this systematic review by Edelman et al.18 Three further reviews55,57,83 articulated the intervention of
interest to our review (although they did not employ the precise terminology of ‘group clinics’) but in only
one specific disease/condition. We therefore decided to prioritise these three reviews as sources of
potential studies for inclusion. The remaining reviews would be checked for their coverage of included
studies and for suggestions of further studies for inclusion.
TABLE 9 Relationship between existing reviews and this review
Review (date) Population Intervention Included study types
Deakin et al.
(2005)47
Type 2 DM (narrow) + Group-based self-management
education +
RCTs
Jaber et al. (2006)48 All populations (broad) ++ Group visits (broad) ++ Research studies
Brennan et al.
(2010)50
Chronic-disease
management in adults
(narrow) ++
Group visits (broad) ++ RCTs and other experimental
designs
Riley and Marshall
(2010)49
Diabetes care (narrow) + Group visits (broad) ++ Review articles and original
research articles
Burke et al.
(2011)87,88
Diabetes care (narrow) + GMV +++ RCTs and quasi-experimental
studies
Edelman et al.
(2012)18
Chronic medical conditions
+++
SMAs +++ RCTs and observational studies
Quiñones et al.
(2012)42
Chronic disease management
in adults (narrow) ++
Group visits focusing on
education (narrow) +
RCTs
Steinsbekk et al.
(2012)51
Type 2 DM (narrow) + Group-based self-management
education +
RCTs
CADTH (2013)52 Chronic disease
management +++
Group care (broad) + Health technology assessments,
systematic reviews, meta-analyses,
RCTs, non-randomised studies,
economic studies and guidelines
Housden et al.
(2013)53
DM + GMV +++ RCTs and observational studies
Slyer and Ferrara
(2013)54
Heart failure + Group visits ++ RCTs, non-RCTs, and quasi-
experimental trials. Qualitative
study designs also considered
Edelman et al.
(2014)55
DM + SMAs +++ RCTs and observational studies
Rolfe et al. (2014)56 All populations +++ Interventions for improving
patients’ trust in doctors and
groups of doctors +
RCTs
CADTH, Canadian Agency for Drugs and Technologies in Health; DM, diabetes mellitus.
+++ represents congruity of a review with this review, ++ represents a partial match and + indicates a significant
departure from our scope. An exact match of scope would, therefore, be represented by +++/+++, representing congruity
of both population and intervention.
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Populations
Two of the included reviews48,56 examined all populations, resulting in a focus wider than that determined for
this review. A further seven reviews47,49,51,53–55,87 focused on one specific condition [in all bar one instance this
condition was diabetes, with the exception being the review by Slyer and Ferrara54 (heart failure)]. Two of
the remaining reviews42,50 were broadly coterminous with our own review, focusing on chronic disease in
adults (however, we also included children and adolescents). Only two reviews18,52 covered the exact same
population as our review, namely patients of any age group with chronic disease/chronic medical conditions.
Interventions
Three reviews demonstrated a specific group education focus.42,47,51 A further five reviews had a scope for
the intervention that was broader than group clinics: for four of these reviews48–50,54 this focus was labelled
‘group visits’ and for the remaining review52 this was ‘group care’. Two reviews18,55 focused on SMAs and
two reviews targeted GMVs;53,57 both of these labels were considered coterminous with our own. The
Cochrane review by Rolfe et al. covered a heterogeneous mix of interventions for improving patient trust,
one intervention of which was a group clinic approach.56
This important review-mapping phase has established the potential of our review to provide the most
comprehensive and most up-to-date coverage of the topic of group clinics for chronic medical conditions
to be found in the published literature.
Review quality
In addition to mapping all 13 of the existing reviews against the population, intervention and study type
characteristics (see Table 9), we explored reasons for a mismatch between our review question and that in
other reviews (Table 10). We then decided to produce a brief summary of the quality of the four key
reviews18,83,85,87 in order to assess any uncertainties underpinning their results (Table 11).
Findings from four key reviews
Edelman et al.18 (+++/+++)
In a review of 19 papers (including 15 RCTs), Edelman et al. investigated the effects of SMAs on a variety
of clinical and health service outcomes.18 Thirteen trials investigated diabetes mellitus and two trials
evaluated group clinic interventions for older adults with high utilisation of health services.
Diabetes
Of the 13 RCTs evaluating clinical outcomes for patients with diabetes, 10 examined type 2 diabetes only,
one examined type 1 diabetes only and two examined a mixed-patient population. The authors detected
statistically significant changes for glycated haemoglobin A1c (HbA1c) and systolic blood pressure (five
studies). However, effects varied significantly across studies and this was not explained by study quality.
Effects on hospital admissions and emergency department visits were explored in five studies. These
showed substantial variation; in three of these, admission rates were lower with SMAs, but the result was
statistically significant in only one study. Two studies found emergency department visits decreased
significantly with SMAs. Four studies reported effects on total costs, but results were mixed. In one, total
costs were significantly higher; in another, total costs were significantly lower; in a third, results did not
differ significantly; and the fourth was conducted in Europe.
Older adults
Edelman et al. retrieved three studies (two trials and one observational study) that evaluated the effects of
group clinic approaches on older adults with high health-care service utilisation rates.18 All studies reported
positive effects on patient experience with SMAs, compared with usual care. Both trials reported effects on
overall health status and functional status, but there was no difference compared with usual care for either of
these measures. Biophysical outcomes were not reported. All three studies showed fewer hospital admissions
in the SMA groups, and both trials reported a statistically significant decrease in emergency department visits
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with SMAs, compared with usual care. Total costs also were lower for the SMA group in each study but
varied substantially across studies. In no study did the difference in total costs reach statistical significance.
Owing to limitations in reporting, Edelman et al.18 were unable to establish whether or not any specific
patient characteristics might lead to a better response to SMAs. Furthermore, the review team evaluated
whether or not baseline HbA1c was associated with response to SMAs: it was not. None of the studies
permitted the team to identify specific intervention components, or intensity, associated with the effects of
SMAs. Exploration of whether or not robustness was associated with effect size demonstrated that it was
not. Edelman et al. concluded that the evidence synthesis had found no data to assess cost-effectiveness,
and there was no definitive evidence of non-patient benefits, such as improved access or staff
satisfaction.18 The review team were unable to isolate key elements to successful implementation.
They observed that the studies were unrepresentative of a ‘real world setting’, in that the research was
conducted either within academic health systems or in independent clinical units that lacked dependencies
on other clinical units (i.e. these were ‘vertically integrated systems’), as would be more typically be the
case in a non-experimental environment.
Burke et al.87,88 (+/+++)
Burke et al.’s review of 11 RCTs and four quasi-experimental trials (2240 patients), performed for the
Joanna Briggs Institute, found clear benefits of GMV for patients’ HbA1c levels, which are consistent in the
effect sizes for post intervention and for change from baseline.87 The most significant effect observed is
with the change from baseline results. Some evidence suggests post-intervention and change from
baseline systolic blood pressure improvement at the 9- to 12-month interval and change from baseline
improvement at the 4-year time point. The review found no evidence that group visits improve low-density
lipoprotein (LDL) cholesterol values of GMV participants. The review concluded that ‘GMVs should be
considered by clinicians as an effective non-pharmacologic intervention that can have a positive impact on
biologic markers such as glycated haemoglobin A1c (HbA1c) and systolic blood pressure’.87
Housden et al.53 (+/+++)
In a review of 26 studies including 13 RCTs, Housden et al.53 reported a positive effect for GMAs on
clinical and patient-reported outcomes, with significant reductions in HbA1c. However, the team were
unable to assess the effect of GMVs on processes of care because of an insufficient number of RCTs
reporting this outcome.
Edelman et al.55 (+/+++)
In the most recent review identified for this project, Edelman et al.55 identified 25 articles representing
17 unique studies that compared SMA interventions for diabetes with usual care. They reported that SMAs
improved HbA1c, improved systolic blood pressure and did not improve LDL cholesterol. Non-biophysical
outcomes, including economic outcomes, were reported too infrequently to meta-analyse. This meant that
it was not possible to draw conclusions for non-biophysical outcomes. The HbA1c result revealed significant
heterogeneity among studies, likely to be secondary to the heterogeneity among included SMA interventions.
Summary of findings from other reviews
The Canadian Agency for Drugs and Technologies in Health (CADTH) health technology assessment
group52 conducted a review of the clinical effectiveness, cost-effectiveness and guidelines of group care
across all aspects of chronic-disease management. They identified eight studies meeting the criteria for
inclusion in their review: three systematic reviews, two RCTs, two non-randomised studies and one
evidence-based guideline. They concluded that there was evidence for improved glycaemic control for
diabetes group care (vs. usual care) and an isolated study in favour of better blood pressure control
for group care of hypertension. However, they had been unable to find any information on effectiveness
of group care for either chronic obstructive pulmonary disease (COPD) or human immunodeficiency virus
(HIV)/acquired immunodeficiency syndrome (AIDS). A significant observation related to the fact that
variations in the structure of group care, together with inadequate detail of reporting for the usual care,
meant that the group felt unable to draw meaningful conclusions.
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Steinsbekk et al.51 reviewed 21 studies, reported in 26 publications, involving a total of 2833 participants.
For the main clinical outcomes, HbA1c was significantly reduced at 6 months, 12 months and 2 years, and
fasting blood glucose levels were also significantly reduced at 12 months but not at 6 months. For the
main lifestyle outcomes, diabetes knowledge was improved significantly at 6 months, 12 months and
2 years and self-management skills also improved significantly at 6 months. For the main psychosocial
outcomes there were significant improvements for empowerment/self-efficacy after 6 months. For quality
of life the authors were unable to draw any conclusion owing to high heterogeneity. For the secondary
outcomes there were significant improvements in patient satisfaction and body weight at 12 months for
the intervention group. The review team found no differences between the groups in mortality rate,
body mass index (BMI) blood pressure and lipid profile.
In a Cochrane review of group based education for diabetes, Deakin et al.47 identified eight RCTs
(n= 1260) and three observational studies (n= 272). Random-effects meta-analyses showed that HbA1c
and fasting glucose concentrations were lower in the intervention group than in the control group
{at 4–6 months [1.4%, 95% confidence interval (CI) 0.8% to 1.9%; p< 0.00001], at 12–14 months
(0.8%, 95% CI 0.7% to 1.0%; p< 0.00001) and at 2 years (1.0%, 95% CI 0.5% to 1.4%; p< 0.00001)}.
Diabetes knowledge scores were greater in the intervention group than in the control group (standardised
mean difference 0.95, 95% CI 0.72 to 1.18) (three trials, n= 432), yet not statistically significantly so.
More patients in the intervention group than in the control group reduced their use of diabetes medication
over 12–14 months (relative benefit increase 825%, 95% CI 202% to 2738%) (five trials, n= 654). One
RCT (n= 314) assessing empowerment and psychosocial self-efficacy reported greater total empowerment
scores in the intervention group than in the control group throughout follow-up (p< 0.05). This indicates
that the group education element of the group clinic intervention may, in itself, be efficacious. A key
issue is the added benefit, if any, that is accrued from employing other supplemental non-group
education-based features of the intervention within a group clinic framework.
Two reviews fall short of current practice for systematic reviews. In a narrative review without meta-analysis,
Jaber et al.48 concluded that there are sufficient data to support the effectiveness of group visits in improving
patient and physician satisfaction, quality of care and quality of life, and in decreasing emergency department
and specialist visits. Significantly, Jaber et al. highlighted a need to abandon old nomenclatures and to clearly
define the structure, processes of care, content of visits and appropriate outcome measures.48
Riley and Marshall49 produced a review of existing reviews including three general reviews8,22,89 as well as
the previously mentioned specific review by Jaber et al.48 They observed that, although ‘a variety of
successes are evident from the entire group visit approach, results are inconclusive regarding any specific
model for group visits and inconsistent regarding improvement of important patient outcomes’.49
Nevertheless, Riley and Marshall concluded that there was evidence that ‘group visits may reduce costs,
physiological outcomes may be improved, and patient and clinician satisfaction may be enhanced’.49 They
cautioned, however, that ‘The group visit model needs further testing to determine the most effective
approach, and the most effective health care provider team to facilitate the group visit, along with
standardization and application across a variety of situations’.49
In a review tangentially related to the topic, looking at interventions for building up trust between patients
and clinicians, Rolfe et al.56 identified three studies that had a group visit component. However, one of
these studies was excluded from our review because it involved an induction visit as part of joining a
health maintenance organisation. The remaining two interventions were included. The focus on trust is,
however, important, as this represents one mechanism by which the group clinic interaction is
hypothesised to work.
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Overall summary of findings from reviews
All of the reviews of group clinic-type approaches exhibit methodological challenges with regard to the
inconsistent use of labels and definitions for the intervention and a lack of detail relating to the
intervention components. Mechanisms for action are poorly theorised, and variability in outcomes and in
subsequent effect sizes makes attribution of effect problematic. With the review team sensitised to the
topic via existing reviews, we attempted to examine the evidence base for effectiveness by bringing
together previously identified trials with new studies identified via sensitive search strategies.
Results of the review of effectiveness
Study characteristics
A total of 32 papers involving 22 trials were identified for inclusion in the review. The search of MEDLINE,
EMBASE, The Cochrane Library, Web of Science and CINAHL databases yielded a total of 12,819 citations.
After adjusting for duplicates, 11,000 remained. Of these, 5255 studies were discarded because after
reviewing the abstracts it appeared that these papers clearly did not meet the inclusion criteria. The full
text of the remaining 133 citations was examined in more detail, from which the 32 papers were selected
and included in the systematic review (Tables 12 and 13). No unpublished relevant studies were obtained.
No conference abstracts were identified that met our inclusion criteria and contained sufficient information
to address the review question.
Setting characteristics
Of the 22 trials, 17 were conducted in the USA.20,31,58,60,63–66,68,71,72,75–77,79,80,86 Of the remaining RCTs, two73,74
were conducted in the People’s Republic of China, two82,85 were conducted in Italy and one was
conducted in Norway.70 Not a single RCT was conducted in a UK setting.
Intervention characteristics
Included studies comprised a total of nine different interventions. Of these, the CHCC (six studies) and
SMA (five studies) models featured most frequently. SMAs were represented by trials that have occurred
during the comparatively recent period of 2010–14, while the CHCC studies occurred during the period
2001–4, with the exception of two recent non-US studies reflecting a resurgence of interest. There
were no RCTs for two of the models, the specialty CHCC model and DIGMAs (Table 14).
Intervention components
Edelman et al.18 has characterised the main features of SMA interventions. Almost 90% of such
interventions had an educational component and nearly 65% are delivered by multidisciplinary teams.
A behavioural intervention is a feature of exactly half of the SMA interventions. A focus on medicine
management is evidenced in the fact that 55% of interventions include medication adjustment. Almost
90% of interventions include peer-to-peer support and just over 40% include clinician training. We did not
find it possible to distinguish intervention content for studies not included by Edelman et al. from those
studies included in their review, implying that findings from their review are generalisable to a wider
population of group clinic approaches.18 As seen in Appendix 4, our review has completed a very detailed
data extraction of intervention components from RCTs. However, the facility to synthesise and analyse
these data is constrained by the fact that (1) these data capture the completeness of reporting of each
report, not the intervention content for that report, and (2) there is considerable variability in these
descriptions, implying that similar components may be described differently or, conversely, that similar-looking
descriptions may mask important substantive differences in content, delivery or both. Indeed, even different
reports of the same study portrayed different depictions of the same intervention. Notwithstanding
these reporting limitations, we found that some element of socialisation was included in 15 of the
studies57,60–62,65,66,68–70,73,74,76,77,79,81 and group discussion (i.e. many-to-many interaction) was reported in
14 studies.63,64,66,68,70,71,73–77,82,85,86 Eleven studies explicitly reported health education/information presentation(s)
by individual clinicians,57,60,65,66–68,70,71,73–75,79 with one for health education/information presentation(s) by
multiple clinicians63 and two for health education/information via booklet, leaflet or video.70,80 Seven studies
DOI: 10.3310/hsdr03460 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 46
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Booth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
33
TABLE 12 Study characteristics: RCTs
Study identifier Included papers Country
Study
design
Sample
size Number in IG
Number
in CG
CLANCY 2003 Clancy et al. (2003)58 USA RCT 120 59 61
Clancy et al. (2003)57
Clancy et al. (2003)59
CLANCY 2006 Clancy et al. (2007)60 USA RCT 186 96 90
Clancy et al. (2007)61
aClancy et al. (2008)62
COHEN 2011 Cohen et al. (2011)63 USA RCT 99 50 49
COLE 2013 Cole et al. (2013)64 USA RCT 65 34 31
COLEMAN 2001 Coleman et al. (2001)65 USA RCT 295 146 149
DORSEY 2011 bDorsey et al. (2011)68 USA RCT 58 15 patients and
14 caregivers
15 and 13
EDELMAN 2010 Crowley et al. (2014)66 USA RCT 239 133 106
Crowley et al. (2013)67
Edelman et al. (2010)69
GRAUE 2005 Graue et al. (2005)70 Norway RCT 116 62 54
GRIFFIN 2009 Griffin et al. (2009)71 USA RCT 153 45 108
GUTIERREZ 2011 Gutierrez et al. (2011)72 USA RCT 103 50 53
JUNLING 2015 Junling et al. (2015)73 The People’s
Republic of China
RCT 1346 692 654
LIU 2012 Liu et al. (2012)74 The People’s
Republic of China
RCT 208 119 89
NAIK 2011 Naik et al. (2011)75 USA RCT 87 45 42
RATANAWONGSA
2012
cRatanawongsa et al. (2012)76 USA RCT 245 0.32 0.34
SADUR 1999 Sadur et al. (1999)20 USA RCT 185 97 88
SCHILLINGER 2008 dSchillinger et al. (2008)77 USA RCT 339 112 115
dSchillinger et al. (2009)78
SCOTT 2004 Scott et al. (2004)79 USA RCT 294 145 149
TAVIERA 2010
(same intervention,
different population)
Taveira et al. (2010)80 USA RCT 118 58 60
Taveira et al. (2011)81 USA RCT 88 44 44
TRENTO 2002 Trento et al. (2001)82 Italy RCT 112 56 56
Trento et al. (2002)83
Trento et al. (2004)84
TRENTO 2005 Trento et al. (2005)85 Italy RCT 62 31 31
WAGNER 2001 Wagner et al. (2001)86 USA RCT 708 278 429
YEHLE 2009 Yehle et al. (2009)31 USA RCT 52 26 26
CG, control group; IG, intervention group.
a Economic evaluation alongside RCT.
b Subgroups by insulin regimen: no insulin (oral diabetes medications only) n= 98, basal insulin and oral medications
n= 62 and complex medications n= 79.
c Three-arm RCT; 34% in weekly automated telephone self-management.
d One hundred and twelve in three-arm weekly automated telephone disease management.
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39
reported medication review and four describe completion of prescriptions.60,63,66,71,75,80,81 Six studies reported
individual consultation within the group session60,65,76,77,84,86, with five describing individual consultation
immediately following the group session for all patients58,59,68,69,82 and three for individual consultation immediately
following the group session for selected patients.73,74,83 Six studies reported routine medical checks being
performed by multiple clinicians57,65,66,74,79,86 and six reported these checks being made by individual
clinicians,60,63,67,73,77,82 while only two studies reported routine medical checks being conducted by the
patient.69,70 Only one study reported telephone follow-up.69
Group size
The smallest group sizes started at around three or four patients and these smaller groups typically did
not extend beyond seven or eight participants (Table 15). Typical group sizes involved between 6 and
10 patients. Three studies had around 20 participants, with the largest of these ranging between 20 and
25 patients. One group involved up to seven patients but also made provision for patients’ families. It was
not clear from most reports whether these numbers were aspirational, reflecting full capacity, or whether
they represented typical attendance. Two studies reported means of 7.7 and 9 patients, indicating that
these were actual attendance figures. It was not possible to make any observations about optimal group
size. Clearly, there is a potential tension between efficiency, as reflected in higher numbers, and optimal
group interaction, which may be represented in smaller numbers while nevertheless needing to realise a
critical mass for viability and interaction.
Visit frequency
Visit intervals ranged from weekly (e.g. Taveira et al.80) through to quarterly (e.g. Dorsey et al.68 and
Trento et al.82) or semiannually (e.g. Wagner et al.86) (see Table 15). Typical visit frequencies were monthly
but even in those instances they varied in duration (e.g. monthly for 3 months, 6 months or 1 year). It was
not clear in most instances whether these reflected a therapeutic interval (as determined by clinical need)
or an evaluation interval (as determined by the needs of a particular study). Most of the studies reported
these intervals only over the period covered by the study and studies made little reference to continuation
beyond the study period or to issues relating to sustainability. It is not clear, therefore, what the optimal
visit interval and frequency is from a therapeutic viewpoint. Some studies employed different visit
frequencies for initiation and maintenance (e.g. fortnightly for first 3 months and then monthly for next
3 months73 or weekly for 4 weeks and then monthly for 5 months63), suggesting a potential line for further
investigation. However, the underlying assumptions for such a pattern were typically not surfaced. It was
not clear whether these periods were determined by clinical considerations, by assumptions of patient
burden or by the available clinical resources in the health service. One study alternated group visits and
individual consultations every 3 months.70 However, it was again not clear what the drivers were for this
particular decision. The study with the longest follow-up required patients to visit four times a year for
2 years then a further seven times over years 3–4.83
TABLE 14 Prevalence of group clinic approaches by number of studies and number of papers
Model (studies) Number of studies Number of papers
CHCC model57–62,65,73,74,79 6 10
SMA63,64,72,80,81,90 5 6
Group clinic66,67,69,71,75 3 5
GMV68,76–78 3 4
Group visit70,82–85 3 5
Chronic care clinic86 1 1
Cluster visit20 1 1
Shared medical visit31 1 1
Specialty CHCC model, DIGMAs and GMAs received no mentions.
RESULTS
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Session duration
A typical length of session was between 1.564,68,76,77 and 2 hours20,58,60,65,73,80 (90–120 minutes) (see Table 15).
Shortest sessions were 60–70 minutes in duration,71,75 although sessions of 40–50 minutes might require
additional time for individual consultations.85 The longest sessions were 2.5 to 3 hours, although one session
was described as ‘half a day’,86 albeit at less frequent intervals. Two interventions reflected variable time
periods either when switching to less frequent intervals (weekly sessions 2 hours and monthly sessions
90 minutes63) again with implicit assumptions about differential requirements for initiation and maintenance
or reflecting differences between a scheduled period and an actual duration (e.g. scheduled for 2 hours but
after first session often 90 minutes69). Methodologically it is very difficult to summarise the information about
the session durations, mainly because some studies record the complete duration from arrival to departure
and others include only the time spent in a group setting. Studies also handle any individual consultations
differently, with some recording these as supplementary (i.e. additional time) and others including these in the
group session times.
Total duration
The value of information on the total duration of all documented sessions is questionable, partly for the
reasons mentioned in Session duration and partly because the denominator is typically determined by the
study period and not by therapeutic considerations. A further limitation is that comparability between
individual and group sessions is not possible; in most cases studies follow an enhancement model, not a
substitution model, and therefore individual consultation sessions take place in both arms. Equally
importantly, we typically do not have details on whether or not the individual consultations in a group
context are typically shorter than those in an individual treatment context. It should be borne in mind that
the total time required by clinical staff is considerable, requiring preparation for the group sessions in terms
of educational content, review of medical notes and results prior to the visit, etc. In addition, provision for
follow-up is often not formally documented in the studies.
Notwithstanding these limitations, we can see from Table 15 that, over the study period, total durations of
12–14 hours are common, with other studies reaching 24 or 30 hours of clinical group input. The longest
duration was a total of 60 hours spread over 4 years, although some studies recorded the total duration as
‘indefinite’, implying ongoing service provision beyond the study period.
In summary, it can be seen that data on such important evaluative group features as size, frequency and
session and total duration, where available, are extremely difficult to synthesise and interpret. In particular,
justification for these features is rarely provided, although we can make some assumptions about their
underpinning rationale (e.g. different assumptions about initiation vs. maintenance). More worryingly,
such considerations seem to be determined primarily by either pragmatic or study considerations rather
than by enhanced effectiveness, optimal curriculum content or empirical evidence on group processes
and interactions.
Narrative summary of study quality
The review of RCTs included 32 papers reporting 22 trials (Table 16). The quality of included RCTs was
assessed using questions relevant for RCTs and from these responses a Cochrane risk of bias was determined
for each study (Table 17). Of the 22 trials, nine studies (11 papers)60–63,65–70,73 were categorised as having a low
risk of bias, 10 studies (11 papers) were categorised as having a high risk of bias20,57–59,64,71,74,75,79–87 and three
studies (four papers) were categorised as unclear.72,76–78 The large number of studies with a high risk of bias
means that any conclusions based on these trials should be treated with caution. The discussion on the
quality of the RCTs will begin by discussing general problems with the studies then consider the groups of
studies with low, high and unclear risk of bias.
A key problem for all of these studies is the possibility of selection bias having impacted on the results. All
studies included patients who chose to participate in group clinics. Patients who wish to participate in group
clinics are likely to give more positive results on self-reported outcomes. Additionally, a patient’s choice to
be involved may indicate greater concern about improving their condition and, as such, they may be more
motivated to implement suggested changes to their lifestyle, thereby improving their clinical outcomes.
RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
44
TABLE 16 Included RCTs with outcomes included and results
Study Outcome measures Results
Clancy et al. (2003)58 Hospital admissions
ED visits
Costs
Concordance with 10 process-of-care
indicators recommended by the ADA
standards of care. (HbA1c levels and
lipid profiles, urine for microalbumin,
appropriate use of ACE inhibitor or
angiotensin receptor blockers, use of
lipid-lowering agents, daily aspirin use,
annual foot examinations, annual
referrals for retinal examinations and
immunizations against streptococcal
pneumonia and influenza)
Group visit patients showed statistically significant
improvement in concordance with 10 process-of-care
indicators (p< 0.001). 76% of group visit patients had
at least 9 out of 10 items up to date, compared with
23% of control patients; 86% of group visit patients
had at least 8 out of 10 indicators, compared with 47%
of control patients
Clancy et al. (2003)57 PCAT
TPS. Attendance records
Patients who received care in group visits showed an
improved sense of trust in their physician, compared
with patients who continued to receive usual care.
There was a tendency for patients in groups to report
better co-ordination of their care, better community
orientation and more culturally competent care. Patient
attendance at groups also indicated good acceptance
Clancy et al. (2003)59 Feasibility
Acceptability
Concordance ADA standards of care
Group visit patients exhibited improvement in ADA
standards of care (p< 0.001) and improved sense of
trust in physician (p= 0.02) and tended to report better
co-ordination of care (p= 0.07), better community
orientation (p= 0.09) and more culturally competent
care (p= 0.09)
Clancy et al. (2007)60 HbA1c
BP
Lipid profiles
Quality of care measures (adherence
to 10 ADA guidelines and three
USPSTF cancer screens) at 12 months
At both measurement points, HbA1c, BP and lipid levels
did not differ significantly for group visit patients vs.
those in usual care. At 12 months, however, group visit
patients exhibited greater concordance with ADA
process-of-care indicators (p< 0.0001) and higher
screening rates for cancers of the breast (80% vs. 68%;
p= 0.006) and cervix (80% vs. 68%; p= 0.019)
Clancy et al. (2007)61 PCAT
DLC survey
TPS
Compared with patients in usual care, group visit
patients’ PCAT scores were higher for ongoing care
(p= 0.001), community orientation (p< 0.0001), and
cultural competence (p= 0.022). Group visit patients
had higher scores for the Powerful-Other Health
Professional subscale of the DLC survey (p= 0.010)
Clancy et al. (2008)62 ED charges
Outpatient visit charges
Group visit patients had reduced ED and total charges
but more outpatient charges than usual care patients.
Group visits increased outpatient visit charges; however,
controlling for endogeneity showed that group visits
statistically significantly reduced outpatient charges
(p< 0.001). Separate treatment effect model of specialty
care visits confirmed that group visit effects on
outpatient visit charges occurred via reduction in
specialty care visits
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Cohen et al. (2011)63 HbA1c
Systolic BP
LDL cholesterol
Diabetes self-care behaviour
questionnaires at 6 months
Randomisation groups similar at baseline in all
cardiovascular risk factors except LDL; significantly lower
in IG. At 6 months, significant improvements from
baseline found in IG for exercise, foot care and goal
attainment of HbA1c, LDL cholesterol and BP but not for
control group
Cole et al. (2013)64 Fasting blood glucose (mg/dl)
Weight (kg)
BMI
Systolic BP
Diastolic BP
HbA1C (%)
Total cholesterol
LDL cholesterol (mg/dl)
HDL cholesterol (mg/dl)
Triglycerides (mg/dl)
A total of 94 participants in two study groups with 69%
completion rate at 1 year (n= 34 SMA, n= 31 control).
Average participant was Caucasian (64%), male (54%),
58.3± 9.6 years, had BMI of 30.8± 4.9 kg/m2 (obese)
and fasting blood glucose of 109± 9.5mg/dl. SMA and
control participants lost mean of 6.6 lb and 3.6 lb,
respectively; neither group met 5% modest weight loss
expected. SMA and control group experienced a mean
drop in fasting blood glucose of 6mg/dl
Coleman et al.
(2001)65
ED visits
Hospitalisations
Primary care visits
On average, patients in IG attended 10.6 group visits
during 2-year study period. IG patients averaged fewer
ED visits (0.65 vs. 1.08 visits; p= 0.005) and were less
likely to have any ED visits (34.9% vs. 52.4%; p= 0.003)
than controls. These differences remained statistically
significant after controlling for demographic factors,
comorbid conditions, functional status and prior
utilisation. Adjusted mean difference in visits was –0.42
visits (95% CI –0.13 to –0.72), and adjusted RR for any
ED visit was 0.64 (95% CI 0.44 to 0.86)
Crowley et al.
(2014)66
Total cholesterol
LDL cholesterol
HDL cholesterol
Triglycerides
At baseline, mean total cholesterol was 169.7mg/dl (SD
47.8mg/dl), LDL cholesterol 98.2mg/dl (SD 41.7mg/dl)
and HDL cholesterol 39.3mg/dl (SD 13.0mg/dl). Median
baseline triglycerides were 131mg/dl (interquartile range
122mg/dl). By study end, mean total cholesterol and LDL
cholesterol in GMCs were 14.2mg/dl (p=0.01) and
9.2mg/dl (p=0.02) lower than usual care, respectively;
76% of GMC patients met goals for LDL cholesterol vs.
61% of usual care patients (p=0.02). Triglycerides and
HDL cholesterol remained similar between study arms.
Treatment intensification occurred in 52% of group
medical clinic patients vs. 37% of usual care patients
between study baseline and end (p=0.04). Mean statin
dose higher in GMC patients at study mid-point and end
Crowley et al.
(2013)67
HbA1c
Self-efficacy
Effect of GMC on HbA1c differed by baseline insulin
regimen vs. usual care (p= 0.05); no differential effect
on self-efficacy (p= 0.29). Among those using complex
insulin regimens at baseline, GMC reduced HbA1c by
study end compared with usual care (–1.0%, 95% CI
–1.8% to –0.2%; p= 0.01). No HbA1c difference
between GMC and UC patients using no insulin
(p= 0.65) or basal insulin only (p= 0.71). No clinically
significant differences in hypoglycaemia by baseline
insulin regimen and IG
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Dorsey et al. (2011)68 Feasibility (ability to recruit participants
and proportion of participants who
completed study)
Quality of life measured by Parkinson’s
Disease Questionnaire 39 items
30 patients and 27 caregivers enrolled. 13 out of
15 patients randomised to GPVs and 14 out of
15 randomised to usual care completed study. Quality
of life measured 12 months after baseline between two
groups was not different (25.9 points for GPVs vs.
26.0 points for usual care; p= 0.99)
Edelman et al.
(2010)69
HbA1c
Diastolic BP
Systolic BP
Hospital admissions
ED visits
Mean baseline systolic BP and HbA1c level were
152.9mmHg (SD 14.2mmHg) and 9.2% (SD 1.4%),
respectively. At end of study, mean systolic BP improved
by 13.7mmHg in GMC group and 6.4mmHg in usual
care group (p= 0.011 by linear mixed model), whereas
mean HbA1c level improved by 0.8% in GMC group and
0.5% in usual care group (p= 0.159)
Graue et al.
(2005)70
HbA1c
Child Health Questionnaire (CHQ-
CF87)
DQoL
101 adolescents (55 intervention/46 control) agreed to
participate, mean age 14.2 years (SD 1.5 years), mean
diabetes duration 6.5 years (SD 3.6 years, range
1–16 years), mean HbA1c 9.3% (SD 1.4%, range
6.1–12.8%). 83 (72%) completed questionnaires at
follow-up (intervention/control 45/38). Significant age by
randomisation group interactions for diabetes-related
impact (p= 0.018), diabetes-related worries (p= 0.004),
mental health (p= 0.046) and general behaviour
(p= 0.029), implying group visit were effective in older
adolescents (above 13–14 years). No significant effects
on mean HbA1c identified
Griffin et al.
(2009)71
Number of visits
INR
28/45 patients participated for the 16-week study
period. Control group included 108 patients seen by
pharmacist for individual anticoagulation appointments.
No significant difference in percentage of INR values
within therapeutic range detected between patients in
group visit model vs. patients receiving individual visits
(59% vs. 56.6%; p= 0.536). 73% of INR values for
Group visit patients within ± 0.2 of desired INR range,
compared with 71.9% of control group (p= 0.994).
79% of group visit patients within the therapeutic range
at their last clinic visit, compared with 67% of patients
who attended individual appointments (p= 0.225).
Group visits preferred by 51% (n= 38) of patients who
completed satisfaction survey. Of 92 patients who
declined group visit participation, 36% indicated that
time of day that group visits were offered was
inconvenient. No thromboembolic or haemorrhagic
events documented in either group
Gutierrez et al.
(2011)72
HbA1c
Quality of life
Diabetes knowledge
Mean decreases in HbA1c level of 1.19% for SMA group
(p< 0.01) and 0.67% for control group (p= 0.02). In
SMA group, quality-of-life and diabetes knowledge
scores increased by 5 points and 1.5 points, respectively
(p< 0.01)
Junling et al. (2015)73 Diastolic BP
Treatment compliance
Self-efficacy
The average diastolic BP decrease in the group visit
groups (1.5mmHg) was significantly more than in the
control groups (0.4mmHg). In group visit groups,
compliance with medicine, physical activities and diet
increased to 14.7%, 9.7% and 10.1%, respectively,
which is more significant than that in control groups
(2.0%, 1.6% and 8.0%); self-reported health and
self-efficacy also improved significantly
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Liu et al. (2012)74 Systolic BP
Changes in 17 self-management
behaviour, self-efficacy and health
status-related variables
Group visit patients, on average, increased their
duration of aerobic exercise by > 40 minutes per week
(p= 0.001); had significant increase of 0.71 in mean
score on self-efficacy to manage diabetes (p= 0.02); and
had significant improvements in measures of illness
intrusiveness and systolic BP. Group visit patients
attended an average of 10.1 out of 12 programme
sessions. 75.6% of them attended ≥ 10 sessions
Naik et al. (2011)75 HbA1c Group visit participants had significantly greater
improvements in HbA1c levels immediately following
active intervention [8.86–8.04% vs. 8.74–8.70% of
total haemoglobin; mean (SD) between-group
difference 0.67% (1.3%); p= 0.03] and differences
persisted at 1-year follow-up [0.59% (SD 1.4%);
p= 0.05]. Repeated-measures analysis found significant
time-by-treatment interaction effect on HbA1c levels
favouring intervention [F(2,85)= 3.55; p= 0.03]. Effect
of time-by-treatment interaction seems to be partially
mediated by DM self-efficacy [F(1,85)= 10.39;
p= 0.002]
Ratanawongsa et al.
(2012)76
Patient activation to create and
achieve goals
Quality of care
Barriers to care
Of 113 eligible PCPs caring for 330 enrolled patients,
87 PCPs (77%) responded to surveys about 245 (74%)
enrolled patients. Intervention patients more likely to be
perceived by PCPs as activated to create and achieve
goals for chronic care when compared with UC patients
(standardised effect size for ATSM vs. UC, + 0.41;
p= 0.01; standardised effect size for GMV vs. UC,
+ 0.31; p= 0.05). Primary care providers rated quality of
care higher for patients exposed to ATSM than for those
receiving usual care (odds ratio 3.6; p< 0.01).
Compared with GMV patients, ATSM patients were
more likely to be perceived by PCPs as overcoming
barriers related to limited English proficiency (82%
ATSM vs. 44% GMV; p= 0.01) and managing
medications (80% ATSM vs. 53% GMV; p= 0.01)
Sadur et al. (1999)20 HbA1c
Hospital admissions
ED visits
Self-reported changes in self-care
practices, self-efficacy, and satisfaction
HbA1c levels declined by 1.3% in CV group vs. 0.2% in
the control subjects (p< 0.0001). Several self-care
practices and several measures of self-efficacy improved
significantly in CV group. Satisfaction with programme
was high. Both hospital (p= 0.04) and outpatient
(p< 0.01) utilisation were significantly lower for CV
subjects after the programme
Schillinger et al.
(2008)77
Participation among clinics, clinicians
and patients
Patient representativeness; patient
engagement with SMS
Participation rates high across all levels and preferentially
attracted Spanish-language speakers, uninsured, and
Medicaid recipients. Although both programmes
engaged a significant proportion in action planning,
automated telephone disease management yielded
higher engagement than GMVs, especially among those
with limited English proficiency and limited literacy
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Schillinger et al.
(2009)78
Systolic BP
Diastolic BP
1-year changes in structure (PACIC),
communication processes (IPC), and
outcomes (behavioural, functional and
metabolic)
Compared with usual care group, ATSM and GMV groups
showed improvements in PACIC, with effect sizes of 0.48
and 0.50 respectively (p<0.01). Only ATSM group
showed improvements in IPC (effect sizes 0.40 vs. usual
care and 0.25 vs. GMV; p<0.05). Both SMS arms showed
improvements in self-management behaviour vs. usual
care arm (p<0.05), with gains being greater for the
ATSM group than for the GMV group (effect size 0.27;
p=0.02). ATSM group had fewer bed-days per month
than the usual care group (–1.7 days; p=0.05) and GMV
group (–2.3 days; p<0.01) and less interference with
daily activities than the usual care group (odds ratio 0.37;
p=0.02). No differences in HbA1c change
Scott et al. (2004)79 Clinic visits, inpatient admissions,
emergency room visits, hospital
outpatient services, professional
services, home health and skilled
nursing facility admissions; measures
of patient satisfaction, quality of life,
self-efficacy and ADLs
Outpatient, pharmacy services, home health and skilled
nursing facility use did not differ between groups. CHCC
patients had fewer hospital admissions (p=0.012),
emergency visits (p=0.008) and professional services
(p=0.005). CHCC patients’ costs were US$41.80 per
member per month lower than those of control patients.
CHCC patients reported higher satisfaction with their
primary care physician (p=0.022), better quality of life
(p=0.002) and greater self-efficacy (p=0.03). Health
status and ADLs did not differ between groups
Taveira et al. (2010)80 HbA1c
LDL cholesterol
BP
Fasting lipids
Target goals in tobacco use
recommended by the ADA
109 out of 118 participants completed study. VA-MEDIC
(n= 58) participants were younger and had greater
tobacco use at baseline than usual care but were similar
in other cardiovascular risk factors. After 4 months, a
greater proportion of VA-MEDIC participants vs. controls
achieved a HbA1c of < 7% and a systolic BP
< 130mmHg. No significant change found in lipid
control or tobacco use between study arms
Taveira et al. (2011)81 HbA1c (change in the proportion of
participants who achieved a HbA1c
< 7% at 6 months)
LDL cholesterol
Hospital admissions
ED visits
Compared with standard care (n= 44), a lower
proportion of patients in VA-MEDIC-D (n= 44) had
systolic BP < 130mmHg at baseline, but similar in other
cardiovascular risk factors and psychiatric comorbidity.
Change in proportion of participants achieving an A1c
< 7% was greater in the VA-MEDIC-D arm than in the
standard care arm (29.6% vs. 11.9%), with odds ratio
3.6 (95% CI 1.1 to 12.3). VA-MEDIC-D participants also
achieved significant reductions in systolic blood
pressure, LDL cholesterol and non-HDL cholesterol from
baseline, whereas significant reductions were attained
only in non-HDL cholesterol with standard care. No
significant change in depressive symptoms for either
arm
Trento et al. (2001)82 HbA1c
Total cholesterol
Systolic BP
Diastolic BP
Costs
Knowledge of diabetes
Quality of life
After 2 years, HbA1c levels lower in group visit patients
than in control subjects (p< 0.002). Levels of HDL
cholesterol had increased in patients seen in groups but
had not increased in control subjects (p= 0.045). BMI
(p= 0.06) and fasting triglyceride level (p= 0.053) were
lower. Group visit patients had improved knowledge of
diabetes (p< 0.001) and quality of life (p< 0.001) and
experienced more appropriate health behaviours
(p<0.001). Physicians spent less time seeing 9–10 patients
as a group rather than individually, but patients had longer
interaction with health-care providers
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Trento et al. (2002)83 HbA1c
Total cholesterol
Systolic BP
Diastolic BP
Costs
Knowledge of diabetes
Quality of life
Observation times were 51.2± 2.1 months for group
visit and 51.2± 1.8 for control groups. HbA1c increased
in control group but not in group visit patients
(p< 0.001), in whom BMI decreased (p< 0.001) and
HDL cholesterol increased (p< 0.001). Quality of life,
knowledge of diabetes and health behaviours improved
with group visit (p< 0.001, all) and worsened among
control group (p= 0.004 to p< 0.001). Dosage of
hypoglycaemic agents decreased (p< 0.001) and
retinopathy progressed less (p< 0.009) among the
group care patients than the control subjects. Diastolic
BP (p< 0.001) and relative cardiovascular risk (p< 0.05)
decreased from baseline in group patients and control
patients alike. Over study period, group visit required
196 minutes and US$756.54 per patient, compared
with 150 minutes and US$665.77 for control group
patients, resulting in an additional US$2.12 spent per
point gained in the quality-of-life score
Trento et al. (2004)84 Knowledge of diabetes
Problem-solving ability
Quality of life
HbA1c
BMI
HDL cholesterol
Knowledge of diabetes and problem-solving ability
improved from year 1 with group care and worsened
among control subjects (p< 0.001 for both). Quality of
life improved from year 2 with group care but worsened
with individual care (p< 0.001). HbA1c level progressively
increased over 5 years among control subjects (+1.7%,
95% CI 1.1% to 2.2%) but not group care patients
(+0.1%, 95% CI –0.5% to 0.4%), in whom BMI
decreased (–1.4 kg/m2, 95% CI –2.0 to –0.7 kg/m2) and
HDL cholesterol increased (+0.14mmol/l, 95% CI
0.07 to 0.22mmol/l)
Trento et al. (2005)85 HbA1c
Total cholesterol
Quality of life
Knowledge of diabetes, health
behaviours
Circulating lipids
Differential costs to the Italian NHS
and to patients
After 3 years, quality of life improved among patients
on group care, along with knowledge and health
behaviours (p< 0.001, all). Knowledge added its effects
to those of group care by independently influencing
behaviours (p= 0.004), while quality of life changed
independently of either (p< 0.001). Among controls,
quality of life worsened (p< 0.001), while knowledge
and behaviours remained unchanged. HDL cholesterol
increased among patients on group care (p= 0.027) and
total cholesterol decreased in the controls (p< 0.05).
HbA1c decreased, though not significantly, in both.
Direct costs for group and one-to-one care were
€933.19 and €697.10 per patient, respectively, giving
cost-effectiveness ratio of €19.42 spent per point gained
in the quality of life scale
Wagner et al. (2001)86 HbA1c
Total cholesterol
Hospital admissions
ED visits
Costs
Process of care received
Satisfaction with care, and the health
status of each patient
In intention-to-treat analysis at 24 months, IG received
significantly more recommended preventative
procedures and helpful patient education. Of five
primary health status indicators, two (SF-36 general
health and bed disability days) significantly better in IG.
IG patients had slightly more primary care visits, but
significantly fewer specialty and ER visits. There were
consistently positive associations between number of
chronic care clinics attended and patient satisfaction and
HbA1c levels
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TABLE 16 Included RCTs with outcomes included and results (continued )
Study Outcome measures Results
Yehle et al. (2009)31 Heart Failure Knowledge Test
Self-Care Heart Failure Index
From baseline to 8 weeks, Heart Failure Knowledge Test
scores improved more for IG than CG (p= 0.038).
No difference in groups’ rates of change on the total
Self-Care Heart Failure Index
ADA, American Diabetes Association; ADL, activity of daily living; ATSM, automated telephone self-management support
with nurse follow-up; BP, blood pressure; CV, cluster visit; DLC, Diabetes-Specific Locus of Control; DM, diabetes mellitus;
DQOL, Diabetes Quality of Life questionnaire; ED, emergency department; ER, emergency room; GMC, group medical
clinic; HDL, high-density lipoprotein; IG, intervention group; INR, international normalised ratio; IPC, interpersonal processes
of care; PACIC, Patient Assessment of Chronic Illness Care; PCAT, Primary Care Assessment Tool; PCP, primary care
physician; RR, risk ratio; SD, standard deviation; SF-36, Short Form questionnaire-36 items; TPS, Trust in Physician Scale;
UC, usual care; USPSTF, US Preventive Services Task Force; VA-MEDIC, Veterans Affairs Multidisciplinary Education in
Diabetes and Intervention for Cardiac risk reduction; VA-MEDIC-D, Veterans Affairs Multidisciplinary Education in Diabetes
and Intervention for Cardiac risk reduction in Depression.
TABLE 17 Quality assessment of RCTs
Study identifier
Cochrane
risk of
bias (low,
high or
unclear)
Did
study
address
clearly
focused
issue?
Trials: was
assignment
of patients to
treatments
randomised?
Trials: all
patients
entering
trial
properly
accounted
for at
conclusion?
Trials:
patients,
health
workers
and study
personnel
‘blind’ to
treatment?
Trials:
groups
similar
at start
of trial?
Trials:
aside from
experimental
intervention,
groups
treated
equally?
CLANCY
Clancy et al. (2003)57
Clancy et al. (2003)58
Clancy et al. (2003)59
High Yes Yes Yes No Yes Yes
CLANCY
Clancy et al. (2007)60
Clancy et al. (2007)61
Clancy et al. (2008)62
Low Yes Yes Yes No Cannot
tell
Yes
Cohen et al. (2011)63 Low Yes Yes Yes No No Yes
Cole et al. (2013)64 High Yes Yes No No No Yes
Coleman et al. (2001)65 Low Yes Yes Yes No Yes Yes
Dorsey et al. (2011)68 Low Yes Yes Yes No Yes Yes
EDELMAN
Crowley et al.
(2013)67
Crowley et al.
(2014)66
aEdelman et al.
(2010)69
Low Yes Yes Yes Yes1 No Yes
continued
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TABLE 17 Quality assessment of RCTs (continued )
Study identifier
Cochrane
risk of
bias (low,
high or
unclear)
Did
study
address
clearly
focused
issue?
Trials: was
assignment
of patients to
treatments
randomised?
Trials: all
patients
entering
trial
properly
accounted
for at
conclusion?
Trials:
patients,
health
workers
and study
personnel
‘blind’ to
treatment?
Trials:
groups
similar
at start
of trial?
Trials:
aside from
experimental
intervention,
groups
treated
equally?
Graue et al. (2005)70 Low Yes Yes Yes No Yes Yes
Griffin et al. (2009)71 High Yes Yes No No No Yes
Gutierrez et al. (2011)72 Unclear Yes Yes Cannot tell No Cannot
tell
Cannot tell
Junling et al. (2015)73 Low Yes Yes Yes No Yes Yes
Liu et al. (2012)74 High Yes Yes Yes No No Yes
Naik et al. (2011)75 High Yes Yes No No Yes Yes
Ratanawongsa et al.
(2012)76
Unclear Yes Cannot tell Cannot tell No Cannot
tell
Yes
Sadur et al. (1999)20 High Yes Yes No No Yes Yes
SCHILLINGER
Schillinger et al.
(2008)77
Schillinger et al.
(2009)78
Unclear Yes Yes Cannot tell No Cannot
tell
Yes
Scott (2004)79 High Yes Yes Cannot tell No Yes Yes
TAVEIRA
Taveira et al. (2010)80
Taveira et al. (2011)81
High Yes Yes No No No Yes
TRENTO
Trento et al. (2001)82
Trento et al. (2002)83
Trento et al. (2004)84
High Yes Yes No No No Yes
TRENTO
Trento et al. (2005)85
High Yes Yes No No No Yes
Wagner et al. (2001)86 High Yes Yes No No Yes Yes
Yehle et al. (2009)31 High Yes Yes No No Yes Yes
a Research assistant completing outcome measures blinded to group assignment. Patients and care teams running group
medical clinics not blinded to treatment group assignment.
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Another significant problem with these studies was that it was not possible to blind patients or health-care
personnel to treatment intervention group, which could lead to bias. Two studies69,83 did state that they
have researchers blinded to patient’s treatment groups to measures outcomes. This bias could potentially
be more significant with certain outcome measures. Clinical outcomes measures, for example, blood
pressure and blood glucose, would be less likely to be affected by this bias. However, outcome measures
around patient satisfaction, self-efficacy, self-reported outcomes or outcomes reported by the team
delivering the group clinics could be open to bias. Some studies had doctors treating patients in both the
intervention and the control group, giving the possibility of a ’halo effect’.72
The majority of the studies had only a short follow-up, generally 6 months to 1 year, making it impossible to
assess the longer-term impact of the interventions. Two of the studies70,79 did have a 24-month follow-up.
The 11 studies assigned a low risk of bias60,61,63,65–70,73,78 were generally large, well-conducted trials.
A total of 13 studies were assigned a high risk of bias.20,31,57,59,64,71,74,75,79,80,82,85,86 One of the studies with a
high risk of bias was a pilot study57,58 with small sample sizes, no blinding, patient selection bias and
short-term follow-up. Five of the studies with a high risk of bias48,71,80,81,83 had patients with different
baseline characteristics.
Three studies were given an unclear risk of bias,72,76,77 owing to insufficient details of the trials
methodology being provided. One of these was a pilot study.72
Study analyses: condition-specific clinical outcomes
Fifteen of the 22 trials included a population with diabetes. By far the majority of the trials (11 out of
22 trials) studied a population with type 2 diabetes.57,60,63,64,72,74–77,80,83 A further four trials studied a mixed
type 1 and type 2 diabetes population,20 a type 1 diabetes-only population70,85 and a population with type 2
diabetes and hypertension.66,67,69
A further group of studies examined the effects of group clinics in populations with a variety of cardiac
problems (heart disease/hypertension71,73 and hypertension/heart failure31). Coleman et al.65 studied a
population with one or more self-reported chronic conditions (e.g. asthma, COPD, congestive heart failure,
diabetes and heart disease). Scott et al.79 also studied a population with a range of chronic conditions
(arthritis, hypertension, difficulty hearing, heart disease, liver disease and bladder/kidney disease).
Recent years have seen group clinics extended to a wider variety of conditions. Dorsey et al.68 studied
a population with Parkinson’s disease and Seesing et al.90 have completed a 6-month follow-up of a
population with chronic neuromuscular disorders.
Diabetes
Eleven of the diabetes trials studied a population with type 2 diabetes only.57,60,63,64,72,74–77,80,83 Sadur et al.20
studied a population with either type 1 or type 2 diabetes. Graue et al.70 worked with adolescents with
type 1 diabetes and Trento et al.82 intervened with a wider type 1 diabetes population. In the most
recent trial, Crowley et al.66,67 and Edelman et al.69 intervened with a population with type 2 diabetes
and hypertension. Most commonly measured outcomes are HbA1c, blood pressure, cholesterol and
health-related quality of life.
Glycated haemoglobin
We identified 13 eligible trials of group clinic approaches for diabetes20,59,61,63,67,69,72,75,80–82,85,86 that
measured HbA1c. Several meta-analyses exist for this outcome. In the review for the Department of
Veterans Affairs, Edelman et al.18 performed a sensitivity analysis and identified six good-quality
studies20,59,69,75,81,91 that demonstrated a significant effect on HbA1c in favour of group clinics. We excluded
one of these studies91 from our review because of a lack of evidence for clinical input, other than
education. The significant effect was not maintained when Edelman et al.18 included the results from seven
poor-/fair-quality trials.61,63,72,80,82,85,86 We identified one additional study with a low risk of bias that
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examined this outcome measure that had not been included in the two previous meta-analyses.67 The
results of this additional study are difficult to integrate with previous studies because the triallists examined
the effect of the complexity of insulin regimens as a possible explanatory factor. Among those using
complex insulin regimens at baseline, the group medical clinic intervention reduced HbA1c by the study’s
end, compared with usual care (21.0%, 95% CI 21.8% to 20.2%; p= 0.01). The triallists found no such
HbA1c difference between group medical clinic and usual care patients using no insulin (p= 0.65) or basal
insulin only (p= 0.71).57
The same outcome measure was examined by Housden et al.,53 who included 10 studies in a
meta-analysis,20,59,69,75,77,81,84–86,92 seven of which are included in our review. They reported a significant
effect of group clinics on HbA1c. They included a study by Rygg et al.,92 excluded from our review owing
to lack of evidence that the intervention involved more than an educational component. Despite the
considerable variation in trial quality and in the trials included by each meta-analysis team, it appears that
we can be fairly confident that an effect does indeed persist for HbA1c. As mentioned in the context of the
Edelman et al. meta-analysis,18 integration of the additional study we identified67 is problematic given
that it examined the effects of using complex insulin regimes. However, this report67 originated from the
Edelman trial69 and would not be eligible for inclusion alongside the original report because of the risk of
double counting. So, neither the meta-analysis by Edelman et al.18 nor that by Housden et al.53 is sensitive
to the inclusion of the newly retrieved study.
Systolic blood pressure
Five studies had previously been identified examining systolic blood pressure.63,69,80,81,91 When these five
studies were pooled together in a meta-analysis, the studies demonstrated a statistically significant effect
favouring group clinics.20 Our review found one additional study74 published in 2012. Liu et al.74 found that
patients in the intervention group had significant improvements in systolic blood pressure with, on
average, 3.72mmHg lower increase in systolic blood pressure (p= 0.04).74 This additional trial, therefore,
appears to strengthen the pre-existing evidence finding in favour of a positive effect of group clinics on
systolic blood pressure.74 However, one of these trials91 was excluded from our review because we were
unable to ascertain clinician involvement in anything other than an educational role.
Housden et al.53 also included five studies (only two58,69 overlapping with the Edelman review18) examining
the effect of SMAs on systolic blood pressure in diabetes. Across these five trials the overall pooled effect
on systolic blood pressure was −2.81 (95% CI −6.84 to 1.21). Four included studies78,81,82,92 failed to find a
significant effect. The pooled effect in both reviews is heavily dependent on the results from a single
study.34 Furthermore, Housden et al.53 included a trial by Rygg et al.,92 which we excluded owing to lack of
evidence that the intervention involved more than an educational component.
Diastolic blood pressure
Based on four trials,69,78,82,92 Housden et al.53 concluded that the effect of SMAs on diastolic blood pressure
was non-significant (−1.02, 95% CI −2.71 to 0.67). These trials included the trial by Rygg et al.,92 which
we excluded owing to lack of evidence that the intervention involved more than a simple educational
component. We found no additional trials examining diastolic blood pressure as an outcome. The review
by Edelman et al.18 did not examine diastolic blood pressure. We have, therefore, concluded that, in
contrast with systolic blood pressure, SMAs do not demonstrate an effect for diastolic blood pressure.
Low-density lipoprotein cholesterol
Based on four previous studies,57,80,81,91 Edelman et al.18 concluded that SMAs did not have an overall effect
on LDL cholesterol. We identified one additional recent study to supplement the pre-existing evidence
base.66 This additional trial reported that by study end, LDL cholesterol in group medical clinics was 9.2mg/dl
(p= 0.02) lower than usual care.66 Housden et al.53 did not pool results for LDL, choosing to examine only
high-density lipoprotein (HDL) cholesterol and total cholesterol. We conclude that the additional trial is
probably insufficient to overturn the previously non-significant result for changes in LDL cholesterol, but this
has not been demonstrated quantitatively.
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High-density lipoprotein cholesterol
Based on three studies previously meta-analysed by Edelman et al. looking at HDL cholesterol,18 we
concluded that effects of group clinics can be considered non-significant. We did not identify any
additional trials to be included in the meta-analysis.
Total cholesterol
Five studies measuring changes to total cholesterol59,82,85,86,91 had previously been examined by Edelman
et al.18 They had found no statistical significance for the effect of group clinics. We had excluded one of
these studies because we found no explicit mention of other than educational input from the clinicians.91
We identified one further study66 to augment the pre-existing data. By the end of the study, mean total
cholesterol in group medical clinics was significantly lower than in usual care. However, this study was not
sufficient to overturn the pooled result of the five previous studies. Housden et al. also examined effect on
total cholesterol, identifying three studies and finding a non-significant effect for the pooled studies.53
Housden et al.53 also excluded the study by Trento et al.91
Health-related quality of life
Three studies of diabetes patients had been previously identified examining disease specific quality of
life;82,85,91 two of these were included in our review.82,85 When pooled together in a meta-analysis these
studies demonstrated a statistically significant effect favouring group clinics.6 Our review found no additional
studies examining disease-specific quality of life as an outcome measure. We therefore uphold the previous
finding of significance for disease-specific quality of life. However, it should be noted that (1) the studies all
relate to the work of a particular team and therefore may not be generalisable, and (2) one of these trials
was excluded from our review91 because we were unable to ascertain clinician involvement in anything other
than an educational role – one criterion for our definition of group clinics. The study by Gutierrez et al.
reported measuring health-related quality of life but did not report the outcomes in the study report.72
Two studies of diabetes had been previously identified examining generic measures of quality of life.28,86
When these studies were pooled together in a meta-analysis the two studies demonstrated a marginally
significant effect favouring group clinics. Our review found no additional studies examining generic measures
of quality of life. We therefore upheld the previous finding of marginal significance for generic quality of life.
Other outcomes
A previous review53 has examined the effect of group clinic-type interventions on BMI (four included
studies),78,84,85,92 weight (three included studies)84,85,92 and triglycerides (three included studies).84,85,92
We identified no additional studies for these outcomes. None of these outcomes was found to be
statistically significant.
Outcome intervals
Examination of the results, even for the largely significant HbA1c outcome measure, appeared to reveal that
the effect of the group clinic intervention was not sustained over a longer period of time. This subanalysis
requires further investigation. However, as illustrated in Table 18, results that are significant up to
12 months are less likely to have a continued effect after this time period. It should, however, be noted
that the included studies make no allowance for trial quality and the table is based only on the availability
of the data. Nevertheless, more research is required on the longer-term outcomes of group clinic
interventions. It would be unwise to assume that the initial impetus of a group clinic intervention is
sustained over longer periods of time as, based on the experience with group education diabetes sessions,
commitment, enthusiasm and engagement with the programme are likely to decay.
Cardiac problems
A further group of studies examined the effects of group clinics in populations with a variety of cardiac
problems. Griffin et al.71 conducted a prospective, randomised, repeated-measures, two-group,
intention-to-treat comparison and survey at a pharmacist-managed anticoagulation clinic in a managed-care
ambulatory care setting.71 Eligible patients were randomly invited to participate in group visits.
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Of 45 patients who consented to group visits, 28 participated for the 16-week study period. No significant
difference was detected between patients in the percentage of international normalised ratio (INR) values
within the therapeutic range in the group-visit model versus patients receiving individual visits (p= 0.536).
Seventy-three per cent of INR values for patients who attended group visits were within ± 0.2 of the desired
INR range, compared with 71.9% of those in the control group (p= 0.994). Of group-visit patients, 79%
were within the therapeutic range at their last clinic visit, compared with 67% of patients attending
individual appointments (p= 0.225). Group visits were preferred by 51% (n= 38) of patients who
completed the satisfaction survey. Of 92 patients who declined group-visit participation, 36% indicated that
the time of day that group visits were offered was inconvenient. No thromboembolic or haemorrhagic
events were documented in either group during the study period.
In a RCT of group visits studying 1024 Chinese patients with hypertension, Junling et al.73 reported an
average diastolic blood pressure decrease in the group visit groups (1.5 mmHg), significantly more than in
the control groups (0.4 mmHg). The study also reported significant differences in favour of the group visit
group for compliance with medicine, physical activities and diet, as well as for self-reported health, and
self-efficacy also improved significantly.73
An additional RCT comparing group care with usual care in adults with hypertension was identified.93
However, this study was excluded from our review because group care involved small group educational
meetings with physicians and dietitians but no apparent clinical input. According to the CADTH rapid
review, which had a broader inclusion of ‘group care’,52 this RCT93 reported on fasting blood glucose,
blood pressure, lipids, weight and BMI. The study did demonstrate that, compared with control, group
care resulted in statistically significant improvement in blood pressure, weight and BMI, but more details of
the intervention are required to establish its eligibility.
Heart failure
We identified one RCT that examined heart failure.31 The status of this study has been questioned in some
reviews because the fullest account has not been published in the peer-reviewed literature. However, the
study has been included in a systematic review of group visits for heart failure.54 The study is small with a
short period of follow-up and many patients dropped out. It is not possible to draw any conclusions on the
basis of such limited evidence.
Parkinson’s disease
In a small feasibility study for a RCT Dorsey et al.68 studied a population with randomly divided patients in
two groups (12 months of group visits vs. regular ‘one-on-one’ style care). Four group visits were
administered over 1 year, each lasting 90 minutes. A total of 30 patients and 27 caregivers participated,
with quality of life not being demonstrably different between the two groups. Although group care was
TABLE 18 Outcome intervals analysed by time (illustrative analysis)
Outcome 0–3 months 4–6 months 6 months to 1 year 13–24 months > 24 months
HBA1c ≥ 5 months after
randomisation: 8.18%
in IG and 9.33% in
CG (p< 0.0001)20
At 6 months: 9.513%
in IG and 9.714% in
CG; difference not
significant57,59
At 12 months: no
significant difference
(p= 0.432), except in
patients with highest HbA1c
(> 7.7%) at baseline
(8.2%± 1.4% in IG vs.
8.8%± 1.4% in CG;
p= 0.012)92
At 1 year: 8.05%± 1.40%
in IG vs. 8.64%± 1.39% in
CG (p= 0.05)75
At 24 months: no
difference between
groups (7.9% in
both groups;
p= 0.9)86
At 3 years:
7.88%± 0.20% in IG
and 8.79%± 1.38%
in CG (p=NS)85
At 5 years:
7.3%± 1.0% in IG
and 9.0%± 1.6% in
CG (p< 0.001)83,84
CG, control group; IG, intervention group; NS, non-significant.
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feasible, it did not offer any enhancement to quality of life. A key issue for this study, as with many others,
is the number of patients who had to be approached in order for this small sample of 30 patients to be
achieved.68 Information on reasons why patients decline participation would be helpful in targeting
potential beneficiaries.
Chronic neuromuscular disorders
Seesing et al.90 completed a RCT of SMAs in patients with chronic neuromuscular disorders.90
Two hundred and seventy-two patients and 149 partners were included. Health-related quality of life
showed greater improvement in patients who had attended a SMA (mean difference 2.8 points, 95% CI
0.0 to 5.7 points; p= 0.05). Secondary outcomes showed small improvements favouring the control group for
satisfaction with the appointment (p= 0.01). Neurologists spent less time per patient during the group clinic
intervention: mean 16 minutes (range 11–30 minutes) versus 25 minutes (range 20–30 minutes) for
individual appointments.
Older adults
Only two randomised trials have evaluated SMA interventions in older adults with a recent hospitalisation or
other criteria for increased utilisation. Coleman et al.65 studied a population with one or more self-reported
chronic conditions (e.g. asthma, COPD, congestive heart failure, diabetes and heart disease) and measured the
effect of the intervention with respect to a range of health-care utilisation measures such as emergency
department visits, hospitalisations and primary care visits. Similarly, Scott et al.79 studied a population with a
range of chronic conditions using utilisation measures (e.g. clinic visits, inpatient admissions, emergency room
visits, hospital outpatient services, professional services, home health and skilled nursing facility admissions);
measures of patient satisfaction, quality of life, self-efficacy, activities of daily living (ADLs) and patient costs.
A further trial, deemed by Edelman et al.18 as being poor quality, predates our date-cut off, having been
published in 1997.94 The study by Coleman did not include any clinical outcomes and so is discussed under
Study analyses: health service utilisation measures.65 We did not find any recent trials studying an older
adult population.
In the trial by Scott et al.79 only participants expressing a strong interest in group care (37% of those eligible)
were randomised occasioning significant concerns relating to external validity. Other methodological
problems included failure to describe allocation concealment, outcomes assessed without blinding to
intervention and poor specification of outcome measures.18 SMA visits for older adults were designed in a
similar way to the diabetes studies, except that fewer disciplines participated in the clinical teams.
Scott et al. conducted their trial in primary care in a group-model health maintenance organisation setting
in the USA.79 The comparison was between SMAs and usual care. The mean age of participants ranged
from 73.5 to 78.2 years of age. The most common chronic conditions were arthritis, hypertension,
difficulty hearing, heart disease, liver disease and bladder/kidney disease. The trial by Scott has been rated
by our team as being at moderate risk of bias.79
Scott et al.79 found that patients assigned to SMAs rated the quality of care 0.3 points higher on a 1–4 scale
than usual care patients did (p= 0.048). Scott et al. did not evaluate staff satisfaction using a validated
measure, nor did they report comparative data on medication adherence.79 Among strongly motivated
participants with a high interest in group visits, Scott et al.79 reported two or fewer visits over 24 months by
approximately 25% of patients.
Biophysical outcomes were not reported, probably because of patient selection being on the basis of age
and health-care utilisation rather than a particular illness.6 Scott et al.79 reported effects on overall health
status (via the Likert scale) and functional status using ADLs or instrumental ADLs; there were no
differences in outcomes for any of these measures. They also reported effects on health-related quality of
life using a 10-point scale.79 Participants randomised to SMAs rated health-related quality of life higher
at 24-month follow-up versus usual care (p= 0.002).
DOI: 10.3310/hsdr03460 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 46
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Booth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
57
Study analyses: health service utilisation measures
In addition to the biomedical outcomes, several health service utilisation measures have been measured in
isolated studies. These are not suitable for meta-analysis but these are reviewed together with an
assessment of the consistency around results.
Diabetes
Group approaches to diabetes have primarily been evaluated with regard to emergency department
utilisation (see below).
Other conditions
We identified two randomised trials65,79 that evaluated the effects of group clinic approaches on older
adults with high health-care service utilisation rates. Both studies reported positive effects on patient
experience from the group clinic approach (specifically SMAs) compared with usual care. There was no
difference compared with usual care for overall health status or functional status. Neither study reported
biophysical outcomes. Both trials showed fewer hospital admissions in the SMA groups.
Emergency department utilisation
Diabetes
Edelman et al.18 report that effects on emergency department visits were reported in five studies.20,57,69,81,86
Two studies reported significantly lower visit rates69 or the proportion with an emergency department
visit.86 Rates were not significantly different in the other three studies.20,57,81
Other conditions
One study of older adults found that participants in a CHCC group were significantly less likely to make
any emergency visit than those in the control group (35% vs. 52%; p= 0.003).65 After controlling for age,
gender, asthma, COPD, congestive heart failure, diabetes, heart disease, functional status and previous
emergency utilisation, the adjusted risk ratio for a group patient making any emergency department visit
compared with a control patient was statistically significant at 0.64 (95% CI 0.44 to 0.86). Similarly, CHCC
participants averaged fewer emergency visits during the 2-year follow-up period than control participants
(0.65 vs. 1.08; p= 0.005). With regard to the frequency of emergency department use, Coleman et al.65
reported that over a 24-month study period CHCC participants were less likely to have made an
emergency visit and also less likely to have made multiple emergency visits (p< 0.001).
In another population of older adults, Scott et al.79 showed a statistically significant difference, with fewer
admissions in the SMA group. SMA visits were also associated with a statistically significant decrease in
emergency department visits.79
Hospital and outpatient services utilisation
Diabetes
Edelman et al.18 identified five studies of diabetes group clinics reporting the effect on hospital admissions.52,58,69,81,86
Four studies reported admission rates involving 603 patients followed from 6 to 18 months. In three of these,
admission rates were lower with SMAs, but the result was statistically significant in only one study.52 The
fifth study86 followed 707 patients for 2 years and reported a statistically non-significant lower proportion of
patients with a hospital admission who were randomised to SMAs (16.9% vs. 21.0%; p= 0.10).
Other conditions
Coleman also examined the effect of group visits on overall utilisation in an older adult population.65 On
average, CHCC participants had fewer hospitalisations (0.44 vs. 0.81; p= 0.04) than did controls.30 Primary
care visits did not differ between the two groups. However, once the group visits themselves were added
to the primary care visits, intervention patients had significantly higher overall outpatient utilisation
(23.5 vs. 13 visits over 2 years; p< 0.01).30
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Acceptability and sustainability
A further important consideration with regard to the effect of group clinic type interventions is the progressive
attrition of a group clinic cohort over time as one progresses along the pathway of care. We undertook a
preliminary analysis using available data to explore indicative types of attrition along this pathway.
Starting with the important area of recruitment to the programme, even if levels of recruitment are
impressively high (e.g. 80% of eligible patients) this still means that alternative provision, by which we
would typically mean an individual consultation plus some type of information provision, is still being
required by one in every five patients. A recent trial found an enrolment percentage of only 31%64 – and
this was with the prospect of 50% of the patients receiving usual care. Alternatively, if group clinics are
mandatory as the only type of provision, this would yield a significantly large proportion of patients who
would be being treated either inappropriately (e.g. those with more complex or more advanced conditions)
or with a high possibility of dissatisfaction. Some commentators hypothesise that those patients most likely
to opt for group care would include patients with shorter disease durations and those with less severe
disease, but this cannot be established from available data.
At the next stage acceptability can be examined through attendance at the clinics. This issue is confounded
because the evidence base is unable to determine optimal frequencies, intervals and intensities for the
intervention. For example, a patient may attend only half of the scheduled sessions but still receive an
‘effective dose’ of the group clinic intervention. Even taking this factor in account we have encountered
figures of 14% of patients attending no visits at all.30 Again, the issue is whether these patients would be
picked up by usual care or whether group clinic type provision would result in a significant proportion missing
out on care altogether. Even assuming that a patient attends some of the scheduled sessions, and that this
actual number of sessions still constitutes an active dose, there are still issues of inefficiency if large numbers
of available slots are unoccupied. An alternative is to overbook, as with appointment systems, but this in turn
may cause problems (e.g. accommodation, scheduling of individual meetings, suboptimal staff-to-patient
ratios, etc.) if all eligible patients turn up for a particular session. Indicative figures suggest that between 12%73
and 22%69 of patients miss one session, with many more missing more than this. Of course, this must be
compared with figures for attendance at individual consultations. Furthermore, Junling et al. separately
analysed attendance for the first 3 months and then the next 6 months, and found that the percentage of
those missing one session increased from 12% to 16%.73 Barriers to attendance include transportation
difficulty, hospitalisations, transferring clinics and scheduling conflicts.75
Next there is the issue of how many patients will continue with the intervention. Unfortunately, for this
issue only limited data are available, relating to short-term attendance. Cole et al. found that 80%
remained at 3 months, and only 69% completed the 1-year assessment.64 Of course, much more critical
would be the corresponding figures for continuation over 3–5 years. Housden et al. signal the absence of
long-term evaluations of group clinic-type interventions:
Fifteen of the 26 studies were 12 months or less in duration, and 6 studies were up to 2 years in
duration. The study with the longest duration followed patients for 5 years after the intervention.
Therefore, the long-term or sustainable outcomes of group medical visits are unclear.53
Evidence from group education sessions suggests that patients ‘satisfice’95 with the information they have
already received and once they have attained perceived benefits of the group intervention they are
correspondingly less motivated to continue to attend. Certainly the evidence examined for this review
indicated that less experienced patients were more likely to want to continue with the intervention than
those with greater knowledge and personal resources relating to their condition.96
Finally, even where patients have adhered to treatment during a carefully prescribed trial period this does
not mean that they would continue outside the limited time period of the experiment. Significantly, in a
group clinic for parents and adolescents, when asked about their views of the group clinic approach,
having experienced the intervention, 66% of parents returning the questionnaire would join a GMA in
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future and 87% would recommend a GMA to other patients. For the adolescents, 46% would join a
future GMA.96 With either one-third or over half of participants preferring not to join a group medical
intervention outside an experimental period, this approach does not appear well suited for the mainstream
provision of chronic disease management.
These limited insights from available data suggested to the review team that circumstances under which a
group clinic intervention might be more successful are:
1. during an initiation period for a particular condition over a time period as determined by both patient
and clinician
2. for a potentially time-limited circumstance (e.g. during preparation for bariatric surgery for obesity).
Outside these circumstances a model that involves periodic booster sessions may prove more effective and
acceptable than the implied lifelong monitoring of the condition within a group dynamic. This also raises
the issue of alternative formats for such refresher sessions, for example using internet virtual technologies
for the socialisation and facilitated interactions. We return to these issues in the Chapter 6.
Summary of main findings from randomised controlled trials
In summary, findings from a total of 33 RCTs, of which almost half are considered to possess a low to
moderate risk of bias, indicate that biomedical outcomes (e.g. blood pressure and HbA1c, specifically within
the disease context of hypertension and diabetes) are most likely to be significantly affected by group
clinic-type interventions,. However, this is by no means the case for all such outcomes. One of our clinical
advisers suggests that factors affecting modification of blood pressure and HbA1c are multifactorial and
are, therefore, correspondingly more likely to respond to a complex, multifactorial intervention such as a
group clinic. In contrast, measurements such as cholesterol are affected by less complex health choices for
which a group intervention may be less appropriate. The reasons for this difference in results across
biomedical outcomes require further investigation.
Where such effects to be demonstrated conclusively, these would be of important clinical significance.
As Housden et al. state:
Small decreases have . . . substantial clinical impacts: a 1.0% reduction in HbA 1c may be associated
with a 37% decrease in microvascular complications, up to a 14% reduction in the incidence of
myocardial infarction and a 21% decrease in the risk of death from diabetes.53
In moving away from easily monitorable and measurable outcome measures it becomes increasingly more
challenging to demonstrate a causal effect. For example, disease-specific health-related quality of life
demonstrates a significant effect (albeit from only three RCTs), whereas generic health-related quality of
life (measured in two RCTs) at a further level of abstraction is only marginally significant. The most
recent systematic review and meta-analysis, including only SMAs in a diabetes context,55 concludes that
published examples were so heterogeneous as to yield genuine uncertainty about which elements of
the intervention make a SMA intervention successful. Furthermore, issues concerning acceptability and
sustainability have been raised from the trial evidence and require further exploration. These issues are
explored in the following sections examining qualitative, UK-centric and theoretical aspects of the group
clinic type of intervention respectively.
Results of the qualitative synthesis
Characteristics of qualitative studies
The review identified 12 qualitative papers27,97–107 reporting 10 studies (Table 19). Seven of the 10 studies
were conducted in the USA,27,98–100,102,104,105 with one each from the UK,97 the Netherlands103 and
Canada101,106,107 (three papers). Four studies explored SMAs27,99,102,103 and one examined DIGMAs.98 The
remainder comprised GMVs (two studies, four papers)101,104,106,107 and group clinics (three papers).97,100,105
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Characteristics of surveys
In addition, the review identified four surveys96,108–110 to be used to corroborate findings from qualitative
evidence. Three of the surveys were conducted in the USA,108–110 with the remaining survey from the
Netherlands96 (Table 20). Two surveys explored GMAs96,110 and one survey examined DIGMAs.108
Jhagroo et al.109 reported an adaptation of three models: the DIGMA, the CHCC and the physical SMA.
As quality assessment of surveys is problematic, these papers were not critically appraised, and data
were used only to triangulate findings and not to generate themes.
Comparison of the distribution of clinic models from the effectiveness literature with that from the qualitative
literature reveals that the principal models of group clinic-type approaches are all well represented.
Eight qualitative studies111–118 were excluded from the qualitative synthesis, as they were available only as
conference abstracts. However, three abstracts111,117,119 related to UK initiatives and so are examined further
in the Results of the review of the UK evidence.
TABLE 19 Intervention label and country for included qualitative studies
Author (year) Model Country Size and nature of sample Disease/condition
Asprey et al. (2012)97 Group
clinic
UK 16 patients and four nurses Osteoarthritis
Capello (2008)98 DIGMA USA Random sample of 30 completers
and seven non-attenders
Hypertension
Cohen et al. (2012)99 SMA USA 17 veterans Overweight/obesity,
metabolic assistance and
smoking cessation
Hroscikoski et al. (2006)100 Group
clinic
USA 45 organisational leaders, external
and internal change leaders,
mid-level clinic managers, medical
and administrative clinic leaders,
front-line physicians and nurses
(53 persons)
Diabetes
Kirsh et al. (2009)27 SMA USA 23 medical students: 12 in SMA
group; 11 in control
Non-specific chronic
disease
Lavoie et al. (2013)101 GMV Canada 34 providers and 29 patients Most common conditions:
diabetes (59%), high BP
(52%) and arthritis (48%)
McCuistion et al. (2014)102 SMA USA 12 medical and administrative staff Non-specific
Mejino et al. (2012)103 SMA Netherlands 46 patients Type 1 diabetes
Miller et al. (2004)104 GMV USA 28 women with at least one
chronic disease
Non-specific
Ovbiagele (2010)105 Group
clinic
USA 13 Spanish-only-speaking
participants; six caregivers; 11 care
providers and nine administrators
Stroke
Piper (2011)106 GMV Canada 9 patients Chronic disease
Wong et al. (2013)107 GMV Canada 63 participants: 10 family
physicians; 7 nurses; 2 nurse
practitioners; 4 primary health-care
co-ordinators; 11 other allied
health workers (e.g. nutritionists,
social workers, medical office
assistants and community health
representatives) and 29 patients
Diabetes, depression,
smoking cessation
BP, blood pressure.
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Study populations and settings
We identified a total of 12 qualitative studies of group clinic type interventions. One-third of these (four
studies) examined the attitudes of patients only. One study96 explored the views of patients and carers, and
four studies investigated both patients and health-care providers.97,100,101,107 One study investigated the
views of providers in isolation102 and one study included views of providers, patients and caregivers.105
A final study examined the views of students regarding SMAs as an educational experience.27 The quantitative
review had revealed a complete absence of measurement of provider experience in the included studies.
The qualitative evidence base clearly has an important part to play in addressing the wider acceptability of
the group clinic intervention within a health-care delivery system.86
Quality of included qualitative studies
The overall quality of the studies included in the review is shown in Table 21, and an assessment of the
quality of each included study is given in Table 22.
TABLE 20 Intervention label and country for included surveys
Author (year) Model Country Size and nature of sample Disease/condition
Hirsh et al. (2001)108 DIGMA USA 32 patients Endometriosis
Jhagroo et al. (2013)109 Adapted three models:
DIGMA, CHCC and
physical SMA
USA 112 patients (51± 14 years,
range 19–87 years) seen in
27 SMAs over 14 months
Kidney stones
Lock et al. (2012)96 GMA Netherlands 38 parents (72%) and
14 adolescents
Haemophilia
Trotter and Schneider
(2012)110
GMA USA 122 patients Breast cancer
TABLE 21 Study design and overall study quality of included qualitative studies
Author (year) Country Study design
Asprey et al. (2012)97 UK Semistructured interviews
Capello (2008)98 USA Semistructured interviews
Cohen et al. (2012)99 USA Focus groups
Hroscikoski et al. (2006)100 USA Semistructured interviews
Kirsh et al. (2009)27 USA Interviews
Lavoie et al. (2013)101 Canada In-depth Interviews
McCuistion et al. (2014)102 USA Audio-recorded key informant interviews
Mejino et al. (2012)103 The Netherlands Questionnaires and online focus group
Miller et al. (2004)104 USA Open-ended interviews
Ovbiagele (2010)105 USA Focus groups and interviews
Piper (2011)106 Canada In-depth interviews
Wong et al. (2013)107 Canada Interviews and direct observation
One study102 was not available by completion of report. For full version of quality assessment criteria please see Appendix 5.
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Population of the conceptual framework
We extracted qualitative data against the elements of the analytical conceptual framework13 (Table 23),
deconstituted into fields on a data extraction form (see Appendix 3). The best-fit framework approach
provides for inclusion of additional inductive elements once the deductive stage of the synthesis is
completed. The qualitative data yielded six principal themes as presented below. However, many of the
data have been extracted from one particularly rich qualitative study101 and, therefore, may represent views
that are not necessarily typical of the study populations across all of the included qualitative studies.
Eight richer studies were particularly influential in populating the conceptual framework and
subsequent synthesis.96–99,101–103,111
Findings 1: feeling supported
A common finding was that the group environment offered individuals an opportunity to derive support
from others in a similar or comparable position to them. Such support could be accessed during the initial
socialisation sessions or, subsequently, when engaging in group education or interaction with clinicians.
There was some evidence to suggest that this feeling of being supported subsequently led to a sense
of security.
You gain; I think you gain a feeling of security, of understanding, of sharing with other people,
of compassion, of support . . . so many things that you wouldn’t gain if you were one on one because of
the humanity of us as people. You know we try to support one another.
Reproduced with permission from Piper106
In such a climate of trust patients were more likely to share information within the group. This in turn
affected the cohesion and a feeling of community within the group, described by one author as an
‘esprit de corps’.99
TABLE 23 Analytic framework to evaluate group visits13
PURPOSE or MISSION of group clinics/GMVs
INPUTS or RESOURCES:
Clinicians
Support staff
Premises
Training
Equipment
ACTIVITIES:
Individual consultations
Group facilitation
Peer support
Information provision
Education
Socialisation
Self-monitoring
OUTPUTS:
Patient participation
EFFECTS (outcomes, impacts)
Short term:
l adherence
l biophysical markers
l patient satisfaction
Mid-term:
l self-efficacy
Longer term:
l self-management
l better disease control
l reduced utilisation
CONSTRAINTS or BARRIERS
to group clinic objectives:
Accessibility
Confidentiality
Privacy
CONTEXT or CONDITIONS of group clinic initiatives
Patient characteristics
Health-care system
RESULTS
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The need for feeling supported is illustrated by one extract, which attests to the feeling of isolation a
patient may feel if they are not receiving necessary support from either partner (husband) or doctor:
You’ve got a group that can back you up . . . understanding what you’re going through . . . if I tell my
husband oh my blood sugar is 2.4 today, he says . . . well you better take some insulin,’ . . . he hasn’t
really bothered to even read about it . . . he’ll get irritated with me. Well that’s the last thing you need.
Reproduced with permission from Piper106
Findings 2: learning from each other (reciprocal learning)
A notable finding from the qualitative research studies was that the group setting offered a context in
which individual group members could learn from the clinicians, where they could learn from other group
members and, significantly, where the clinician could learn from the group members. This last finding was
one of a number that signalled at a shift in the power differential from the clinician dominance of the
one-to-one consultation. This important consequence of group clinic approaches was explicitly highlighted
by several commentators:
Overall, the power dynamic between patient and physician was lessened as the patient now viewed
themselves as being able to impart information to the physician.102
Learning from clinicians
Improved learning from clinicians was frequently identified as a benefit from group approaches: ‘enhanced
learning by being able to cover more information than what would be provided in a traditional visit’.102
Such enhanced learning was expressed in both qualitative and quantitative terms. Piper charted a move
from an information flow that aligns with the power dynamic towards something more dynamic and,
ultimately, more creative:
The learning in the GMVs occurs from the shared experiences of participants and the medical expertise
of the physician and the other health care providers. The loose boundaries created changed the typical
linear exchange of information from authority to client to a circular flow of questions and answers . . .
Reproduced with permission from Piper106
Learning from other group members
The sharing of information with other members was viewed as a form of social bartering by which they
could affirm their membership of, and value to, the group; many participants spoke about the satisfaction
of sharing their knowledge of living with a chronic illness.
Sharing . . . acknowledged their personal experience and it was hoped that they would be able to help
others in managing their chronic condition: –You learn from other people and hopefully they learn
something from me.
Reproduced with permission from Piper106
The emphasis is on what is described as ‘reciprocal learning’:
You feel you’d like to share with a group because you think that they can learn from this problem as
well as you can learn from their problems.
Reproduced with permission from Piper106
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In addition to problem-solving, sharing includes the experience of the disease as well as practical tips
for self-management; learning what other veterans had experienced and ‘tips’ on chronic disease
self-management provided a much needed perspective for many. A powerful vignette of the practical
value of group-based interactions is evoked in the context of a UK-based acupuncture clinic:
Somebody perhaps will go swimming, so they’ll say, ‘This was a nice swimming pool and it was easy
to get to’ so it sort of spreads into all sorts of things . . . which you would not actually have if you
were sat on your own in a cubicle.
Woman in her 50s97
Clinician learning from group members
The group situation may encourage clinicians to acquire a greater understanding of what life with a
chronic condition is like for their patients.
Yeah, they learn things they wouldn’t have learned in one on one, and I could see that . . . Dr. [name]
admitted it even in front, to everybody the other day. He said that more than once that he’s had
revelations that he would not get from one-on-one visits.
Reproduced with permission from Piper106
In addition to learning that may equip a provider to demonstrate more empathy and understanding, there
was some evidence of more instrumental learning:
It [the GMV] has helped me to be more creative in looking at ways to meet people’s needs. Some of
that just comes from the patients themselves because they often have some really neat ideas about
how to overcome challenges or difficulties in dealing with the diabetes.
Provider101
Such suggestions simultaneously become a resource to the group at that time but also a future resource
for use by the provider:
. . . they’ve given me some really good tips and ideas . . . stuff I learned that I wouldn’t have learned if I
had done it on an individual basis. There’s a lot of value that comes out of . . . impromptu patient
teaching of each other.
Provider101
Indeed, a clinician’s willingness to learn did itself acquire a symbolic function as a contributing factor to
improved trust in the clinician–patient relationship:
Being emotionally present allowed the physician to listen and to be genuine in trying to understand
life with a chronic condition: – I trust him [doctor] more when I see that he’s open to learning and
figuring out new things that are only happening in group dynamics.
Reproduced with permission from Piper106
Findings 3: legitimising question answering
A group clinic environment may represent a less intimidating clinical context for patients who are more
reticent. Safety, and indeed strength, in numbers may be perceived as an antidote to the power imbalance
experienced when a patient encounters a clinician on a one-to-one basis.
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A safe environment
The idea of a safe haven, both as a protection and as a source of encouragement, is expressed by
several participants.
I let the physician dominate me a little more in a one-on-one situation than . . . in a group situation.
I’m more likely to open up in a group . . . because there are witnesses . . . a doctor is less likely to be
verbally abusive or mistreat me when there are other people watching and listening. . .101
Surrogate question answering
Wider evidence suggests that patients will often be reluctant to ask questions in a one-to-one consultation.
In a group context they may find that a more active participant is more able to vocalise their own
concerns. Patients therefore become vicariously exposed to information that would not otherwise
be forthcoming.
And sometimes if you’re a little too timid to ask the questions maybe someone else will ask them for
you. So that’s one of the benefits of the group, of course, is the fact that there are a number of
people there up to twelve or thereabouts.101
Encouragement from others
Provided the group is sufficiently informal, cohesive and relaxed and, importantly, does not add to the
stress already encountered from experiencing the condition, it can offer a setting that is conducive to
relationships and positive interaction:
The more relaxed, less-structured environment inherent in GMVs lends itself to meaningful relationship
building for participants who might be shy in a one-on-one visit or who might need more time to
build a trusting patient–provider relationship.101
Benefits for ‘lurkers’
Even if a patient has not formulated a question that they wish to have answered that might correspond to
a question asked by another group member, there is some evidence that they can still derive benefit from
information being shared within the group:
Patients reported learning from others’ experiences, gaining additional information from their provider
based on his/her responses to other attendees’ questions . . . Both patients and providers also reported
that patients felt less intimidated and more secure interacting with PHC [primary health care] providers
in a group, thus sharing more health information.101
Here the analogy is to a virtual discussion list, where some feel more comfortable as active participants
while others feel equally comfortable at being ‘lurkers’. Indeed, these respective roles may be transitory as
lurkers ease themselves gently into the group before feeling empowered to pursue their own
information agendas.
Findings 4: structure and content
We were able to map the qualitative findings on the individual components of group clinics to those
aspects of self-management (Table 24) identified in the report by Taylor et al.29
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TABLE 24 Components of self-management as identified from Taylor et al.29
Example from group clinics Component29
There’s a sort of certain socio-educational aspect to it as well, which is
supportive . . . and they’ll discuss other therapies such as chondroitin or that sort
of thing . . . there’s quite an exchange of information going on97
1. Education about condition
and management
The nurses confirmed that this kind of information exchange took place among
the patients, including discussions about the advice and treatment they had
been given by different healthcare professionals97
2. Information about available
resources
Empowering Patients in Care (EPIC) – clinician-led, patient-centred group clinic
consisting of 4 sessions on setting self-management action plans (diet, exercise,
home monitoring, medications, etc) and communicating about progress with
action plans65
3. Provision of/agreement
on specific action plans
and/or rescue medication
And, of course, then having their conditions checked. I think there’s this level of
comfort too for them, they come in, they know they’re being seen, they’re
feeling that they’re being really well looked after . . . [the GMV] gives them a bit
of peace of mind101
4. Regular clinical review
It isn’t just me sitting telling you what to do. They hear from their peers which
its, people will change doing something, I could tell them ten times and as soon
as somebody beside them with the same condition tells them to do it they
listen, they do101
5. Monitoring of condition with
feedback to the patient
People were still struggling with integrating it into their life, right? I think just
understanding those things a little bit better and just to be able to express those
things seemed to be helpful . . .101
6. Practical support with
adherence (medication
or behavioural)
No illustrative quotations 7. Provision of equipment
A little bit more than just one-on-one, if it’s going to be in a group medical visit
you might be safer, you might not be probed, poked quite so much101
8. Safety netting
If you have a group medical visit on a particular subject there’s a certain
protection there in numbers too, I mean there’s probably not going to be a
whole lot of ‘in your face’ and things done to you or maybe even more
probing questions101
9. Training/rehearsal to
communicate with health-
care professionals
. . . there was evidence that participants shared useful information with each
other, particularly about managing . . . on a daily basis:
Or someone says ‘Oh well I find if I lay this way or do that it eases it’ and, of
course, it all helps everybody . . . so you’re picking up the information’97
10. Training/rehearsal for ADLs
Patients reported that peer teaching and peer pressure to adopt better self-care
strategies were welcomed, and understood as supportive. When such pressures
came from providers in a one-on-one CE [clinical encounter], the same
behaviour was portrayed as abusive or threatening101
11. Training/rehearsal for practical
self-management
I don’t think it’s all medical: a lot of it is mindset . . . it’s like football players,
they like to hang out with other football players . . . you hang out with other
people who know what you’re dealing with and you can talk to and they know
what you’re talking about
Reproduced with permission from Piper106
12. Training/rehearsal for
psychological strategies
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Noticeable from the above mapping process (see Table 24) is that group clinics are able to fulfil many of
the extended self-management roles that may be required from any clinician–patient interaction. In
particular, the group context is strong in meeting a need for training/rehearsal of communication with
health professionals, for ADLs, for practical self-management and for psychological strategies, providing a
safe environment in which these activities can be modelled. The group setting is able to fulfil some
requirements for social support, especially when these needs are not being met by a patient’s significant
others or by their health professional. However, what is missing from the Taylor framework29 (see Table 24)
are the functions of ‘groupness’ seen in socialisation, a sense of shared experience, modelling of realistic or
ideal behaviours and identity through group cohesiveness. Clearly the group clinic approach cannot be
conceived simply in terms of its self-management function, even though this was a major driver in the
origins of group clinics.
Findings 5: confidentiality and privacy
One qualitative study in particular107 focused on issues relating to confidentiality and privacy, a frequently
expressed concern in the context of group approaches. Certain protections can be easily instituted such as:
1. initiating each session with a discussion of confidentiality
2. setting ground rules with examples
3. gaining permission for disclosure of particular types of information (e.g. laboratory values)
4. emphasising that participation in the group is not dependent on sharing of personal information
5. asking specific consent to share information of a particular patient at times during a session when it is
considered potentially valuable as a resource to a group.
This latter approach is described very positively by one participant as a way of allaying initial concerns
about attendance:
But he’s [doctor] he’s been very good because he, he makes sure each person gives permission for him
to relate any information about them. You have to agree. So do you mind if I talk about your disease
or whatever’ and you can say yes or no.
Reproduced with permission from Piper106
Reciprocal learning and circular questioning require similar protections and filters in order to protect the
confidentiality of those sharing the learning. An elegant example of how the distinction between the
contexts of information sharing and confidentiality is presented in a small-town context:
[O]ne provider explained to the group that if he/she learned something about thyroid disease, then this
information could be shared with others. The provider went on to tell the group that what was to
remain confidential was who ‘Mrs. Jones, our neighbor’ was the person who has a thyroid condition.107
TABLE 24 Components of self-management as identified from Taylor et al.29 (continued )
Example from group clinics Component29
the social aspect of it is important for people, it’s like meeting old friends . . .
they love coming in, having a cup of coffee with their friends and just talking
about things101
13. Social support
Forty-two per cent of the patients and 76% of the health care providers had the
opinion that more information about lifestyle is discussed during an SMA.
However, 46.7% of the patients thought that the amount of information
provided about lifestyle was similar to that in an individual visit103
14. Lifestyle advice and support
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Findings 6: the life cycle of the group
It is interesting to observe different views of the group process depending on the stage a person was at
in the life cycle of the group. These views can be clustered around the three phases of contemplation,
initiation and maintenance of group attendance.
Contemplation
Initially, when the prospect of a group clinic is raised, patients may view this with apprehension. It was not
uncommon for participants to express discomfort on contemplating a first visit to a group clinic: feelings of
apprehension of the unknown, wondering what it would be like to speak about their health status in front
of strangers and what it would be like to listen to others’ stories, fearing judgement by others and feeling
pressured to share their experiences of living with a chronic condition.106
This initial hesitance is described by one participant:
I was a bit skeptical at first. I wasn’t sure I wanted to sit ensconced in a clinic and learn all about
everybody’s problems. And then I wondered what it would be like to talk about, it’s like showing off
your, you know.
Reproduced with permission from Piper106
Participants often need to overcome this barrier by attending at least one session:
At first I was wary about this program, but only one visit converted me. It felt warm and friendly vs.
clinical, which is exactly what I needed.
Breast cancer survivor120
Initiation
In some cases observing other patients can serve as an antidote to the initial apprehension, as with group
visits to an acupuncture clinic:
I was just a little apprehensive at first, but I saw all the other brave ladies there not flinching or
anything, so I thought, ‘Oh well, it can’t be too bad.’97
In other cases it is the facilitation skills of the provider that can allay such concerns:
But he’s [doctor] he’s been very good . . . it worked out very well but like I say we were a bit
skeptical at first, just kind of reticent about it a bit. But after we got going it’s, it’s really, it’s
educational actually.
Reproduced with permission from Piper106
The duration of this initiation period is highly variable and personalised; many of the interviewees stated
that it only took attending one GMV before they became comfortable with the concept.106 The initiation
phase was, therefore, seen as the time when participants were at their most vulnerable, presented almost
as a make-or-break time:
Participants who have attended two or more GMVs could identify the vulnerability in first timers . . .
The first one they come to they’re quite quiet . . . don’t ask very many questions, they just listen . . . as
they come to other DIGMAS . . . they are more relaxed all the time and it works, it’s working for them.
Reproduced with permission from Piper106
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Maintenance
While the initial visit serves an initial function in allowing participants to understand what to expect, more
observable benefits accrue with repeated attendance. Participation, and in particular sharing openly,
leads to increased self-confidence in understanding their chronic condition, which leads to improved
self-management.
One man spoke of how he was able to see personal growth in individual participants that led to improved
self-management.
[Y]ou can see their growth because you see them willing to take more risk . . . and be more open
within the group. And if that isn’t growth, you know, of the individual then growing towards
self-management. That’s why the group is so great, I mean . . . it gives you a great feeling.
Reproduced with permission from Piper106
This level of engagement is described by one participant as really getting ‘into a group’:
And these people are really taking this in and they’re helping themselves and they’re sharing with you
. . . you don’t feel comfortable until you really get into a group and become part of it and then
you can.
Reproduced with permission from Piper106
There is some evidence to suggest that the perceived benefits of learning in a group context may diminish
over the life of the group as individual patients become more experienced. For example:
None of the experienced patients reported an increase in acquired knowledge (P< 0.001). In children
‡12 years, all less experienced adolescents reported learning of new aspects of their disease, unlike
the 75% of experienced adolescents who reported no learning effect (P= 0.011).96
In contrast, other patients observed the importance of being reminded of information that they had
previously learned but subsequently forgotten. Some patients reflected that they had thought they knew
about high blood pressure, but learned more.98
Interestingly, none of the qualitative studies makes a distinction between an inception cohort-type group
(where all members of the group grow together) and a self-replenishing group (where new members are
continually added). One might anticipate that a self-replenishing group might become frustrating for those
who have been with the same group for some time. However, this could be mitigated, at least partially,
as group members migrate roles from being primarily beneficiaries to becoming primarily donors of
information and experience.
Summary of main findings from qualitative studies
Clearly, socialisation played a large part in the group clinic intervention, with this factor being mentioned
consistently across the qualitative studies. Several respondents mentioned the relaxed atmosphere where
they were not afraid to share health issues with others. Linked to this is the role of the clinician as
facilitator with the group being cast in the expert role – unless misinformation needs correction.101
Providers benefit from adopting this communicative role101 and also learn more about their patients’
experience of their condition and their medication than they typically might in a one-to-one setting.
There is some evidence of patients benefiting from role models, not necessarily in the sense of modelling
ideal behaviours but often in the sense of conveying a realistic expectation for what the patients are going
through.97 Such modelling extended to normalisation of group behaviours, especially with regard to
management of their condition.
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Information exchange is a key component of the group interaction, with patients sharing technical
knowledge of their condition, practical suggestions, detail on available resources and their own personal
experience. However, it is interesting to observe that patients do not adopt a particular role within a group
setting. To use the analogy of online forums, there are those who are active participants and those who
are quite comfortable being ‘lurkers’. Lurkers benefit from information shared within the group. They may
also benefit from ‘information surrogacy’, that is someone asking a question of concern to them (either
serendipitously or because this question has surfaced during socialisation and is then articulated by a more
vocal member of the group). This explains why group interventions can be fulfilling for these quite
different personality types:
the interview data did not support this hypothesis [that a more gregarious personality would find the
groups situation more acceptable] . . . more private people appeared to be content to read a book or a
newspaper or to listen to others rather than to join in . . .97
Adverse events/negative opinions
Shared medical appointments were not experienced positively by all.103 One parent indicated that he or she
was not informed properly about the purpose of SMAs, which resulted in he or she having incorrect
expectations. SMAs were also viewed negatively by some parents (25%) when patients were present who
did not want to participate or when patients did not interact with each other.
Confidentiality
Wong et al.107 conducted in-depth interviews with 34 primary health-care providers and 29 patients living in
nine rural communities in British Columbia, Canada, and the team identified three themes specifically related
to confidentiality: (1) choosing to disclose – balancing benefits and drawbacks of GMVs, (2) maintaining
confidentiality in GMVs and (3) gaining strength from interdependent relationships – patients learning from
each other. The study concluded that confidentiality can be addressed and was not a major concern for
either patients or providers.
Results of the review of the UK evidence
Characteristics of UK studies/initiatives
A total of 12 reports97,111,116–118,121–128 reflecting nine initiatives within current UK practice were identified
from the literature (Table 25). One further UK initiative, a phenylketonuria group clinic at Great Ormond
Street Hospital,119 was identified from web searching. Owing to the limited volume of UK evidence,
information from conference abstracts was included, where the initiative met the inclusion criteria.
Quality of included UK studies
Although the remit of this report was to identify all published examples of UK group clinic practice, this
approach can be seen to have had a deleterious effect on quality. Of the 13 identified studies, only
five97,118,125,127,128 could be considered either research or evaluation and so could be formally assessed for
quality (Table 26). Four of these were audits, service evaluations or patient questionnaires, leaving just
one observational study125 (moderate risk of bias) and one good-quality qualitative study.97
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Contact with UK advisers
Given the absence of rigorous UK evaluations the review team decided to approach (1) clinicians involved
in delivering group clinic interventions and (2) clinicians delivering care to patients with diabetes, as this
was the group most represented by international evidence (15 of 22 RCTs). The team contacted three
clinicians (two replies) delivering diabetes care and two academics (two replies) involved in evaluation of a
group acupuncture initiative (see Acknowledgements). Clinicians were sent a four-page summary of review
findings to date as of mid-September 2014. Questions explored with clinicians are reproduced in Box 2.
For ease of interpretation observations from these clinical specialists have been integrated as far as possible
with relevant findings from the literature (see Study analyses).
TABLE 25 Summary of UK studies/initiatives
Author (date) Type of clinic Condition Study type
ASPREY (2011) Group clinics Multiple rheumatological
conditions
Asprey et al. (2011)111 Abstract only
Asprey et al. (2012)97 Qualitative
Berkovitz et al. (2008)118 Group clinics Chronic knee pain Audit
Birrell (2009)121 Group clinics Rheumatoid arthritis Abstract only
Birrell et al. (2010)122 Group clinics Osteoporosis Abstract only
Cummings (2012)123 Group clinics Chronic knee pain Letter
Da Costa (2003)124 Group clinics Diabetes Book chapter – case study
de Valois et al. (2012)125 Group clinics Breast cancer Observational study
Kay et al. (2012)126 Group clinics Diabetes Abstract only
Raymond et al. (2010)119 Group clinics Phenylketonuria Abstract only
Seager et al. (2012)127 SMA Obesity Satisfaction study
White et al. (2012)128 Group clinics Knee osteoarthritis Evaluation
Winfield et al. (2013)117 Group DMARD
counselling clinics
Rheumatoid arthritis Abstract only
DMARD, disease-modifying antirheumatic drug.
TABLE 26 Quality of UK group clinic studies
Author (date) Study type Study quality
Asprey et al. (2012)97 Qualitative Low risk of bias
Berkovitz et al. (2008)118 Audit High risk of bias
de Valois et al.(2012)125 Observational study Moderate risk of bias
Seager et al. (2012)127 Questionnaire study High risk of bias
White et al. (2012)128 Service evaluation with cost savings High risk of bias
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Patient and public involvement
The short time frame for the review and the heterogeneity of group care models, coupled with an overall
review strategy that already accommodated patient perspectives from the qualitative and UK research
literature, meant that it was not considered feasible to elicit unique perspectives from current or past NHS
patients. We accept that had there been more examples of current UK initiatives this could have proved a
useful source of additional data. We therefore recommend that any future UK-based evaluations seek to
engage patients and the public through robust involvement mechanisms.
Study analyses
What UK models of group clinics currently exist?
Table 27 reports the frequency of the terminology relating to group clinics in the UK ordered according to
mentions in the UK literature. It is noticeable with regard to terminology that UK initiatives favour the
terminology of ‘group clinic’ (Table 27). This tendency may mask the theoretical and philosophical origins
of UK initiatives and make any attribution of potential effectiveness from US-based trial evidence
potentially more problematic.
BOX 2 Questions for consultation with UK stakeholders
For this consultation we would like you to address the following questions:
1. For clinical experts (e.g. diabetes) – how might you explain the fact that group clinics appear to have a
significant effect for haemoglobin and systolic blood pressure (and indeed for disease specific quality of life)
but not for other biomedical or wider outcomes?
2. To what extent is it feasible to join together clinical consultation and group education activities within a
National Health Service context? What are current typical levels of group education provision (i.e. is group
education a common part of current service provision?)
3. Could you foresee any potential cost savings from introducing a group clinic approach?
4. Which activities do you see as most appropriate within a group clinic approach? Are there any specific
populations for whom a group clinic approach would seem particularly inappropriate?
5. Which type of conditions might be most suited to a group clinic approach?
6. Have you any other observations, relating to the above information or to the topic of group clinics in
general, that you would like to share with our review team?
TABLE 27 Most frequently described group clinic approaches in the UK
Model Number of studies
Group clinic97,111,118,119,121–128 9
SMA127 1
Other: group DMARD counselling clinic117 1
DMARD, disease-modifying antirheumatic drug.
No mentions of CHCC model; specialty CHCC model; DIGMAs; chronic care clinics; cluster visits; GMAs; GMVs; group visits.
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How do UK patients feel about group clinics?
Three studies from a related programme of research by Asprey et al. on attitudes to group acupuncture
provide some useful insights as to UK considerations for group clinic provision.97,111,128 In a published
abstract Asprey et al. reports that most patients were very positive about the clinics, reporting several
benefits, both physiological (reduction of pain) and social (useful support and information sharing with
fellow sufferers).111 In a more extensive qualitative study by the same author there was a ‘generally positive
and often very enthusiastic attitude towards the group sessions’.97 Significantly, patients took great pains
to emphasise the differentness of their own personal experience while drawing strength from being in the
same situation. This illustrates that group homogeneity may be considered an artificial construct. Group
interaction can be perceived by some as ‘idle chitchat’ yet by others as a valuable exchange of advice,
support and information. Even though people saw themselves as different from each other they were still
interested in other’s experience of treatment especially if it was seen to make a difference. They were
also interested in learning how someone who was essentially different and yet who faced the same
situation (e.g. difficulties in getting out of bed) coped with their own challenges. However, for others the
need to be with like-minded people was an important factor in a satisfactory group experience.
One added benefit from the group experience relates to the perception that it will be a forum for sharing
experience; this contrasts with the individual consultation where interaction between individuals is limited
as they serially follow each other through the consultant’s door. This suggests that certain desired features
of the group clinic such as socialisation and information sharing might be harnessed without necessarily
utilising the formalised group clinic structure.
An interesting observation from the group acupuncture programme of research is that patient preferences
could extend in either direction between what patients received and what they would have liked to
receive. Additionally, patients were not always able to anticipate accurately what their actual experience of
a particular modality might be. There was thus a sense that patients would truly know how they respond
to the situation only once they were receiving the modality. For example, they may feel that they have very
little to contribute within a group situation only to discover that they can provide reassurance to another
patient and thus feel good about their role within the group. The group dynamic also tended to deflect
attention away from the therapist as a single key part of the treatment programme to focus on what the
group might collectively contribute through their conversations and interactions.
Finally, the reality in a knee osteoarthritis context was that group clinic approaches might be perceived as a
delaying tactic as patients were willing to try anything to put off the uncertain prospects of knee surgery
for as long as possible. In such a context the altruism that one might contribute to the group could
conceivably be viewed as a post hoc response to make the best of a situation where one is running out of
viable alternatives.
Are there any negative reactions to group clinics from UK patients?
One patient from 16 interviewed by Asprey et al. had a negative reaction to the group experience and
ceased to attend.111 No specific details were provided regarding the nature of this reaction. Privacy was not
considered to be a problem even in mixed-sex clinics, but single-sex clinics were preferred. However, as the
authors comment, the condition under study, knee osteoarthritis, does not carry any specific sensitivities.
The concerns expressed related to the intimacy of conversations among women and potential
embarrassment relating to physical appearance, as expressed by women or perceived by the men.97 It was
suggested by patient representatives that it would be helpful to forewarn patients about what the
procedure will involve before their arrival at the clinic and suggest that they dress accordingly. Although
this issue arises in a specific treatment context, it links with other qualitative comments about the
importance of communicating realistic expectations of what will happen within the group process.
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How do UK health providers feel about group clinics?
Asprey et al. reported that four nurses interviewed perceived benefits of group clinics in terms of
cost-efficiency, the efficacy of the acupuncture treatments and the positive effect of group interaction on
their patients.111 The same author further reported the specific needs, as mentioned by one nurse, to make
provision for ‘Asian ladies’, by which the nurse specifically meant Muslim women.97 Generally, single-sex
clinics were preferred to mixed-sex clinics even though the level of physical privacy required for
osteoarthritis clinics was not significant. Another population group for whom group approaches may not
be an attractive option is those with hearing difficulties, who may find it difficult to interact and participate
and may not benefit fully from information exchange.
What evidence is there about feasibility or costs?
In an abstract presentation Winfield et al. described the use of group clinics for disease-modifying
antirheumatic drug (DMARD) treatment in South Devon.117 Over a period of 3 months 90 patients were
seen in clinic, representing an average of 2 hours and 40 minutes per week saved by counselling patients
in groups. The average time of wait from referral to appointment was 10 days. However, the authors
report that some patients took longer than this because of abnormal tests or personal issues such as
holidays. Levels of patient satisfaction were very high, with average scores ranging from 4.6 to 5 out of 5
across the seven questions in the group clinic and from 4.8 to 5 in the individual clinic. There was minimal
variation between the scores given by the two groups, with the largest variation in whether or not patients
felt confident in starting the medication. Here, the individual clinic gave an average score of 4.8, with the
group clinic giving an average score of 4.6. Winfield et al. conclude that group DMARD clinics allowed the
clinics to keep up with demand for slots while freeing up nurses to undertake other duties.117 Patient
satisfaction was generally maintained across group clinic and individual settings. However, the authors alert
readers to an ongoing need to address all patient ideas, concerns and expectations.
The group acupuncture setting described by Asprey et al.97,111 and White et al.128 involves the use of a
dual-purpose room and a carefully crafted logistic timetable. A single room is used with a single
practitioner who is present for, say, 2 hours. Treatment in the group is given to patients while they are
seated, with about 12 chairs situated around the room. The very first appointment is different: the patient
is seen alone (to establish therapeutic relationship, and in case confidential issues arise) and treated on a
couch (in case of fainting, which may occur on the first treatment with acupuncture). For convenience, the
couch may be in the same room as that in which the group is held, in which case the initial, individual
appointment would take place during specially identified time slots at the beginning or end of the group
clinic. All subsequent attendances are in the group: patients arrive at different times and join the other
patients already there, and are treated by the practitioner in the presence of the other patients.
Two clinical advisers reported unpublished experience from trying to join up the clinical consultation and
group education aspects of diabetes care. This attempt had not worked very well as large numbers of
patients did not attend and among those who did attend there was a fall-off in attendance as the
appointments went on. These issues regarding acceptability and long-term sustainability have been
previously flagged in the literature and are returned to later in this report. Interestingly, an explanation
advanced from both clinical advisers from their team was that group education is currently presented as an
optional extra and is not an essential part of the treatment. This observation highlights the important
mechanisms that engage with the symbolic function of the group clinic.
Another concern from the group acupuncture programme of research related to the spatial implications of
delivering services within a group. One participant felt that the presence of equipment for multiple patients
within a confined space might impair others’ experiences of group treatment. Similar considerations may
well pertain where equipment and activities relate to monitoring instead of treatment. Again, we can
conceive that inadequate space may serve as a symbolic as well as a practical barrier, in that inadequate
resourcing of the group clinic premises may be taken as signalling a lack of importance attached to this
specific activity.
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Summary of main findings from UK evidence
Thirteen papers were identified that described initiatives from the UK.97,111,117–119,121–128 None of these
represented experience from rigorously conducted experiments. Descriptions of several initiatives were
available only as abstracts. Acceptability of group clinics is high among a population requiring group
acupuncture for knee osteoarthritis. However, the sensitivity of health and lifestyle topics is not a key issue
for this particular population. Even within this context there was an expressed demand for single-sex
sessions, including in a Muslim population.97 Patients considered that single-sex sessions represented good
practice, regardless of specific religious and cultural considerations. A good-quality qualitative study from
the UK highlighted the importance of situational factors such as a physical space and a flexible
appointment system.97 Patients for whom group clinic sessions may not be as appropriate include those
with complex conditions, those with extreme pain97 and those with hearing difficulties.
It should be noted that the absence of empirical studies from a UK context has led to a disproportionate
reliance on the reported experience from UK group acupuncture clinics. Two particular considerations are:
1. Group acupuncture clinics differ from other group clinics because patients arrive with the expectation
that they will receive treatment. For group clinics in general, treatment and follow-up is more typically
contingent on the findings from the monitoring and consultation processes. Potentially, patients
attending group acupuncture clinics may have stronger motivations for attendance than those
attending for routine monitoring.
2. Acupuncture treatment involves patient downtime (typically at least 20 minutes) as the patient receives
treatment. Although the efficiency argument (in terms of number of patients who can be seen by a
consultant) is frequently rehearsed in opinion papers the driver for acupuncture clinics may be seen as
an example of where a clinical team may be able to ‘work smarter’. Although this driver may be seen to
make group acupuncture clinics demonstrably different from other monitoring contexts this could have
the potential benefit of showcasing another type of situation that might potentially benefit from group
approaches in other disease areas.
Contact with the clinical experts revealed other potentially important issues, in that the acupuncturist was
not formally trained in or charged with the task of facilitating the group. As a consequence, group
interaction was expected to be more organic and less manufactured. Furthermore, socialisation, as we
have termed it elsewhere in the report, could not really be considered a formal part of the ‘programme’.
However, potential benefits have been identified where group communication occurs opportunistically,
such as (a) the normalisation of symptoms, (b) the sharing of information on resources available and
(c) encouragement to adhere (or, more accurately, to continue to attend even though improvement may
take a few weeks to become noticeable).
Other contextual UK evidence
The review team also accessed a UK-based discussion on group clinics hosted by the GP-UK (an e-mail
discussion list for the UK Education and Research communities focusing on UK general practice topics)
discussion list.129 Several observations from list members are worthy of note. First, one correspondent
observed that use of the word ‘clinic’ in ‘group clinics’ might be considered problematic as it might create
the impression of an individual session. This might remain the case even though there is provision of
explanatory information to the contrary. Two studies,97,103 including one from the UK,97 observed that
patients or their carers had different expectations of the group clinic arrangement and this resulted in
negative perceptions of the clinic when these expectations were not actually met.
DOI: 10.3310/hsdr03460 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 46
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Booth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
77
Some patients felt that the explanations supplied by nurses were occasionally incomplete and could be
inconsistent, which would result in problems.98
It (mixed sex clinic) wasn’t something I was expecting, wasn’t something I was told about before I
went in . . . you know we’re not all beautiful shapes or whatever, and it’s sort of a bit embarrassing.
Woman in her 50s97
And:
One parent indicated that he/she was not informed properly about the purpose of SMAs, which
resulted in incorrect expectations.103
The GP-UK discussion list also raised concerns about confidentiality as, for example, erectile dysfunction
might be discussed during a diabetic clinic and this may be difficult if couples are present. Sudell discusses
that women may feel able to discuss such matters with their female friends, but this may result in the
partner feeling embarrased.130
This observation highlights that assumptions must not be made about the content of a group discussion
simply on the basis of the condition itself – a sensitive condition might engender sympathetic discussion
and yet a general condition may equally yield embarrassment. The critical aspect is the dignity of those
who are participating and not the condition per se.
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Chapter 4 Realist review of quantitative and
qualitative evidence
Towards programme theory
From a reading of qualitative studies and review and trial evidence, the review team developed a large
number of candidate programme theories as to how the group clinics might work. In particular, we looked
for mechanisms by which patients or providers might be motivated to sustain their involvement in a group
clinic-type approach.
Our initial overarching programme theories are given in Table 28.
TABLE 28 Overarching programme theories for group clinics
‘Label’
Programme theory
Patients with chronic disease
benefit from attending group
clinics if . . . Relevant theory Clinic components
By activity
PT1: ‘feeling supported’ Individuals gain support from
others in the same position as
they are, or worse101
Social support Group sessions; socialisation
Social support
PT2: ‘building trust’ Individuals build up relationships
with care providers resulting in
increased trust, sharing of
concerns and responding to
advice101
Individual and group
components
Training to communicate with
health-care professionals
Individuals build up relationships
with peers resulting in increased
trust, the sharing of concerns and
responding to advice
Socialisation
Social support
PT3: ‘learning by doing’ Individuals model activities in a
safe environment that they can
subsequently repeat at home
Self-efficacy: social
cognitive theory
Group sessions
Training for practical
self-management activities;
training for ADLs
PT4: ‘monitoring as
ownership’
By participating in self-monitoring
individuals experience greater
engagement with their self-care
Self-monitoring activities
PT5: ‘acquiring problem-
solving strategies’
Individuals are exposed to a
variety of problem-solving
strategies from both clinicians
and fellow patients101
Group sessions
Training in psychological
strategies
PT6: ‘gaining information’ Individuals gain both general
and personalised information for
self-care97,103
Didactic group and individual
components
Information about resources
continued
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TABLE 28 Overarching programme theories for group clinics (continued )
‘Label’
Programme theory
Patients with chronic disease
benefit from attending group
clinics if . . . Relevant theory Clinic components
PT7: ‘legitimising question
asking’
Individuals observe and imitate
other group members seeking to
meet their own information
needs103
Empowerment
social learning
theory
Didactic group and individual
components
Training to communicate
with health-care
professionals
PT8: ‘information seeking
surrogacy’
Individuals benefit from
questions asked by others on ‘the
group’s behalf’101
Group sessions
Information about resources
training to communicate
with health-care
professionals
PT9: ‘looking for warning
signs’
Clinicians can identify individuals
who require personalised
follow-up101
Review of clinical data;
self-monitoring; group
sessions
Monitoring with feedback to
the patient
PT10: ‘gaining
understanding’
Clinicians achieve greater insight
into disease experience of their
patients
Symbolic/emblematic
PT11: ‘observing a
difference’
Individuals are able to observe
the impact of self-care on their
own health and that of group
members
Self-monitoring
Monitoring with feedback to
the patient
PT12: ‘modelling positive
behaviours’
Individuals observe strategies of
fellow patients as role models for
their own self-care
Group sessions; socialisation;
specific action plans
PT13: ‘normalising on
group behaviour’
Individuals identify helpful
self-care behaviours triumphing
over realistic patterns of relapse
Social norms Group sessions; socialisation
Specific action plans; lifestyle
advice and support
PT14: ‘signalling
importance’
Individuals perceive that self-care
for their chronic disease is
important enough to justify a
dedicated initiative
Regular group clinic slots
PT15: ‘making a difference’ Clinicians gain satisfaction from a
more impactful intervention as a
change from routine clinics
Group clinics
PT16: ‘joining-up care’ Clinicians and patients perceive
a more joined up team-based
approach with potentially greater
continuity of care103
Multiprofessional team
working
PT, programme theory.
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Programme theory 1: ‘feeling supported’
The group clinic model allows for support from two main sources – from clinicians and from other patients –
to contribute to what has been described as a supportive environment.120 In theory this dual support should
result in an additive effect over that offered either by a one-to-one consultation – ‘I trust him more when I see
that he’s open to learning and figuring out new things that are only happening in group dynamics’101 or from
attendance at a peer support group:
You know we try to support one another, it’s kind of human to do that. It’s human to have
compassion for other people who have problems and you can show that and you can feel that from
other people when you’re in a group, you don’t in isolation.101
Support may be verbal or may be the effect of perceived solidarity:
I was just a little apprehensive at first, but I saw all the other brave ladies there not flinching or
anything, so I thought, ‘Oh well, it can’t be too bad’.97
However, other implications for this dual source of support are that patients may access support judiciously
and appropriately by deciding between the two sources or that they may use the availability of an
alternative source of support to compensate, for example, for the perceived inadequacies of support from
clinical staff.
The same behaviors are not portrayed as a problem by patients when coming from peers . . . When
such pressures came from providers in a one-on-one CE [clinical encounter], the same behavior was
portrayed as abusive or threatening.101
Of course, the availability of both kinds of support requires careful management when misinformation is
being given.
Programme theory 2: ‘building trust’
Following an effectiveness review for the Department of Veterans Affairs in the USA, two experienced
researchers, Kirsh and Aron, have undertaken Theory Driven, Context Dependent Studies of Shared
Medical Appointments: A Realist Work in Progress.131 They propose that a key mechanism to the success
of SMAs is the build-up of trust in the peer group. We also found evidence of trust being built up in the
relationship of the patient with the care provider:
I’ve learned to trust him. I trust him more than I used to and that’s important, that bond of trust has
to be there.101
This establishment of trust with the care provider explains inclusion of group visit interventions in a
Cochrane review of interventions to build up trust.56
Programme theory 3: ‘learning by doing’
Kirsh and Aron also identify the importance of ‘learning in context’.131 Although this is not a complete match
with our concept of ‘learning by doing’, it does share mechanisms by which what is being learnt becomes
familiar and therefore no longer carries a connotation of anxiety. We consider that ‘learning in context’
would more appropriately characterise a home-based intervention. In contrast the type of activities that we
characterise as ‘learning by doing’ (e.g. taking blood glucose or blood pressure measurements) within a group
clinic setting become familiar from experience and support. Although not by any means a home environment
per se, the group clinic becomes a ‘safe environment’ where an individual can trial an activity and seek
recourse to help before incorporating the activity into his or her independent self-management routine.
Trialability is considered an important characteristic that impacts on people’s likelihood to contemplate change.
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Programme theory 4: ‘monitoring as ownership’
Fundamental to a group clinic approach, as exemplified by SMAs, is the ‘combination of witnessed and
private individualised interactions between patients and their physicians, as well as an educational
component’.132 In the RCT by Edelman et al.,69 pharmacists and physicians developed individualised plans
for alterations in medication and lifestyle management, apparently before meeting with the patients
themselves. However, there is sufficient evidence relating to the principles of co-creation to suggest that
more effective behaviour modification will result from patients generating their own plans, with a provider
simply helping to facilitate. In this context, the involvement of patients in their own monitoring, particularly
where this requires hands-on engagement with monitoring equipment, may be both a practical and a
symbolic way of getting them to start to engage with their own management.
Programme theory 5: ‘acquiring problem-solving strategies’
The qualitative studies demonstrated a clear role of the group clinics in the context of problem-solving.
First, patients were reassured by being placed in a group of people who shared the same problems:
Well it was quite nice being in the group, because you kind of think, well other people have got the
same sort of problems, you’re not completely weird!97
Ostensibly, problems do not seem to be conceived as problems if they are issues that other participants
also have to face on a day-to-day basis. However, aside from such reassurance, there is a strong line of
argument regarding the problem-solving function of the group clinic meetings:
Yeah it’s beneficial in a group from the point of view you’ve got someone to talk to, you’ve got an
exchange of ideas or problems or whatever. Whereas if you sit there on your own you’re basically
waiting for the clock to tick round to say, ‘Well I’m finished now’.97
Furthermore, patients gain reassurance from other patients having their own problems resolved:
[Y]ou can follow the other people and you can see what the doctor is doing for their problems . . . we
can see where we’re heading and try to stop it before we get there. We know we’re going to get
there eventually but we want to slow down getting there.101
Programme theory 6: ‘gaining information’
The gaining of information is seen by many patients as one of the primary purposes for participating in a
group situation. This information may relate to the technical aspects of the condition or how a treatment
works, or it may relate to how people cope practically or emotionally with their condition:
There was evidence that participants shared useful information with each other, particularly about
managing the arthritis on a daily basis:
Someone says ‘Oh well I find if I lay this way or do that it eases it’ and, of course, it all
helps everybody . . .97
It may relate to facilities or aids that can help to manage the implications of their condition or how to
navigate health services or other facilities:
They would exchange ideas, their own experiences, how long that they’d had the condition, how, you
know, how much support locally they had, or not (laughs) . . . often they would say ‘Which doctor do
you see here? My doctor says this,’ because they might see different consultants in this hospital.97
They’ll say, ‘This was a nice swimming pool and it was easy to get to’ so it sort of spreads . . . And
how the shop-mobility works . . . all sorts of things, really, which you wouldn’t actually have if you
were sat on your own in a cubicle.97
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Programme theory 7: ‘legitimising question asking’
In the context of the group clinic patients may feel more empowered to ask questions than they might
otherwise be during an individual consultation. The fact that others ask questions during a group session,
together with the potential modelling of how questions should (or even should not) be asked, can
encourage individuals to feel that asking questions is legitimate. However, there is a corollary because
people may be discouraged from asking questions either because the topic is not one they feel
comfortable sharing with a group or because they are generally reticent in a group situation. Good
facilitation skills are required for the group process so that no question is considered ‘too stupid’ and that
individual contributions are valued by the group. The comparative comfort with which patients may ask
questions within the group will also depend on the comparator, namely how comfortable they have felt in
corresponding one-to-one situations with a health-care provider.
Programme theory 8: ‘information seeking surrogacy’
There is significant evidence to suggest that, in the time-pressured environment of the individual
consultation, patients often forget to ask questions that concern them.133 Furthermore, even if they do
remember to ask pertinent questions they often forget the answers that they have been given.134 Being
present when others are asking questions may have several effects:
1. Someone may ask a question that addresses an issue that concerns another patient.
2. A question asked by someone else may prompt a patient to remember a related question that concerns
him or her.
3. The asking of any question by someone else legitimises the question-asking process.
4. Observing the question-asking-and-response process may provide a less pressurised environment for the
taking-in of information relating to the condition.
The corollary to this is that a patient may be deterred from asking a question in a group setting because of
the number or characteristics of the other group members, they may consider their question less important
or more trivial than other questions asked by members of the group and they may become more passive in
the role that they choose to assume in the question-answering process.
Good facilitation skills are required by the provider in order to elicit questions from patients who may be
reticent, to manage the influence of more vocal patients and to correct any misinformation that may arise
during the group interaction.
Programme theory 9: ‘looking for warning signs’
One of the functions of the group clinic from a clinician’s viewpoint is that it offers the possibility of
unobtrusively observing and monitoring a group of patients and thus of ‘triaging’ those who require
specific follow-up. This feature would be particularly important in a model in which individual consultation
is not universal but, rather, is reserved for those for whom it is indicated and/or for a selected population
with particularly complex or heavy requirements. Although in practice this type of group observation differs
little from the observation that might take place during an individual consultation, it is interesting to find
that the participating clinician may frame it differently:
It [the GMV] creates an environment that is the trickery in medicine – to think people are having a
social gathering and you’re working the crowd and doing the medical work while they are having a
good time, I mean that’s optimal.101
Although the overall impression from this data extract is that the ‘trickery’ is in the patients’ best interests
and that it is justified by the fact that the patients are enjoying themselves, this type of comment further
illustrates the importance of setting initial expectations about how information gathered through the
group component of the process will be used.
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The same clinician then seeks to explain how such trickery might work:
. . . people are enjoying themselves . . . and yet there’s a team going around getting all the information
that needs to be gleaned . . . that’s the secret, so you turn it into a really positive experience for the
patients so that’s why they want to keep coming back . . .101
Programme theory 10: ‘gaining understanding’
Although much of the rhetoric of the group clinic literature relates to efficiency for the provider and
improved information and social support for the patient, we were able to identify qualitative benefits
to the health-care professional in terms of their improved understanding of the patient’s situation,
the constraints of his or her condition and, specifically, issues relating to his or her medication or
wider treatment.
I think that it [the GMV] has helped me to be more creative in looking at ways to meet people’s
needs. Some of that just comes from the patients themselves because they often have some really
neat ideas about how to overcome challenges or difficulties in dealing with the diabetes.101
Furthermore, the group clinic interaction also served to enhance providers’ skills and awareness:
Through interaction with patients, providers reported having gained a more advanced communication
repertoire, and developed greater self- and situational awareness.101
Programme theory 11: ‘observing a difference’
One of the motivations for attending a group clinic is observing a difference that is perceived to have the
potential to make a difference to a participant’s own life. Such a difference may be seen in a reduction in
unhelpful behaviours:
A number of the patients mentioned that they had reduced their use of pain killing drugs as a result
of participating in the acupuncture clinics:
I took it upon myself to reduce the medication . . . I have reduced it by 50% so, you know, that is a
big difference, but ultimately I want to not be taking diclofenac at all.97
In other cases patients may observe a change in their underlying health condition and be encouraged to
persist. Observability is considered another characteristic that impacts on people’s likelihood to
contemplate change.
Programme theory 12: ‘modelling positive behaviours’
One of the putative mechanisms for effect in a group context is that other group members may model the
desired behaviours required from the patient group and, therefore, participants will adopt the desired
behaviour. This is supported at a theoretical level by the various social theories itemised in Chapter 1.
We found some empirical data to support this effect. For example:
. . . participants specifically mentioned the usefulness of meeting role models—women who were
successful in coping with their disease.127
We always know we’re not the only one in that boat, when you’re in a lot of pain you think, ‘Oh I
don’t know, is it just me, am I exaggerating? Is it mental? ‘ like this. And you see how everyone else
suffers and how they cope with it.97
Programme theory 13: ‘normalising on group behaviour’
Kirsh and Aron identify an important mechanism as ‘motivation to comply with others’.131 This corresponds
quite closely with our conception of ‘normalising on group behaviour’. A group member can establish a
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benchmark against which they can critically appraise their own behaviour. Although this mechanism is
linked with the idea of other group members ‘modelling positive behaviours’, which may then encourage
an individual group member to comply with others, there is some evidence that models may exhibit realistic,
and hence reassuring, behaviours that might allow a person to aspire to slight but feasible behaviour
modification rather than to a more dramatic and thus less attainable change. A potential adverse effect of
the concept of the ‘opinion leader’ as such is that the very characteristics that make them stand out as an
opinion leader may be the same characteristics that make their example seem unattainable to an ‘average’
person targeted by a group intervention.
A further issue relates to the implied need for homogeneity within the group in order to harness shared
norms and values. This issue, which is apparent in web-based articles, has not been explored in depth in
the research literature. It is conceivable that minority interests in the group may be overlooked or
neglected and that the minority individual may feel marginalised. Interestingly, in the study by Raballo
et al.,135 the concepts most used by patients with type 1 diabetes to define group visits were as follows:
‘comparing,’ ‘knowledge,’ ‘educational’ and ‘friendship.’ In patients with type 2 diabetes, the group visit
resonated with ‘friendship,’ ‘I feel good,’ ‘I like this,’ ‘I learn’ and ‘interesting.’
Programme theory 14: ‘signalling importance’
As illustrated in the UK evidence (see Chapter 3, Results of the review of the UK evidence) there are data
to suggest that one mechanism for engagement relates to signalling to patients, and indeed to clinicians,
that the group clinic, and by implication the activities that take place there, are considered important.
These ‘signals’ may be literal (i.e. in the communications sent to the patients) or tacit (e.g. in the premises
and activities assigned to the group clinic activity). There is reason to believe that there may be an
asymmetrical effect in operation, in that negative perceptions of the premises may have a more powerful
effect in deterring attendance than positive perceptions of the premises might do in encouraging
attendance. However, this needs further investigation.
Programme theory 15: ‘making a difference’
For clinicians, persuasion that group clinics can make a difference is important if they are to contemplate
the not inconsiderable organisational and professional adjustments that may be required for such clinics’
successful implementation. The qualitative studies appeared to indicate that clinicians were monitoring
whether or not the group clinic interventions were making a difference and this had a positive effect on their
own belief in the intervention. When clinicians witness the achievement of the group clinic approach against
an implied inability to engineer change, they are moved to contemplate the advantages of the intervention:
They will self-manage with the group. It isn’t just me sitting telling you what to do. They hear from
their peers . . . people will change . . . I could tell them ten times and as soon as somebody beside
them with the same condition tells them to do it they listen . . .101
This statement indicates the influence of observability and relative advantage, both of which are important
characteristics when someone is contemplating behaviour change.
Programme theory 16: ‘joining up care’
Group clinics are perceived by some staff as an opportunity to develop shared team approaches to patient
care.100 In a UK context a further mechanism relating to joining up care relates to bringing together the
clinical consultation activity and the group education activity that have previously existed separately. Such
co-ordination may result in potential efficiencies but may also be seen symbolically in signalling the
importance of a co-ordinated approach to chronic disease management. Joining up care is therefore not
simply about bringing the two activities together but about emphasising their genuine partnership as
activities of complementary importance.
DOI: 10.3310/hsdr03460 HEALTH SERVICES AND DELIVERY RESEARCH 2015 VOL. 3 NO. 46
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Booth et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
85
Summary of consideration of theory
Programme theory
Group clinics can improve outcomes through socialisation, improved information flows and patient
self-monitoring when health professionals:
l create an atmosphere of trust in which information is freely shared
l encourage patients to take responsibility for the management of their own condition
l supply information that is genuinely attuned to the needs of the patients
and when patients:
l present to the group clinics frequently enough to allow effective monitoring
l do not perceive that group clinics are an inferior option to one-to-one consultations
l do not have reservations in respect of the issues discussed and questions to be answered
l perceive that the needs of partners, carers and significant others are being met appropriately within the
group clinic arrangement.
It is helpful to consider the process of engaging with group clinics as being composed of three key stages:
1. Contemplation – patients must feel that group clinics are a viable and meaningful alternative to the
engrained model of the one-to-one consultation. In an experimental context those refusing to
contemplate a group clinic approach will refuse to enter into randomisation. In a service setting patients
holding similar views will not participate in such a service.
2. Initiation – patients must have the desire and circumstances to start attending the group clinic
sessions. In an experimental context those agreeing to participate will submit themselves to
randomisation but may not subsequently attend any group clinic sessions. In a service setting an
agreement to attend may be overtaken by other circumstances or events.
3. Maintenance – patients must experience continuing ongoing benefits from attendance at the group
clinics. In essence they construct a temporal balance sheet of ‘costs’ versus ‘benefits’, and as soon as
the balance sheet is perceived to be irredeemably located in the ‘red’ they will no longer attend. Such
circumstances may relate to the perceived quality and relevance of the curriculum, the desirability of the
group interaction or the effort taken to attend. It is important that such non-attendance is not solely
attributed to ‘problem patients’; it may equally indicate a lack of flexibility or other suitability of clinic
provision. In either a research or a service context such circumstances may be reflected in infrequent
attendance, a tapering-off pattern of attendance or discontinuation after a certain period of time.
A further consideration, operating at a population rather than an individual level, relates to:
4. Sustainability – should a clinical team continue to work with an inception cohort of patients for as
long as the group remains viable, should they transfer their efforts to a more recent group, assuming
that a residual effect will persist in the original group without further intervention, or is the optimal
model one of periodic group replenishment with members joining or leaving as their desire and as
circumstances allow? In the final case, there are challenges associated with group coherence and
shared learning, although more experienced group members may increasingly become a resource to
other members of the group and find this altruistic role an alternative source of fulfilment, thereby
prolonging their engagement with the group.
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This brief consideration of theory reveals that the question ‘under what circumstances are group clinics
effective for patients with chronic disease conditions’ may be constructed around three key issues:
1. Under what circumstances do patients with chronic conditions agree to participate in group
clinic approaches?
2. Having agreed to attend group clinics, why do some patients with chronic conditions decide not to
attend any group clinic sessions?
3. Having started to attend group clinics, why do some patients with chronic conditions discontinue a
group clinic programme?
Finally, given key issues 1–3 in the above list, what is the most sustainable model of group clinic delivery
from (a) the ongoing cohort; (b) ‘out with the old, in with the new’; and (c) periodic group replenishment.
We will return to these issues in Chapter 6.
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Chapter 5 Brief overview of cost issues and
feasibility
Overview
This chapter first addresses the costs of group clinic interventions before moving on to more general issues
of implementation and feasibility. Using information from studies assessing the costs of group clinics and
economic evaluations of interventions, this chapter aims to:
1. identify key cost elements of group clinic interventions (i.e. where costs might be incurred or saved as
part of a group clinic intervention)
2. identify information relating to the actual costs of these interventions (i.e. the costs of establishing and
running a group clinic intervention and the savings attributed to a group clinic intervention).
Costs
Methods
The methods for this section are found in Chapter 2.
Results of the literature search
The results of the three-stage literature search are presented in Table 29. The analysis of costs used
eight studies.
Included and excluded articles
The included articles consisted of one cost-effectiveness analysis,134 four RCTs with costs included58,69,79,86
and three cost–utilisation analyses.62,136,137
The included studies are summarised in Table 30. Full details of the data extraction can be found
in Appendix 3.
Overview of studies
Of the eight papers included, seven reported studies undertaken in the USA58,62,69,79,86,136,137 and one reported
a study undertaken in Italy.134 The medical conditions for which the group clinics were run were diabetes
(five articles), comorbid diabetes with hypertension (one article) and complex behavioural health and medical
needs (two articles). The patients in this last group were frequent users of the emergency department.
For all of the papers, the perspective was of the health system. The health settings were a diabetes clinic,134
Kaiser Permanente health maintenance organisation,79,137 Puget Sound health maintenance organisation,86
Veterans Affairs Medical Centres,69 university affiliated medical centre58,62 and a hospital.137
TABLE 29 Results of the literature search: costs
Search
Retrieved and screened
at abstract Screened at full text Included
Stage 1: identification of papers during screening
for study inclusion
6 6 2
Stage 2: search of Reference Manager database 1030 17 6
Stage 3: search of MEDLINE and EMBASE 100 15 (7 duplicates) 0
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What are the key elements in examining the costs of group clinics?
Costs incurred in setting up/running a group clinic
Edelman et al.69 calculated the costs of a group visit using data on staff time to run the GMV and staff
time to make follow-up telephone calls. Scott et al.79 estimated costs for CHCC meetings according to the
amount of time that providers spent at the meeting and their mean hourly salaries.
Costs saved as a result of the group clinic
Evidence on costs saved as a result of group clinics tended to be related to health service utilisation,
for example hospital admissions, urgent care visits, primary care visits, specialty visits and group visits.
Clancy et al.62 portioned charges into outpatient visits, emergency department visits and inpatient stays.
What evidence exists for the costs of group clinics?
Costs incurred in setting up/running a group clinic
Edelman et al.69 estimated a cost of US$504 (range US$445–578) to conduct a group visit, with an annual
per-patient cost of US$460 (range US$393–554). Crane et al.136 estimated the total annualised direct
costs of the programme as US$66,000. Scott et al.79 estimated an average per-patient group cost over
24 months of US$484. Staff salaries constituted 77.4% of the total average cost (US$375).
Bondonio et al.134 undertook a cost-effectiveness analysis of RCTs in type 1 and type 2 diabetes. For type 2
diabetes, they calculated that over the study period (4 years), €119.25 was spent by the Italian health
service on each intervention patient, compared with €90.44 for the control group over the same period.
For type 1 diabetes, over the study period (3 years), €271.24 per patient was spent on the intervention
group and €120.15 per patient was spent on the control group.
Costs saved as a result of the group clinic
One study showed no significant difference in costs between group clinics and usual care.86 There were
differences in utilisation, with intervention patients visiting primary care almost one time more than usual
care patients, although there were significant reductions in specialty and emergency room visits among
intervention patients.
Clancy et al.58 established that total costs were higher for intervention patients than for control patients in
terms of outpatient costs (US$1444 vs. US$1099; p= 0.008) and inpatient costs (US$1410 vs. US$365).
However, emergency department costs did not differ.
TABLE 30 Summary table of cost studies
Author (date), country Type of study Condition
Bondonio et al. (2005),134 Italy Cost-effectiveness analysis Diabetes
Clancy et al. (2003),58 USA RCT Diabetes
Clancy et al. (2008),62 USA Cost–utilisation analysis Diabetes
Crane et al. (2012),136 USA Cost–utilisation analysis Low-income, uninsured patients
Edelman et al. (2010),69 USA RCT Diabetes
Levine et al. (2010),137 USA Cost–utilisation analysis Older people
Scott et al. (2004),79 USA RCT Older people
Wagner et al. (2001),86 USA RCT Diabetes
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There was no difference in health service utilisation in the study by Levine et al.137 and they found that
the difference in total costs between intervention and control patients was not statistically significant
(US$8845 vs. US$10,228; p= 0.11).
Edelman et al.69 found a pattern of reduced health service utilisation in the group medical care group
compared with the usual care group as follows: emergency care visits (0.9 vs. 1.3 visits per patient-year;
p< 0.001), primary care visits (5.3 vs. 6.2 visits per patient-year; p= 0.01).
Crane et al.136 compared patients before and after a DIGMA intervention in terms of emergency
department and inpatient charges and also compared DIGMA patients with a control group. The median
total costs (emergency department and inpatient charges) prior to the intervention starting was US$1167
and 12 months after the intervention these had fallen to US$230 (p< 0.001). This was as a result of
reduced utilisation: per person per month emergency department visits dropped from 0.58 in the
12 months prior to involvement to 0.23 (p< 0.001).
Scott et al.79 found that the intervention (CHCC) group had lower health service utilisation [admissions
χ2= 5.8 (p= 0.012); emergency department visits χ2= 9.8 (p= 0.008); and professional services χ2= 7.5
(p= 0.005)]. However, in other aspects of utilisation there was no significant difference between the groups.
Intervention group costs associated with emergency department visits were significantly lower for intervention
than control patients; although there were no other significant differences, costs were lower for health
service utilisation in the intervention group. The overall cost saving was US$41.80 per member per month.
Group clinic patients in the study by Clancy et al.62 found reduced emergency department (49.1% lower)
and total (30.2% lower) charges but higher outpatient charges (34.7% higher) when comparing patients
in the intervention group with those in the usual care group. However, controlling for endogeneity (the
potential for unobserved patient characteristics to influence adherence), group clinics significantly reduced
outpatient visit charges through a reduction in specialty visits (for which group clinics were found
to substitute).
Cost-effectiveness analysis
Bondonio et al.134 undertook a cost-effectiveness analysis. For type 2 diabetes group care patients, using
Diabetes Quality of Life questionnaire (modified) score as a proxy outcome, the cost-effectiveness ratio was
€2.28 and for type 1 diabetes group care, it was €19.46. The authors stated that they were not able to
calculate a quality-adjusted life-year outcome.
Discussion
Group care is more expensive to set up and run, and although not many studies have actually calculated
these increased costs, they have reported increased use of physician time, increased educational resources,
increased frequency of appointments per patient and the existence of one-to-one appointments for patients
on group care, all of which will increase costs when compared with usual care. The lack of information
relating to the costs of the intervention in the studies we examined means that it is challenging to draw
conclusions about the cost of group clinics. From the data from the RCTs, we can understand more about
the key cost elements of group clinics. However, this information would need to be considered in a full
economic analysis in order to be meaningful.
From the studies we examined, we can make better judgements on the cost savings as a result of patient
participation in group clinic interventions. The majority of studies examined addressed the changes in
utilisation and the subsequent changes in costs. There was a mixed pattern of changes in utilisation, with
some studies reporting that intervention patients used fewer health services overall while others reported
an increase in some areas (primary care, inpatient and outpatient). This mixed pattern was repeated in the
assessment of changes in costs; understandably, in studies where utilisation decreased, there was a
decrease in costs. With this mixed set of results, it would not be meaningful to cluster studies together in
terms of utilisation and cost changes.
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It would have been informative to identify whether or not the savings identified are realised over a longer
period of time. We found evidence to suggest that the US health-care system reimbursement process
means that these interventions will always be delivered in a standard way to ensure that insurance claims
are reimbursed, thereby making costs across interventions (although not cost savings) more uniform. It may
be possible to hypothesise that as group clinics become more widespread, staff costs will decrease as more
staff become trained (training being a major part of establishing a group clinic, as identified in the
main review).
Clancy et al.58 aimed to determine why costs were higher for intervention patients than for control
patients. In addition to small sample sizes, they note that participating in an intervention such as a group
clinic might ‘activate’ patients who had previously missed care to catch up with the care that they had
missed, thereby increasing health service utilisation. In addition, the length of study is important: improved
self-care (which is often an outcome of group clinic interventions) may have a time lag, and so for a
shorter study 6 months is not sufficient time to demonstrate a decrease in utilisation and, therefore, to
observe a decrease in costs.
Summary of included studies
Our assessment of costs and feasibility across a heterogeneous set of studies has showed mixed effects of
group clinic interventions on costs and savings. A full economic analysis of group clinics, along with the
robust collection of costs data alongside group clinic interventions, is recommended. A full economic
analysis could allow for data included in RCTs, such as the type of clinician delivering the intervention and
how long each group clinic lasts, to be costed in order to get a more complete picture of the costs of
group clinic. Primary research assembling information on the running of group clinics and the costs that
are saved specifically within a NHS setting would be essential to inform decisions about group clinic
provision in a UK context.
Feasibility
Overview
Feasibility conflates many issues, such as acceptability to patients and providers, practicality in terms of
required procedures (whether alongside or as a substitute for existing practice) and affordability, in terms
of financial considerations and available equipment and premises. The evidence to be mapped against this
domain is drawn from qualitative studies of provider and patient attitudes, implementation studies not
otherwise included in this review and an overall picture of likely cost-effectiveness, as has emerged from
Chapter 4. Feasibility includes general issues to be considered within any context for implementation of
group clinics and specific issues relating to implementation within a NHS context.
What are the key considerations regarding feasibility?
Key to a consideration of feasibility in this context is affordability. Although claims are made of cost savings
these are based on either (1) US studies of limited geographical or temporal relevance or (2) a simplistic
argument of more patients seen by a clinician per hour. In particular, there is limited evidence of cost
implications in a UK study. Indeed, although the insights from group acupuncture clinics are informative in
terms of the group interactions and dynamics within a UK context, the actual assessment of costs would
be potentially misleading. As will be explained later in this report the achievements of the group
acupuncture clinics are located within a ‘work smarter’ treatment delivery model. These otherwise
promising achievements have, therefore, limited relevance to the monitoring model that is fundamental to
group clinic provision.
A further concern relates to acceptability. Our clinical advisers point out that there is a strong expectation
in the NHS of being seen by a specialist clinician within an individual consultation. Even if group clinic
provision were to become the default position, a sizeable proportion of the population would still require
access to the more traditional model, perhaps because of the complexity or severity of their condition or
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because they would demand it through exercising patient choice. Such preference may be affirmed on
commencement of treatment or, as illustrated by UK group acupuncture clinic qualitative data, may
emerge following patients’ experience of the group clinic provision. In particular, the willingness of patients
to try a new modality of service provision should not be interpreted as those patients’ commitment to that
service modality on a long-term basis.
Practical issues relate to the requirement to be able to access all patient records and results in advance
of a single SMA. This may place a burden on diagnostic services but may also prove problematic for the
individual specialist, who would have to make time for review of the notes. The latter factor is examined in
a US context of uncompensated clinician time.132
Other feasibility concerns relate to the need for clinician training, particularly in group facilitation, and the
need for suitable premises. Within the wider picture of feasibility it would be worth exploring whether or
not the individual components considered essential to the group clinic approach could be delivered in an
alternative format. For example, in some circumstances the socialisation or the interaction with a group
facilitator could be offered virtually, offering the opportunity for the clinical team to identify those needing
particular help.
What evidence exists on the feasibility of group clinics?
Little evidence exists on the feasibility of group clinics, even though much of the literature suggests how
they might be introduced. Particularly noticeable is a shortage of data from the UK. The wider
non-NHS-specific literature informs such aspects as implementation and confidentiality. A feasibility study104
revealed such positive aspects of GMVs as personalised attention (77%), self-care education (69%), access
to medication refills and examinations (69%) and advice from peers (62%). Negative aspects included
insufficient personal attention (23%), logistical barriers (8%) and loss of confidentiality.104
Kirsh et al.27 have explored implementation issues relating to SMAs. They identified such important
promoting factors as the formation of a core team committed to quality and improvement with strong
support for the clinic leadership from other team members. Notably, tailoring had to take into account
such ‘key innovation-hindering factors’ as limited resources (such as space), potential to alter longstanding
patient–provider relationships, and organisational silos (disconnected groups) with core team members
reporting to different supervisors. The last point emphasises that group clinics should be seen not in
isolation but as a potential vehicle towards interprofessional team working, with all of the associated
culture changes that this might necessitate.
Concerns relating to confidentiality were raised consistently in the reviewed literature. This issue was
examined specifically in a study by Wong et al.107 This study aptly highlights that GMVs can impact on the
clinician–patient relationship as patients are ‘able to draw upon more informational resources and social
support from attendees and often feel more empowered to pose questions to their providers than they
might otherwise in individual encounters’.107 However, providers reported that ‘the most common reason
for not attending a GMV was patients’ concerns about confidentiality and hence a preference for
individual visits’.107 Nevertheless, one overall finding from the study was that patients who did attend a
GMV consciously selected which information they were comfortable sharing in a group situation.107
Although it could be perceived as a drawback that patients filtered the information they felt able to share,
some interventions included a discussion of confidentiality with practical examples as a component of the
initial group clinic sessions.
Discussion
The review team has identified specific concerns relating to the interpretation of predominantly US data
within a specific UK context. In particular, many of the interventions have been delivered within the
context of health-care financing that determines the exact configuration of approved packages of group
clinic provision and, for example, requires guaranteed access to an individual consultation if requested.
Advice from our clinical advisers suggests that a model in which an increasing amount of the content of
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the previous individual consultation is assumed in a group context, facilitated perhaps by a member of
staff who is not the specialist clinician, may be an alternative form of substitution. This might facilitate
shorter individual consultations, although this issue remains to be investigated. Importantly, however, such
provision would need to be in a context where group education is seen as more central to the chronic
disease management process and not as an optional extra.
Summary of included studies
Although the evidence from the USA and that from a UK group acupuncture clinic context does inform a
discussion of feasibility, a specific need remains for further investigation of the monitoring model of group
clinics within a UK context. This research requirement sits naturally alongside the suggestion made in the
previous chapter for a full UK-centric economic evaluation and the need for qualitative exploration of the
attitudes of NHS patients, providers and caregivers towards group clinic provision. In addition, there is a
requirement to explore the feasibility of ‘substitution’ of specific functions from the individual consultation
with a corresponding group-based provision, along with any training and role development issues this
might occasion.
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Chapter 6 Discussion
Summary of evidence on the effectiveness of group clinics
Health outcomes
By far the majority of studies examining clinical outcomes relate to diabetes and focus on basic biomedical
outcomes that are relatively easy to monitor routinely. It is, therefore, difficult to extrapolate these effects
to other chronic conditions.
Diabetes
Although there is consistent and promising evidence in favour of an effect of group clinics for basic
biomedical measures, particularly haemoglobin and systolic blood pressure, this evidence does not extend
to other important biomedical considerations such as control of cholesterol. Group-based training for
self-management strategies in people with type 2 diabetes is effective by improving fasting blood glucose
levels, HbA1c and diabetes knowledge and reducing systolic blood pressure levels, body weight and the
requirement for diabetes medication.
Disease-specific quality of life improved significantly in a small number of studies and yet this effect was
not found to be as significant for generic health-related quality of life.
Other conditions
For other conditions in older adults benefits have been observed with regard to positive effects on patient
experience with group clinic approaches, compared with usual care. However, no difference from usual
care was reported for overall health status, functional status and biophysical outcomes.
Health service outcomes
Diabetes
Effects of group clinic approaches on hospital admissions and emergency department visits were explored
in five studies on patients with diabetes.20,58,69,81,86 In three of these,58,69,82 admission rates were lower with
group clinic approaches, but the result was statistically significant in only one study.20 Two studies found
that emergency department visits decreased significantly with group clinic approaches.69,86
Other conditions
Two trials in older adults showed fewer hospital admissions for group clinic approaches and a statistically
significant decrease in emergency department visits for group clinic approaches, compared with
usual care.65,79
Summary of evidence on the feasibility, acceptability and
meaningfulness of group clinics
Practical concerns remain. A practical impact of seeing patients individually over separate consultations is a
spreading of workload demand on laboratory and other diagnostic services. In contrast, a group clinic
relies on all patients having their results available for the same clinic. To what extent is this feasible given
the heavy time and workload pressures on diagnostic services? In mitigation it should be said that we
found little reason to believe that the actual burden of workload would be any greater as a result of
seeing patients as a group rather than individually; batches of diagnostic test results could still be
processed within the intervals between clinics. However, there would be a need for improved record
keeping. Perhaps more significantly, the expectations of patients that their test results will be available will
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be shaped by ‘normalisation’ alongside others in attendance at the group clinic. Nevertheless, for
conditions such as diabetes, a significant part of the interaction is derived from self-monitoring and not
from external test results.
Confidentiality is another important consideration, and its full impact has been masked by methodological
issues: those with significant concerns may well refuse to enrol in trials or qualitative studies in the first
place. Furthermore, their concerns may be neglected in studies if they withdraw and are consequently lost
to follow-up. On a positive note, Wong et al.107 concluded that confidentiality can be addressed and was
not a major concern for either patients or providers. In fact, they observed that patients adopted strategies
to address their own and others’ concerns regarding confidential health information. In turn, health-care
providers used multiple strategies to maintain confidentiality within the group, including renegotiating
what information is shared and providing examples of what information ought to be kept confidential.
These practical considerations should be contemplated by anyone planning group clinic-type approaches.
Summary of evidence on the cost-effectiveness of group clinics
The eight relevant studies examining the cost-effectiveness of group clinics were all associated with
settings that are not directly comparable with a UK setting (i.e. seven were from the USA58,62,79,86,117,135 and
one was from Italy133). In addition, some studies relate to time periods that do not reflect current clinical
practice. Medical conditions at which group clinics were targeted were diabetes (five articles)58,62,79,86,133
comorbid diabetes with hypertension (one article)133 and complex behavioural health and medical needs
(two articles),79,136 resulting in very narrow coverage of clinical areas that potentially could be explored in a
group clinic context.
The heterogeneity of the included studies and their different time and geographical settings explain, at
least in part, the uncertain effects of group clinic interventions on costs saved. A full economic analysis
of group clinics, along with the robust collection of costs data alongside group clinic interventions, is
recommended. A full economic analysis would accommodate data included in RCTs, such as the type of
clinician delivering the intervention and how long each group clinic lasts, to derive a richer picture of the
costs of group clinics. Research bringing together information on the running of group clinics and potential
cost savings in a UK NHS context would be particularly valuable.
Certain costs were not explicitly identified within the included studies. For example, it is likely that a group
clinic intervention may require the specialist training of health-care staff, particularly in relation to
facilitation skills.
Perceived and actual benefits and disadvantages of a group consultation
when compared with an individual consultation
Although crude analyses compare the number of patients seen within a group session with the number of
those seen individually in the same time period, such an approach is inadequate for the purposes of a
rigorous evaluation. There is substantial evidence that provision must be made for individual consultations
and also that costs may be displaced to other parts of the health-care system. The cost of individual
consultations must factor in the provision for such consultations within the group session, for those who
are displaced to sessions outside the group clinic and for those for whom group provision is either
inappropriate or unacceptable. Although one assumption encountered in the literature is that the
reduction of health costs will take place over an extended time period, studies that have been conducted
to date have not covered a long enough evaluation period to demonstrate this realisation of cost benefits.
The value of group education
The cost benefit of group clinic approaches depends on whether or not current provision (usual care)
includes existing group education provision and, specifically, whether this is delivered by health
professionals or by lay peer supporters. Group education has been found to have an effect on some of
those biomedical measures addressed by group clinics but not typically to the degree realised by most
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group clinic studies. The cost issue, therefore, becomes ‘what is the demonstrable cost–benefit to be
realised by delivering the specific group clinic intervention compared with the individual consultation plus
group education sessions?’. As indicated by some of the foregoing, this question is complicated by the
issue of what can be quantified as benefits. In particular, is the evaluation framework to be exclusively
that of cost savings – in which case group clinics are unlikely to deliver against this agenda – or is the
evaluation to be situated in the context of joined-up improved-quality interprofessional care?
The value of multiprofessional approaches resulting from simultaneous
clinical involvement
We found some evidence that involvement in group clinics may have accrued particular advantages in
relation to interprofessional team working and mutuality:
[T]he flexibility of the individual team members is manifest during the SMA sessions. A weekly meeting
. . . continues to occur to discuss patients and processes to assure that all team members have an open
forum to voice concerns and make group changes.7
The literature around uni-professional, multi-professional and inter-professional working emphasises
flexibility of roles and a degree of interchangeability as the means by which interprofessional working
might be achieved.138
Issues emerging from the evidence?
The large majority of studies have been conducted within the disease area of diabetes. Diabetes appears
particularly suited to the group clinic approach; it is a chronic condition that requires regular monitoring,
and a high number of potential complications are common to the experience or concerns of a large
number of patients. For the clinician, the attractions of a group clinic approach for diabetes are quite
compelling. As one of our clinical advisors noted, successful management of the condition requires patient
co-operation in the provision of their clinical data and their participation in self-management. The
consequences of non-participation may be serious in terms of both effects on health and utilisation of
emergency departments or other specialist services.
The majority of studies of group clinic type approaches have been conducted in the USA. Although this is
typically an underlying concern for all health service and delivery topics we found evidence that it may be
particularly significant for this topic area. The US health-care funding system is very prescriptive in terms of
acceptable models of GMV for the purposes of reimbursement. Extensive research and evaluation has
been conducted but in only a very limited range of possible models. Such prescription is likely to result in a
stifling effect with regard to experimentation and innovation, potentially denying a range of possible
models from which the NHS might conceivably benefit. Our clinical advisors have highlighted that, in NHS
patient culture, there is significant expectation of receiving an individual consultation, as well as a
reluctance to participate in group care activities and an appetite for only minimal requisite levels of patient
information and education.
A major limitation of this review is that it has not been able to examine the evidence base for the
individual components of the group clinic intervention, such as the individual consultation, group
education, self-monitoring, peer support, etc. We concur with Edelman et al. that:
Without further, more mechanistic studies that attempt to elucidate the key components of an SMA
intervention, implementation of a diabetes SMA or design of an SMA for another condition will be at
least partially based on reasoned judgment rather than strict evidence-based decision making.18
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Our review was unable to find data to address some very critical key questions in relation to group clinic
provision. The evidence base is insufficient to address the issue of what constitutes either a minimally
effective or an optimal dose with regard to the duration, intensity and content of the GMV. Furthermore,
we detected a tension between what care providers consider to be an optimal curriculum to be covered in
the educational component of the GMV and the expressed requirement for a programme to be coproduced
in order to meet participant needs. It would be particularly helpful to be able to answer questions regarding
the time period over which clinically significant outcomes are achieved, the time period for which any
positive outcomes are sustained while the participant is receiving the intervention and the ‘washout period’
following cessation of the intervention, after which effects are no longer achieved. Related to this final
point is the effectiveness of top-up or refresher sessions, together with questions about the duration,
intensity and content of any refresher provision. The discussion with our clinical advisers suggested that
answers to some of these questions may be linked to research findings for group education provision more
generally, although (1) data of the particularity specified above are not typically contained in published
reports and (2) group clinics engage, at least in theory, with additional mechanisms when compared with
group education, and so their effect might be underestimated if this source of data is used.
Discussion with our clinical advisors also revealed an evidence gap with regard to longer-term attendance.
Published research studies tend to interpret attendance in a forgiving manner; some even considered that
attendance at a single clinic constituted a patient being an ‘attender’. More typically, an aggregate of
attendances per person is given, which does not allow us to detect a decay in attendance and
commitment over time. Furthermore, attendance patterns may be confounded by the flexibility or
otherwise of the clinic, the number of alternatives on offer and other issues relating to access and
alternative health-care provision.
Under what circumstances do patients with chronic conditions agree to
participate in group clinic approaches?
From the theoretical literature, we have identified four principal components of a group clinic approach,
as follows:
1. Monitoring: this is a traditional activity in the individual consultation but there is some evidence that
group clinic approaches may turn this into more of a shared activity between the patient and clinician,
with the patient becoming involved in some of the monitoring activities.
2. Self-management: the group clinic approach encourages patients to become more active in managing their
condition. In contrast to an individual consultation, the group-based approach may offer both role models in
those who manage their own condition and tips on techniques and resources acquired from fellow patients.
3. Peer support: this is a completely discrete activity from the individual consultation and one which offers
additional sources of support beyond the clinician and the significant others of the patient. Commonly
in the UK there is a separation between clinical activities and group education approaches.
4. Education and information: quantitatively, there is the opportunity for the clinician to share information
with several patients at the same time, reducing duplication and repetition, and resulting in greater
consistency in information provision. Qualitatively, patients may respond better to information shared in
a less didactic manner or to information originating from fellow patients. More reticent patients may
benefit vicariously from questions asked by more proactive members of the group, in effect becoming
‘lurkers’ within the group.
Typically, patients with chronic conditions appear to make an overall assessment of the benefits of
participation before agreeing to participate. There is some evidence that the disadvantages of participation
are not adequately explained to participants by clinical staff. A significant proportion of those invited to
participate decline, largely because they do not recognise the benefits of group clinic approaches against
the perceived advantages of an individual consultation. Expectations of being seen in an individual
consultation, whether specified by a health plan as in the USA or through cultural conditioning in the UK,
appear to militate against the use of a group clinic approach. Alternative provision will probably be
required for this sizeable group of patients and the very availability of such an alternative may have a
negative effect on uptake.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
98
Having agreed to attend group clinics, why do some patients with chronic
conditions decide not to attend any group clinic sessions?
Constraints related to the logistics of attending the group clinic appointment (e.g. timing, other
commitments, etc.) play a major role in determining whether or not patients with chronic conditions will
attend. However, these same constraints are also present for those seeking individual appointments.
The primary consideration, therefore, appears to be the flexibility of attendance patterns. In particular,
attendance may depend on whether group clinics employ a closed cohort-based approach or more of a
drop-in model.
Having started to attend group clinics, why do some patients with chronic
conditions discontinue a group clinic programme?
There is some evidence to suggest that some patients will attend with a specific goal of receiving
sufficient information for self-management of their condition. Once they feel that they have obtained this
information, their motivation for attendance wanes. For others, the social aspect of a group is particularly
important and this may contribute to their motivation for ongoing attendance, even if the other benefits of
attendance degrade over time. Finally, there are others for whom the sense of shared community persists,
which is recognised from their transition from being beneficiaries to becoming donors to the overall
group process.
Which is the most sustainable model of group clinic delivery?
The identified research literature does not support a detailed analysis of sustainability. Most initiatives were
evaluated over only a relatively short time period. For example, Cohen et al. claimed to have demonstrated
‘that the pharmacist-led group intervention program was an efficacious and sustainable collaborative care
approach’ and yet only evaluated the initiative over a period of 2 years.63 In fact, within the context of
group clinics such an evaluation period is comparatively long. Housden et al.53 reported that 15 out of
26 studies were 12 months or shorter in duration, and six studies were up to 2 years in duration. The
study with the longest duration followed patients for only a period of 5 years after the intervention. We
conclude with Housden et al. that:
. . . the long-term or sustainable outcomes of group medical visits are unclear, and it is difficult to
know if the outcomes were maintained for a substantial length of time after the intervention.53
Qualitatively, there is very little discussion in the published literature about the practicalities of managing
different models of group membership. Such contrasting models have considerable implications for
facilitation, educational content and the group dynamic. These are now briefly discussed, together with
their possible implications.
The ongoing cohort
Explicit to the chronic care clinic and group visit models is the idea of the group representing an ongoing
cohort of patients who have the opportunity to ‘grow’ together. However, there is no discussion in the
included research studies about the implications of withdrawals and dropouts for the group viability
and for its dynamics. Clearly, in an older population, or equally for those with a chronic condition, the
likelihood that the numbers in attendance will diminish, either through natural wastage or through
the utilisation of alternative inpatient or long-term care health services, poses a significant challenge for
the ongoing sustainability of a particular group. Increasing numbers of patients with the chronic condition
means that there is further need for extra facilitators, additional training and greater utilisation of premises.
‘Out with the old, in with the new’
Another potential model of group membership, given that resources for facilitation and group processes are
likely to be finite, would be to work with a particular group to a pre-defined temporal or developmental
point and then to disband the whole group and return to individual consultations. This model was not
identified in the literature, although it is unclear if this is because it is not prevalent or if the relatively short
research and evaluation time frame precludes the study of its longer-term sustainability.
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This model assumes that the initial life of the group is a key point in the disease trajectory, that the
curriculum is relatively finite and stable and, importantly, that there is a carry-over of the group effect
beyond the lifespan of the group. Such a group model makes unchallenged assumptions about shared
information needs and a common pace of learning for all group members. Maintaining a group for a finite
period, identified a priori, may help to sustain the impetus of the group but, paradoxically, may reduce
people’s commitment to the group. One challenge for the facilitator is in identifying an optimal lifespan for
the group, an issue not addressed by the literature.
Periodic group replenishment
A final model would be to treat the group as a more fluid vehicle, with patients being able to leave or join at
any point, subject to the accommodation of numbers within the group membership. From an efficiency point
of view such a model is attractive, as it ensures that provision is sustainable and safeguards against the
attrition of members. However, this ‘mixed’ model may present challenges to facilitation, both in terms of
building up relationships from new with facilitators and with existing group members and, educationally, in
terms of planning of content for a group with heterogeneous learning needs and varying experiences.
One study of this kind of fluid group, for people with haemophilia, measured discernible differences in the
perceptions of the value of group attendance between parents of less experienced and parents of more
experienced members of the group:
The majority of parents (62%) did not regard the additional time investment for GMA as inconvenient
(74% less experienced, 30% experienced; P-value 0.023).96
This was further reflected in differences between the patients themselves in terms of learning:
In children < 12 years, all less experienced adolescents reported learning of new aspects of their
disease, unlike the 75% of experienced adolescents who reported no learning effect (P-value 0.011).96
It is true that more experienced group members could be harnessed as a resource to be utilised by the
facilitator to benefit newer members:
Several veterans enthusiastically volunteered to attend future group clinics to share their chronic
disease self-management experience.99
However, the fluidity of group membership may have adverse effects in terms of commitment to the
group ‘community’.
Strengths and limitations of this review
This was a protocol-driven review conducted by multiple investigators. The information specialist
conducted a very comprehensive subject search of bibliographic databases and this was supplemented by
the extensive pursuit of references and use of citation search techniques. In particular, this allowed us to
identify clusters of associate studies reporting more complete data where available.38 We believe that we
have identified more published trials than any previous review; this has meant we have included more
studies and have been able to review reports included in previous reviews but excluded from our own
inclusion criteria, together with reasons. We performed a rigorous process of checking for inclusion and
subsequent quality assessment. In implementing an innovative methodology of ‘progressive fractions’ we
extended the review resources beyond a narrow focused question defined by the term ‘group clinics’ to
engage with a wider body of the most relevant literature with a range of synonyms. We also employed
exhaustive supplementary search techniques such as follow-up of references, citation searching and
searching for study clusters. We are, therefore, confident not only that we have identified the most
significant literature related to the review question but also that we have minimised the risk of missing
relevant qualitative, cost and UK studies.
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The time scale of this review, telescoped within half the time period of a conventional systematic review,
and its ambition in covering feasibility, appropriateness and meaningfulness in addition to the effectiveness
and cost-effectiveness most typically covered by comparator reviews have prompted the use of several
rapid-review methods. For example, our approach was to examine the extent to which recently published
evidence from RCTs has made a supplementary contribution to the existing evidence base. In actuality,
because of the relatively small number of recent trial reports and the extensive quantity and coverage of
previous reviews, this additive contribution has not been as significant as was initially anticipated. As
this was a rapid review we were unable to perform independent double data extraction and quality
assessment. However, frequent iteration between extracted data and the full text of articles minimises the
likelihood of important errors.
Methodological limitations of the included studies
In conducting the review we identified a systematic bias in the reporting of group clinic interventions.
Selection bias was very likely to occur; even though some studies made strenuous efforts to locate and
collect data from patients who had dropped out, success was limited,97 making it ‘not possible to
investigate the possible disadvantages that some patients might experience’.97 In addition, the positive
group effect, particularly from qualitative studies, may well have been ‘influenced by the fact that those
who do not gain benefit drop out, leaving only patients with a positive experience’.97 Furthermore, there is
considerable under-representation of patients from UK relevant ethnic minority backgrounds (US studies
include Latino/a and African American participants), making it ‘not possible to identify any potential
differences that might be experienced by these groups’.97
Included studies and their corresponding inclusion in systematic reviews typically confused different models
of group clinic provision. One economic attraction of a group clinic approach relates to a ‘substitution’
model, that is where patients attend a group clinic instead of attending individual consultations. It appears
that the rationale underpinning a substitution model is flawed as (1) most US provision of GMVs/SMAs
requires the provision of individual consultations in addition to group clinic provision, and (2) studies may
report individual consultations at the time of the group clinic but are less likely to report these outside
the group clinic session, resulting in an incomplete picture of resource use. One of our clinical advisers
suggested that in a UK setting a different form of substitution might take place, in that the group clinic
facilitator, typically a nurse or dietitian for primarily economic reasons, may fulfil several roles otherwise
assumed by a clinician in an individual consultation (e.g. review of patient results). The challenge in such a
UK substitution model lies in how to decide the extent to which the duration of the individual consultation
might be reduced, the impact this might have on the topic content of the individual consultation and
the logistics of co-ordinating the individual and group sessions. Unless a study demonstrates an explicit
reduction within the experimental group in the corresponding time for the individual consultation input,
compared with the control group, the model being described is essentially an enhanced care model
(i.e. previous individual consultation enhanced by GMV).
Our typology of group clinics models characterised two further variations:
1. the group clinic plus model, where every patient is offered an individual consultation (i.e. universal
same-session individual appointments) and savings are achieved for each patient who deems an
individual consultation unnecessary
2. the group clinic triage model (i.e. an indicated simultaneous individual appointment), where a clinician
offers a consultation only where the group session reveals a cause of particular concern and savings are
achieved by not consulting with patients who do not merit special attention.
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A disappointing feature of the evidence base relating to group clinics is the predominance of diabetes as a
studied disease area. As Edelman et al.18 observed, little evidence is available for other chronic conditions
of interest such as coronary artery disease, chronic heart failure, asthma, COPD, hyperlipidaemia or
hypertension. In addition, the included studies focus on achievement of biomedical outcomes, with
comparatively little information on organisational or system-wide factors.18
We approached this review with the perhaps simplistic expectation that group clinics would represent a
genuine alternative to the individual consultation. In actuality, individual consultations continued to be
delivered, mainly as a result of patient expectations and the stringencies of the US health-care system.
The revised research questions, for which we have remarkably little evidence, relate to the extent to which the
duration of an individual consultation can be reduced and the extent to which information from this
consultation can be delivered by other, less specialist staff in a group context. A further disappointment
relates to the lack of clarity with regard to intervention components and their corresponding mechanisms
of action. It thus becomes problematic when seeking to identify which are the active ingredients, which
components might be considered essential and to map which components address each requisite from the
group clinic intervention. In addition, we have identified a research paradox, in that the effectiveness of
the group clinic intervention is believed to be related to the degree of coproduction achieved by patients
and clinicians in the group but such coproduction makes it correspondingly more difficult to ensure the
fidelity of the intervention. In addition, to this evaluation challenge there are attendant consequences in
terms of subsequent implementation.
Another methodological limitation relates to the outcomes being studied. Substantial variability in
outcomes, together with the previously mentioned heterogeneity of interventions, makes it problematic
when seeking to explain the observed variability in intervention effects. Generally, for this reason,
we have resisted the use of meta-analyses using summary measures of treatment effect, as these may
not adequately describe the expected effects of the intervention (cf. Edelman et al.18). Indeed, the main
function of the availability of analyses for such outcome measures appears to be in developing a hierarchy
of outcome measures according to how easy it might be to demonstrate an effect and, indeed the
converse likelihood of a systematic measurement error. We also note the comparative absence of repeated
measurements for outcomes making it difficult to isolate the point at which improvements take place and,
indeed, the trajectory of the management of the disease. As mentioned above, this absence of outcome
data makes clinical decisions, specifically about optimal dosage, intensity and duration, problematic.
Furthermore, the limited time window covered by the included studies does not address the very important
issue of the long-term sustainability of such an intervention.
Research implications
Although the review team identified a sizeable body of evidence around group clinic type approaches, the
practical value of this research for the specific review question is limited. Much of the research has been
conducted in the USA, within a different health system, often with a requirement to make provision for an
individual consultation. The dominant model, therefore, is one of enhancement of interaction and not of
substitution. There is therefore a need for research that specifically focuses on the role of group clinic
approaches in substituting for identifiable components of, or the whole content of, individual consultation
episodes. In addition, RCTs have been conducted predominantly in the context of diabetes and rigorous
evaluations are required across a wider range of chronic conditions. Finally, the indistinct nature of the
different service models, and a lack of clarity regarding their individual constituents, requires research that
elicits more detail of individual service components, their putative mechanisms and their associated costs.
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The team identified five ongoing trials in group clinic type interventions (see Appendix 6). However, none
of these ongoing trials is taking place in the UK. Three of these trials relate to diabetes care, one relates to
heart failure and one relates to the new disease area (with respect to group clinics) of atopic dermatitis.
This research is unlikely to overturn any of the research implications or implications for practice, although
the studies in the less investigated contexts of heart failure and dermatitis are to be particularly welcomed.
Numerous commentators have observed on the heterogeneous nature of group clinic type interventions6,135
and this has several implications for this review. First, although we may identify some overall biomedical
effects from group clinic approaches across a wide range of settings, strengthening the likelihood of
generalisability, it is correspondingly more difficult to isolate the ‘active ingredients’ of what are essentially
complex multifaceted interventions.132
In an implementation context, given the typically poor standard of description of each intervention in
included studies, ensuring the fidelity of a particular type of group clinic intervention is problematic:
Implementation fidelity is often presented as critical to achieving the levels of efficacy demonstrated in
clinical trials. However, it became apparent that descriptions of SMA interventions provided insufficient
detail to guide implementation into differing clinical settings.27
This heterogeneity provides operational challenges to the definition of interventions for inclusion in this
review and also explains the apparent inconsistency of inclusions across previous reviews, which in turn
may partially explain some of the reported differences in effect.
From a cost viewpoint we know little about the added benefit of incremental additions to a particular
group clinic model. In fact, given that there is some evidence for the effectiveness of group-based
education interventions accompanied by individual clinician visits, it is unclear what the superiority or
added benefit of the more complex group clinic model might be over this comparatively simpler version.
At the same time, heterogeneity, although complicating the evaluation of group clinic-type interventions,
may offer attractions in the context of innovation. One potential criticism for the preponderance of
US-based models is that there is little evidence of genuine innovation around a familiar-looking menu
of group clinic models, perhaps due to the characteristics of the US funding system. The UK offers
considerable scope for innovation, provided that the components of each model are clearly identifiable,
isolatable and costable.
With regard to future comparators of the group clinic-based intervention two technological developments
require further investigation. With improved availability of internet technologies virtual clinics may offer a
technology-supported alternative to members of a group being present in person.139 In addition, the relatively
good performance of automated telephone disease management systems as a comparator for group clinics
suggests that, for some patients at least, support might be offered via such technologies.77,78 These weekly,
rotating automated (prerecorded) telephone calls take between 6 and 12 minutes to complete with any
‘out of range’ responses triggering a personal call back by a nurse manager.77,78 One attraction of these
contrasting technological approaches is that they may cater for the needs of two quite different population
demographics. Schillinger’s use of telephone support was particularly welcomed by those with language
difficulties.77,78 These approaches need rigorous evaluation in the context of the UK NHS.
Further studies of different patient populations in various practice settings are needed to identify the best
protocols and to assess the true benefits of group clinic approaches. It is hoped that these would reveal
that complementary, innovative and evolving care approaches involving multidisciplinary teams are useful
tools for meeting the significant challenges to access, cost and quality that now face the health-care
delivery system.137 Our findings confirm that there are limited data on satisfaction, patient access and other
key patient-centred outcomes.18
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As with the most recent review identified by this project, our review ‘uncovered far more gaps in the literature
than it found definitive results’.55 Gaps include the heterogeneity of the group clinic approaches intervention,
characterised as a ‘black box’, with ‘many components that are hard to capture and tease out, even in a
well-conducted analysis’.55 In seeking to add value by examining putative context-mechanism-outcome (CMO)
configurations we attempted to advance an explanation for what makes particular group clinic type
interventions successful.
In summary we have identified a requirement for future research to extend the breadth of chronic
conditions within a wider evaluation framework in rigorously conducted trials in a UK context, to focus on
benefits of substitution not enhancement, to characterise interventions by their components rather than
their labels and to target these individual components for specific evaluation of both costs and benefits.
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Chapter 7 Conclusions
What, if anything, does the evidence reveal about the different
models of group clinics?
The evidence reveals significant variation in the use of labels for interventions and, more significantly,
in the components included in each type of group clinic approach. Indeed, many approaches share
common theoretical or philosophical origins. Particularly problematic with regard to isolating the specific
contribution of each of the different models are variations in the key characteristics required for evaluation.
These include the frequency and duration of sessions, the numbers present, the clinician input, the role
(if any) of an individual consultation and the content and duration of individual intervention components.
What, if anything, does the evidence reveal about the uptake
and rate of the spread of group clinic approaches across
different chronic conditions?
Group clinic approaches originated in the clinical area of diabetes and were popularised in the context of
older patients with multiple health conditions. Discussion with our clinical advisers confirms that diabetes
is a strong candidate for such approaches because of the need for ongoing monitoring, the frequency,
complexity and severity of complications and, more generally, the high prevalence of group education
interventions. More recently there has been increased interest, as reflected in the published research, in the
use of group clinic approaches in other common chronic conditions, such as heart disease and hypertension.
In the UK there have been limited, but not rigorously evaluated, attempts at using the group clinic approach
for rheumatological conditions. Limited published experience with conditions typically first encountered
earlier in life, such as inherited metabolic conditions, reveals enthusiasm for group approaches early in the
learning curve for an individual condition, but also possible practical difficulties in terms of access, availability
and attendance, as well as diminution in support and perceived usefulness as participants become more
acquainted with their condition and its management. A significant UK movement to use group clinic
approaches for acupuncture seeks to capture aspects of socialisation and peer support promulgated by
the models. However, as highlighted by one of our clinical advisers, acupuncture clinics have the specific
requirement for a patient to be immobile while they receive treatment, and we therefore consider a regular
treatment-oriented group clinic to be conceptually different from approaches that harness such mechanisms
as monitoring and self-management.
What, if anything, does the evidence reveal about where group
clinic approaches might be most promising in a UK setting?
As mentioned when considering UK-based initiatives, it is difficult to map such experiments against the
underpinning theoretical and philosophical foundations invoked by the trial evidence. In many cases the
literature is mobilised generically, with little attempt made to ensure the fidelity of a particular model.
Indeed, the heterogeneity and lack of distinctness of the models and terminology make it questionable as
to whether or not such fidelity is actually achievable. A more promising line of inquiry may require future
researchers to identify and isolate specific intervention components and their specific effects in the
context of rigorous evaluation. Such an approach should specifically seek to surface the added value of a
co-ordinated group clinic intervention over and above an ‘individual consultation plus group education’
provision, particularly given that the systematic review provides some evidence for comparable effects from
group education.
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Discussion with our clinical advisors suggested several models of group care that might prove more
appropriate than others:
1. Group clinics in the context of initial diagnosis, education and self-monitoring of a new
condition close to onset. Group attendance when patients have high initial anxiety, intense
information needs and a requirement to learn self-management behaviours may harness patient
commitment at a critical early phase in their chronic disease. This might be supported at a later time by
ongoing periodic refreshment at longer intervals. A clinical advisor suggested that, in addition to being
suitable for diabetes, this model might be appropriate for asthma care including instruction on inhaler
use. We also located a protocol for a RCT of women carrying the breast cancer gene BRCA1 and BRCA2
suggesting a potential role for group clinics in supporting women with the breast cancer gene. This
model requires research and evaluation.
2. Group clinics for a time-limited circumstance. Although the CenteringPregnancy initiative is the
most common example of this approach from outside the scope of this review, in the sphere of chronic
disease there is the potential for chronic conditions that lead to an acute intervention to be managed
through a group clinic approach. Bariatric surgery for obesity features in the literature and was
mentioned by a clinical adviser; however, in this instance attendance at group sessions is a mandatory
condition of eligibility for surgery and so does not strictly conform to the voluntary philosophy of group
clinics perpetuated in the US studies.
3. Group clinics as a venue for treatment. The best documented approach of group clinic use in a UK
context involved acupuncture for knee osteoarthritis. In contrast to the model of self-monitoring and
intervention where required, which characterises most of the other group clinic models, this clinic
carries an expectation that patients will receive treatment. This limits the generalisability of some of the
acceptance data, although evidence on the group processes does remain valid. As acupuncture
treatment has a duration of about 20 minutes we have characterised this as a ‘working smarter’ model
for group clinic intervention, confirmed by the team. Within an NHS context there may be additional
opportunities to offer group clinic provision where a patient might otherwise be waiting for or
undergoing treatment or other non-monitoring procedures.
In particular, what does the evidence from diverse sources
reveal about the feasibility, appropriateness, meaningfulness,
effectiveness and efficiency of group clinic approaches for
chronic medical conditions?
Feasibility (evidence from qualitative research, cost studies and UK studies
and informants)
UK informants highlighted a current separation between the clinical consultation and the provision of
group education, as evidenced in diabetes care. Even within existing UK provision the coverage and quality
of group education is believed to be extremely variable. Wider issues relating to feasibility concern
appropriate premises for delivery97 and training in facilitation skills for participating clinical staff.101
Appropriateness (evidence from qualitative research, UK studies and
UK informants)
The evidence for the appropriateness of a group clinic approach, as perceived by patients, is largely
equivocal. Patients report substantively comparable perceptions of improvement across both group and
individual interventions, with the groups sharing concerns about appointment availability. There was little
evidence of dissatisfaction with care from those actually receiving group clinic approaches. However, other
considerations may result in patients’ poor adherence to the group clinic regime. More typically, those
who had vocalised reservations regarding group clinic approaches expressed this concern by withholding
consent to entry into a group intervention arm. We have made some initial observations based on data
available on recruitment and maintenance from included studies. This suggests that any assessment of
effectiveness should pay close attention to those who, although eligible, exit the intervention prior to its
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commencement. In practical terms this population will require alternative health-care provision, which may
make a dual model of service delivery particularly problematic.
The perceived advantages of group-based approaches include greater flexibility in duration of appointments
and more time with the clinician.97,128 Improved flexibility is expressed in the fact that a group clinic ‘can be
altered to fit various patient populations, specific physician practices/organisations, and a number of health
care delivery systems)’.48 Recent qualitative evidence suggests that the group clinic approach may have a
beneficial effect in terms of challenging the previous clinician–patient dynamic, thereby producing a
‘levelled playing field’.101
Corresponding disadvantages include a perceived lack of privacy, although this was not found to be a
significant problem in existing UK studies (albeit in the context of group acupuncture clinics). Of significant
concern, however, is the fact that participants attending individual sessions perceive little apparent
advantage in switching to a group-based approach and report difficulty in imagining how such group-based
approaches might be feasible.
Given the outstanding questions about the sustainability of group clinic approaches, the severity of
attrition and the lack of long-term outcome measurement (with the longest follow-up being 5 years),84
it is problematic to consider the use of group clinics in the context of lifelong chronic disease
management provision.
Group clinics may not be appropriate for certain patients or under certain circumstances. In addition to
religious and cultural considerations, as exemplified by the specific reference to Muslim women made by a
nurse in one study (see Chapter 3, Results of the review of UK evidence, Study analyses, How do UK
health providers feel about group clinics?), group clinic approaches may be less acceptable to patients of
an older generation or in instances where there is a perceive threat to patients’ dignity or an increased
likelihood of embarrassment (e.g. the revealing of unsightly varicose veins, etc.). Although concerns
regarding privacy are underplayed in the included studies, this may reflect the types of conditions being
reported and a focus on those who have consented either to randomisation (for RCTs) or to a group
intervention (for other research designs). Some concerns may be alleviated by such factors as the design
of single-sex group sessions or groups offered to particular ethnic populations, although providers should
be sensitive to the fact that such measures may not necessarily result in the addressing of all of the target
population’s concerns.
Other considerations regarding appropriateness were implied by the exclusion criteria employed in the
included trials. Many trials have purposely excluded patients with dementia or cognitive impairment.
Others excluded those with hearing difficulties or other communication-related constraints. The exclusion
of patients who do not speak the predominant language was also evident. For qualitative studies it was
less obvious whether such exclusions relate to the specific group nature of the intervention or were a
function of the methods of investigation. In either case, it is clear that the group clinic approaches are not
suited to particular segments of the population. For other patients, concerns about access and attendance,
for example in the case of those who do not have their own transport or those who work during clinic
hours, are also evident.
Meaningfulness (evidence from UK studies and UK informants)
Individuals using the NHS have, as a marker of good-quality individualised care, a general expectation that
they will receive an individual consultation with a clinician. This impression may be strengthened by use of
the word ‘clinics’ and by the fact that several patients will have specific expectations of the group clinic,
notwithstanding any information provided. Furthermore, group education in the NHS is seen by some as
an alternative to the individual consultation but typically presented as a ‘bolt-on extra’ and, as a result,
could be regarded as optional or less important by patients and/or health providers.
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Effectiveness (evidence from systematic reviews and randomised
controlled trials)
We identified 13 systematic reviews, including multiple variations of the GMV. Ten of these studies were
analysed in detail, while one was at the protocol stage and another was unavailable and used only in
summary form. The majority of these reviews are disease specific, with the primary focus being on
diabetes. One Cochrane review included two studies of group visits as interventions designed to increase
patient trust in their clinician, one of the putative mechanisms of the group clinic effect.
Taken as a body of evidence, the reviews shared common conclusions:
l evidence of a significant positive effect in terms of HbA1c and systolic blood pressure
l non-significant effects in relation to LDL, HDL and total cholesterol
l a significant effect in relation to disease-specific quality of life
l a moderately significant effect on generic quality of life.
l equivocal evidence in relation to potential cost savings.
Many of the reviews concluded that the heterogeneity of group clinic-type interventions made it
problematic to classify such initiatives, to isolate the effect of specific intervention components and,
subsequently, to evaluate their effects.
We identified 22 RCTs (32 papers) published between 1999 and 2014. A total of 17 of the 22 studies
were conducted in the USA,20,31,58,60,63–66,68,71,72,75–77,79,80,86 with two conducted in Italy,82,85 two in the People’s
Republic of China73,74 and one in Norway.70 Included studies recruited a total of 5572 patients. Diabetes
was the most represented condition, being present in 23 of the 31 papers and representing, in turn, 15 of
the 23 RCTs.20,58,60,63,66,67,69,70,72,74,79,80,82,85,86 One further study was conducted in a pre-diabetes population.64
Other conditions included asthma,65 cardiovascular disease, heart disease/hypertension (three RCTs),31,71,73
stroke/transient ischaemic attack, and Parkinson’s disease.68
We found six trial reports64,66,67,73,74,76 (five trials) published over the period 2012–14. Only one previous
review55 had included any of these reports (n= 1).
Biomedical outcomes
Three reports66,67,74 contributed information to existing meta-analyses. Liu et al.74 confirmed a significant
improvement effect on systolic blood pressure finding. Crowley et al.67 confirmed previous findings of a
significant effect on HbA1c in good-quality trials. However, this effect was observed only among those
using complex insulin regimens at baseline, with no observed difference between group medical clinic and
usual care patients using no insulin (p= 0.65) or basal insulin only (p= 0.71). Crowley et al.66 found
significant effects for total cholesterol and LDL cholesterol. This finding contributes to an overall
pattern from a meta-analysis of previous studies that found non-significant effects for LDL cholesterol
(four previous studies) and for total cholesterol (five previous studies).
In addition to the biomedical outcomes, several health service utilisation measures have been measured in
isolated studies. These are not suitable for meta-analysis but they are reviewed in chronological order
with an assessment of the consistency around results.
Health service utilisation
Edelman et al.18 reported that effects on emergency department visits were reported in five
studies.20,58,69,81,86 Two studies reported significantly lower visit rates69 or the proportion with an emergency
department visit.86 Rates were not significantly different in the other three studies.58,81,86 Group clinic
participants were significantly less likely to make any emergency visit than those in the control group and
averaged fewer emergency visits during the 2-year follow-up period than control participants. Coleman
et al.65 reported that, over a 24-month study period, CHCC participants were less likely to make an
emergency visit and also less likely to have made multiple emergency visits.
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Edelman et al.18 identified five studies reporting the effect of SMAs on hospital admissions.20,58,69,81,86
Admission rates were lower for SMAs in three studies, but the result was statistically significant in only
one study.20 The fifth study reported a statistically non-significant lower proportion of patients with a
hospital admission in the SMA group.86 In a further study, group clinic participants had, on average, fewer
hospitalisations than controls.65 Primary care visits did not differ between the two groups. Studies in older
adults show a pattern of lower health-care utilisation, but the number of studies and participants are
relatively few and these results cannot be considered conclusive. In patients with diabetes, lower
hospitalisation was the most consistent effect, but effects on other utilisation outcomes are inconclusive.
It is important to note that once the group visits themselves are added to primary care visits, group clinic
patients have significantly higher overall outpatient utilisation.65
Efficiency (cost-effectiveness) (evidence from cost studies)
The evidence for the cost-effectiveness of group clinic approaches is equivocal. The efficiency of group
clinics is determined by the perspective from which the group intervention is being examined, the level of
current (comparator) provision and whether or not there is recognition of a need for the provision of such
enhancements as training for clinicians (e.g. to act as facilitators) and accommodation for group activities.
A full economic evaluation is required in a UK setting with recognition of the factors described above
regarding feasibility and the other realities of implementation.
Rehearsing the main arguments
In summarising the evidence base we return to a consideration of the four principal drivers for the
introduction of group clinic type interventions as identified in Chapter 1.
The substitution argument
An initial attraction of group clinic approaches, as encapsulated in our review protocol, was the
assumption that such approaches might offer a viable alternative to and substitute for individual
consultations. In reality, many models make routine provision for individual consultations, offer follow-up
consultation on demand or use the group setting as a mechanism for singling out those requiring specific
support. The implications of these three different approaches are similarly varied. In the first instance
efficiencies are gained only to the extent that the information giving that would have taken place in an
individual setting is provided in a group setting and the corollary that the duplication of genuinely shared
concerns may be commensurately reduced. In the second instance, the numbers of on-demand
consultations may be difficult both to predict and to provide for, with the consequent dangers of under- or
overutilisation of clinical staff and, in the latter case, decreased patient satisfaction. The third variant,
whereby those requiring an individual consultation are ‘triaged’ through the group processes, is heavily
dependent on the clinician’s capacity to identify genuine need amid a preoccupation with group processes
and facilitation. Perversely, those least likely to communicate or engage in a group setting may be the very
patients who are most need of supplemental individualised care.
We found no compelling evidence that, within the context of the entire health system, the group
clinic approach offers efficiencies over the usual care system. Considerations here are that a large
proportion of patients will not take up group clinic provision – either because of initial preferences or
following personal experience of the approach – and will require individual consultations. Furthermore, the
large majority of group clinic approaches make provision for individual consultations within the model,
with additional cost consequences. Investigation of this phenomenon, which ran counter to the original
perceived rationale for conducting this review, revealed that this may be primarily an artefact of funding
arrangements in the USA, where most evaluations have taken place. For example, Blue Cross/Blue Shield
Corporate Reimbursements will not cover group visit (SMAs) if the patient is not able to access an
individual consultation with the physician and both individual and group interaction must be documented
in the patient’s medical record to receive reimbursement.140 Detailed evaluation in a UK setting is required
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in order to assess the proportion of patients who would avail themselves of an individual consultation in
addition to the group interaction or who would find a group clinic unacceptable.
The quality of care argument
The achievement of positive biomedical or associated outcomes is variable. Although it is conceivable that
ongoing self-monitoring, allied to hands-on experience of aspects of self-care and the positive support of
realistic models and peers, may achieve a beneficial effect, it is unclear if group clinics are the optimal
method for harnessing such mechanisms.
The acceptability argument
Although concerns over confidentiality and privacy are not as plentiful as might be expected, it must
be recognised that the views of those who are not willing to enter into a group clinic trial at all are
imperfectly captured by either quantitative or qualitative studies. In addition, individuals may be able to
enter a group clinic arrangement on an experimental basis but may subsequently decide that the
experience was not positive enough for them to continue such an approach beyond the lifespan of the
trial. Indeed, there is little evidence on the sustainability of group clinic approaches.
The enhancement model
Typically, group clinic approaches have been investigated as an alternative to individual consultations.
Comparisons between different types of group intervention of differing intensities and with/without
clinical input are required to examine the differential benefit of the added group clinic-specific input.
Considerations for the feasibility of group clinics may centre on whether or not group clinics are seen as
an entirely new intervention or whether or not they represent a means of systematising and joining up
existing group education and individual clinician input and, therefore, placing group education provision in
a more central role than currently appears to be the case.
Translating the evidence to a UK context: a ‘translational
appendix’
When translating the evidence from the (primarily) US trials to a UK context, health service managers
should recognise that:
l The research, evaluation and service delivery agenda has been heavily influenced by US
health-provider funding patterns. Although current UK initiatives favour the phrase ‘group clinics’,
this term is not commonly used by the predominantly US-based evaluated models. This difference in
terminology may mask common theoretical foundations and intervention components, making the
comparability of real practice with available research particularly challenging. In addition, the solutions
developed by the USA do not by any means reflect the wide range of formats, content and intensities
that might be of value in a NHS setting.
l There is little empirical evidence examining the most attractive model for the UK, namely
group clinics as a substitute for the individual consultation. In the UK patients have a strong
expectation that they will be seen by a clinical specialist. For these reasons the potential to alter the
content of the individual consultation by transferring some of this content to a group context, or
indeed other formats, may well be more attractive than complete substitution of a new model.
However, the joining up of individual consultation and group education approaches may be
problematic, given that the latter are often seen as an optional extra by patients, primary care
physicians and other health-care providers.
CONCLUSIONS
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l In particular, it must be recognised that provision must still be made for those whose
complex needs or other circumstances may militate against a group clinic approach. A
particular concern is the possible effect on those who may otherwise seem disadvantaged in terms of
access to health or health care. Specific populations mentioned were those with hearing impairment,
for whom the group environment may be unaccommodating, and those from specific ethnic minorities,
where cultural considerations may impact on dignity, respect and privacy.
l With regard to facilities, the availability of suitable venues and of suitably trained staff is a
key consideration. If group approaches are delivered badly then this may be taken as a sign of a lack
of commitment on the part of the health-care providers.
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Appendix 1 Feasibility, appropriateness,
meaningfulness, effectiveness framework
TABLE 31 Components of FAME framework11
Feasibility (F)a Appropriateness (A)b
Meaningfulness (M) to
specific populations,
cultures and settingsc Effectiveness (E)d
Economic
evidence (EE)
Excluding
developing
countries
Staff attitudes Cultural values Clinical outcomes
Health services outcomes
(including utilisation)
Costs
Cost–benefit
a ‘The extent to which an activity is practical and practicable. Clinical feasibility is about whether or not an activity or
intervention is physically, culturally or financially practical or possible within a given context’.
b ‘The extent to which an intervention or activity fits with or is apt in a situation. Clinical appropriateness is about how an
activity or intervention relates to the context in which care is given.’
c Evidence of meaningfulness: ‘the extent to which an intervention or activity is positively experienced by the patent.
Meaningfulness relates to the personal experience, opinions, values, thoughts, beliefs and interpretations of patients
or clients’.
d ‘The extent to which an intervention, when used appropriately, achieves the intended effect. Clinical effectiveness is
about the relationship between an intervention and clinical or health outcomes.’
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Appendix 2 Search strategies
The following electronic databases were searched for published and unpublished research evidence from1999 to present and were searched on 1 April 2014 to 11 April 2014:
l The Cochrane Library, including the Cochrane Systematic Reviews Database, Cochrane Controlled Trials
Register, DARE, HTA and NHS Economic Evaluation (NHS EED) databases
l MEDLINE (Ovid)
l EMBASE (Ovid)
l CINAHL (EBSCOhost)
l Science Citation Index (via ISI Web of Science)
l Social Science Citation Index (via ISI Web of Science)
l Conference Proceedings Citation Index – Science (CPCI-S) (via ISI Web of Science).
Search strategies for each database are provided below.
MEDLINE
Search strategy
1. group visit$.tw.
2. group clinic$.tw.
3. *Group Processes/
4. group appointment$.tw.
5. group care.tw.
6. group meeting$.tw.
7. group medical visit$.tw.
8. group medical clinic$.tw.
9. group medical appointment$.tw.
10. group medical care.tw.
11. group medical meeting$.tw.
12. gmv.tw.
13. gma.tw.
14. shared medical appointment$.tw.
15. shared medical visit$.tw.
16. cluster visit$.tw.
17. (group outpatient$ adj1 (visit$ or clinic$ or appointment$ or meeting$ or care)).tw.
18. or/1-17
19. limit 18 to (english language and yr=“1999 –Current”)
EMBASE
Search strategy
1. group visit$.tw.
2. group clinic$.tw.
3. *group process/
4. group appointment$.tw.
5. group care.tw.
6. group meeting$.tw.
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7. group medical visit$.tw.
8. group medical clinic$.tw.
9. group medical appointment$.tw.
10. group medical care.tw.
11. group medical meeting$.tw.
12. gmv.tw.
13. gma.tw.
14. shared medical appointment$.tw.
15. shared medical visit$.tw.
16. cluster visit$.tw.
17. (group outpatient$ adj1 (visit$ or clinic$ or appointment$ or meeting$ or care)).tw.
18. or/1-17
19. limit 18 to (embase and english and yr=“1999 –Current”)
The Cochrane Library
Search strategy
ID Search
#1 “group visit*”:ti,ab,kw (Word variations have been searched)
#2 “group clinic*”:ti,ab,k this term only
#4 “group appointment*”:ti,ab,kw (Word variations have been searched)
#5 “group care”:ti,ab,kw (Word variations have been searched)
#6 “group meeting*”:ti,ab,kw (Word variations have been searched)
#7 “group medical visit*”:ti,ab,kw (Word variations have been searched)
#8 “group medical clinic*”:ti,ab,kw (Word variations have been searched)
#9 “group medical appointment*”:ti,ab,kw (Word variations have been searched)
#10 “group medical care”:ti,ab,kw (Word variations have been searched)
#11 group medical meeting*:ti,ab,kw (Word variations have been searched)
#12 gmv:ti,ab,kw (Word variations have been searched)
#13 gma:ti,ab,kw (Word variations have been searched)
#14 shared medical appointment*:ti,ab,kw (Word variations have been searched)
#15 shared medical visit*:ti,ab,kw (Word variations have been searched)
#16 “cluster visit*”:ti,ab,kw (Word variations have been searched)
#17 “group outpatient visit*”:ti,ab,kw (Word variations have been searched)
#18 “group outpatient clinic*”:ti,ab,kw (Word variations have been searched)
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#19 “group outpatient appointment*”:ti,ab,kw (Word variations have been searched)
#20 “group outpatient meeting*”:ti,ab,kw (Word variations have been searched)
#21 “group outpatient care”:ti,ab,kw (Word variations have been searched)
#22 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or
#16 or #17 or #18 or #19 or #20 or #21
w (Word variations have been searched)
#3 MeSH descriptor: [Group Processes]
Cumulative Index to Nursing and Allied Health Literature
Search strategy
# Query
S22 (S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16
OR S17 OR S18 OR S19 OR S20 OR S21)
S21 TI group outpatient care OR AB group outpatient care
S20 TI group outpatient meeting* OR AB group outpatient meeting*
S19 TI group outpatient appointment* OR AB group outpatient appointment*
S18 TI group outpatient clinic* OR AB group outpatient clinic*
S17 TI group outpatient visit* OR AB group outpatient visit*
S16 TI cluster visit* OR AB cluster visit*
S15 TI shared medical visit* OR AB shared medical visit*
S14 TI shared medical appointment* OR AB shared medical appointment*
S13 TI gma OR AB gma
S12 TI gmv OR AB gmv
S11 TI group medical meeting* OR AB group medical meeting*
S10 TI group medical care OR AB group medical care
S9 TI group medical appointment OR AB group medical appointment
S8 TI group medical clinic* OR AB group medical clinic*
S7 TI group medical visit* OR AB group medical visit*
S6 TI group meeting* OR AB group meeting*
S5 TI “group care” OR AB “group care”
S4 TI group appointment* OR AB group appointment*
S3 (MM “Group Processes”)
S2 TI “group clinic*” OR AB “group clinic*”
S1 TI group visit* OR AB group visit*
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Web of Science
Search strategy
#24 #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR #14 OR #13 OR #12 OR #11 OR #10 OR #9 OR
#8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
Refined by: LANGUAGES: (ENGLISH)
DocType=All document types; Language=All languages;
#23 #22 OR #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR #14 OR #13 OR #12 OR #11 OR #10 OR #9 OR
#8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
DocType=All document types; Language=All languages;
#22 TI=(gma)
DocType=All document types; Language=All languages;
#21 TOPIC: (gmv)
DocType=All document types; Language=All languages;
#20 TOPIC: (“group outpatient care*”)
DocType=All document types; Language=All languages;
#19 TOPIC: (“group outpatient meeting*”)
DocType=All document types; Language=All languages;
#18 TOPIC: (“group outpatient appointment*”)
DocType=All document types; Language=All languages;
#17 TOPIC: (“group outpatient clinic*”)
DocType=All document types; Language=All languages;
#16 TOPIC: (“group outpatient clinic*”)
DocType=All document types; Language=All languages;
#15 TOPIC: (“group outpatient visit*”)
DocType=All document types; Language=All languages;
#14 TOPIC: (“cluster visit*”)
DocType=All document types; Language=All languages;
#13 TOPIC: (“shared medical visit*”)
DocType=All document types; Language=All languages;
#12 TOPIC: (“group medical clinic*”)
DocType=All document types; Language=All languages;
#11 TOPIC: (“group medical meeting*”)
DocType=All document types; Language=All languages;
#10 TOPIC: (“group meeting*”)
DocType=All document types; Language=All languages;
#9 TOPIC: (“group care”)
DocType=All document types; Language=All languages;
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#8 TOPIC: (“group appointment*”)
DocType=All document types; Language=All languages;
#7 TOPIC: (“shared medical appointment*”)
DocType=All document types; Language=All languages;
#6 TOPIC: (“group medical appointment*”)
DocType=All document types; Language=All languages;
#5 TOPIC: (“group medical care”)
DocType=All document types; Language=All languages;
#4 TOPIC: (“group medical visit*”)
DocType=All document types; Language=All languages;
#3 TS=(“group processes”)
DocType=All document types; Language=All languages;
#2 TOPIC: (“group visit*”)
DocType=All document types; Language=All languages;
#1 TOPIC: (“group clinic*”)
DocType=All document types; Language=All languages;
Search strategies for finding details of UK initiatives/experts
(Google)
S1. “united kingdom” AND “group clinics”
S2. “united kingdom” AND “shared medical appointments”
S3. “united kingdom” AND “group medical appointments”
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Appendix 6 Other UK group clinic initiatives
identified
The following UK group clinic initiatives were identified during the course of the project. Contact wasmade with any projects identified early in the course of the review. Other projects are listed for the
sake of completeness.
TABLE 35 Ongoing UK group clinic initiatives
Title of initiative
Disease
condition Details Contact details
Northumbria Osteoporosis
Project: Group Clinics
Osteoporosis National Osteoporosis
Society
Northumbria Healthcare
NHS Trust
Mrs Norma Cardill, North Tyneside
General Hospital, Rake Lane, North
Shields, Tyne and Wear, NE29 8NH.
Telephone: XXXX
Pilot study of acupuncture in a
group setting for chronic knee
pain: ScrutiKnee
Chronic
knee pain
National Institute for Health
Research Research for
Patient Benefit
Plymouth Hospitals NHS
Trust
Dr Liz Tough, Plymouth Hospitals NHS
Trust, ITTC Building, 1 Tamar Science
Park, Davy Road, Plymouth, Devon,
PL6 8BX XXXX
Transforming our insulin pump
service
Diabetes Nottingham University
Hospitals NHS Trust,
Nottingham, UK
Kay S, Soar C, Page RCL.
Transforming our insulin pump
service. Diabetic Medicine Conference:
Diabetes UK Professional Conference,
7–9 March 2012, Glasgow, UK.
Diabetes Med 2012;29:99–100
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Appendix 7 Existing systematic reviews related to
group clinics
TABLE 36 Systematic reviews with outcome measures and results
Reference
Total number
of patients Biologic markers Other outcomes/measurements
Edelman et al.
(2014)55
(2921 in RCTs;
326 in OS)
Haemoglobin: SMAs improved HbA1c
(Δ=−0.55 percentage points, 95% CI
−0.11 to −0.99 percentage points);
HbA1c result had significant
heterogeneity among studies, likely to
be secondary to heterogeneity among
included SMA interventions
BP: SMAs improved systolic BP
(Δ=−5.2mmHg, 95% CI −3.0 to
−7.4mmHg)
Cholesterol: SMAs did not improve LDL
cholesterol (Δ=−6.6mg/dl, 95% CI
2.8 to −16.1mg/dl)
Non-biophysical outcomes, including
economic outcomes, were reported too
infrequently to meta-analyse or to draw
conclusions from
Rolfe et al.
(2014)56
11,063 patients None Trials showing small but statistically
significant increase in trust included a
trial of group visits for new inductees
into a health maintenance organisation
and a trial of group visits for diabetic
patients. However, trust was not affected
in subsequent larger trial of group visits
for uninsured people with diabetes.
There was no evidence of harm from any
of the studies
CADTH (2013)52 Not stated Glycaemic control: better glycaemic
control achieved for group care vs. usual
care
BP: one included study found that for
adults with hypertension better control
of BP is achieved with group care vs.
usual care
There was no information on the
effectiveness of group care for COPD or
HIV/AIDS
No cost-effectiveness evaluations of
group care models were identified.
No evidence-based guideline specifically
on group care for chronic disease
management was identified. One
guideline on diabetes management
recommended that diabetes education
should be delivered in groups or
individually, but did not recommend a
preferred model
Housden et al.
(2013)53
2240 patients HbA1c: there were clear benefits of
GMVs for HbA1c levels, which are
consistent post-intervention and change
from baseline effect sizes. The most
significant effect is change from baseline
results
BP: there was some evidence for
post-intervention, and change from
baseline, systolic BP improvement at
9–12 months’ interval and change from
baseline improvement at 4 years
Cholesterol: there was no evidence that
GMVs improve LDL cholesterol values
None reported
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TABLE 36 Systematic reviews with outcome measures and results (continued )
Reference
Total number
of patients Biologic markers Other outcomes/measurements
Slyer and
Ferrara (2013)54
108 participants
(52 in RCT)
Two studies: one RCT (52 participants)
and one cohort study (56 participants)
The review examined knowledge, quality
of life, self-care and readmissions
Knowledge: the RCT reported statistically
significant improvement in heart failure
knowledge at 8 weeks, compared with
control, which was not maintained
at 16 weeks
Quality of life and self-care: there were no
statistically significant differences in
self-care and health-related quality of life
between groups at 8 and 16 weeks
Readmissions: no trial data
Edelman et al.
(2012)18
4157 patients 10 out of 13 RCTs evaluating outcomes
for patients with diabetes examined
type 2 diabetes only and one examined
type 1 only. Two examined a mixed
patient population
HbA1c: studies enrolled patients with
poor glucose control (thresholds varied
from HbA1c 6.5% to > 9%); a minority
required elevated BP or lipids. All studies
reported effects on average HbA1c at the
end of intervention. SMAs associated
with lower HbA1c vs. usual care at
4 to 48 months’ follow-up (mean
difference=−0.55, 95% CI −0.99 to
−0.11). Effects varied significantly across
studies; this was not explained by study
quality
Cholesterol: eight studies reported
effects on either total or LDL cholesterol,
showing small but statistically
non-significant treatment effects that
varied across studies
BP: five studies reported effects on
systolic BP, showing consistent and
statistically significant effect
(mean difference=−5.2, 95% CI
−7.40 to −3.05)
Two trials described effects on patient
experience. Neither showed greater
satisfaction for SMAs vs. usual care
Quality of life: five studies reported large
improvements in health-related
quality of life (SMD=−0.84; 95% CI
−1.64 to −0.03). Effects were greater for
disease-specific measures. Findings from
OS were generally consistent with RCTs
Admissions/ED visits: effects of SMAs on
hospital admissions and ED visits were
explored in five studies on patients with
diabetes. In three out of the five studies
admission rates were lower with SMAs.
The result was statistically significant in only
one study. Two studies found that ED visits
decreased significantly with SMAs
Costs: four studies reported effects on total
costs. Results were mixed. In one, total
costs significantly higher; in another, total
costs were significantly lower; in the third,
results did not differ significantly; and the
fourth was conducted in Europe
Health-care utilisation: two RCTs and one
OS evaluated effects of SMAs on older
adults with high health-care service
utilisation rates. All studies reported
positive effects on patient experience for
SMAs vs. usual care. Both trials reported no
difference vs. usual care for overall health
status and functional status. Biophysical
outcomes were not reported
Hospital admissions/ED visits: three studies
(two RCTs and one OS) showed fewer
hospital admissions in SMAgroups.
Both trials reported statistically significant
decrease in ED visits for SMAs vs. usual
care. Total costs were lower for SMA group
in each study but varied substantially across
studies. They did not reach statistical
significance for any study
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TABLE 36 Systematic reviews with outcome measures and results (continued )
Reference
Total number
of patients Biologic markers Other outcomes/measurements
Steinsbekk et al.
(2012)51
2833
participants
4 out of 10 participants were male,
baseline age= 60 years, BMI 31.6 kg/m2,
HbA1c 8.23%, diabetes duration 8 years.
82% used medication
HbA1c reduced at 6 months (0.44 %
points; p= 0.0006, 13 studies,
1883 participants), 12 months
(0.46 % points; p= 0.001, 11 studies,
1503 participants) and 2 years
(0.87 % points; p< 0.00001,
three studies, 397 participants)
Blood glucose: fasting blood glucose
levels reduced at 12 months
(1.26mmol/l; p< 0.00001, five studies,
690 participants) but not at 6 months
Knowledge: diabetes knowledge
improved at 6 months (SMD 0.83;
p=0.00001, six studies, 768 participants),
12 months (SMD 0.85; p<0.00001,
five studies, 955 participants) and 2 years
(SMD 1.59; p=0.03, two studies,
355 participants)
Self-management: self-management skills
improved at 6 months (SMD 0.55;
p=0.01, four studies, 534 participants).
Improvement for empowerment/
self-efficacy (SMD 0.28; p=0.01,
two studies, 326 participants) after
6 months
Quality of life: no conclusion could be
drawn due to high heterogeneity
Other outcomes: significant improvements
in patient satisfaction and body weight at
12 months for IG. No differences between
groups in mortality rate, BMI, BP and lipid
profile
Burke et al.
(2011)87,88
2240 patients HbA1c: clear benefits of GMVs for
patients’ HbA1c levels which are
consistent in the post-intervention and
change from baseline effect sizes. Most
significant effect is with change from
baseline results
BP: evidence suggests post-intervention
and change from baseline systolic BP
improvement at 9- to 12-month interval
and change from baseline improvement
at the 4-year time frame
Cholesterol: no evidence that group
visits improve LDL cholesterol values of
GMV participants
No details
Riley and
Marshall
(2010)49
Not stated HbA1c, BP, lipids: diabetes-focused group
visits that incorporate group education
and a health provider office visit vs.
traditional brief office visit failed to
demonstrate consistent statistical
improvement in HbA1C, BP or lipids
Other outcomes: group visits may reduce
costs, some physiological outcomes may
be improved, and patient and clinician
satisfaction may be enhanced
Jaber et al.
(2006)48
Not stated None Although heterogeneity renders
assessment of group visit model
problematic, there are sufficient data to
support the effectiveness of group visits
in improving patient and physician
satisfaction, quality of care and quality of
life, and in decreasing ED and specialist
visits
Future research may benefit, however,
from abandoning old nomenclatures and
clearly defining structure, processes of
care, content of visits and appropriate
outcome measures
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TABLE 36 Systematic reviews with outcome measures and results (continued )
Reference
Total number
of patients Biologic markers Other outcomes/measurements
Deakin et al.
(2005)47
1532
participants
Haemoglobin: results favour group-
based diabetes education programmes
for reduced HbA1c at 4–6 months (1.4%,
95% CI 0.8% to 1.9%; p< 0.00001), at
12–14 months (0.8%, 95% CI 0.7% to
1.0%; p< 0.00001) and 2 years (1.0%,
95% CI 0.5% to 1.4%; p< 0.00001)
Blood glucose levels: reduced fasting
blood glucose levels at 12 months
(1.2mmol/l, 95% CI 0.7 to 1.6mmol/l;
p< 0.00001)
BP: reduced systolic BP at 4–6 months
(5mmHg, 95% CI 1 to 10mmHg;
p= 0.01)
Reduced body weight at 12–14 months
(1.6 kg, 95% CI 0.3 to 3.0 kg; p= 0.02);
improved diabetes knowledge at
12–14 months (SMD 1.0, 95% CI
0.7 to 1.2; p< 0.00001)
Reduced need for diabetes medication
(odds ratio 11.8, 95% CI 5.2 to 26.9;
p< 0.00001; RD= 0.2; NNT= 5).
For every five patients attending a
group-based education programme,
one patient would reduce diabetes
medication
BP, blood pressure; ED, emergency department; IG, intervention group; NNT, number needed to treat; OS, observational
study; RD, risk difference; SMD, standardised mean difference.
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Appendix 8 Characteristics of qualitative studies
and surveys
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Appendix 9 Data extraction elements
TABLE 40 Elements of data extraction form
Concept
Population
Facilitation
Group size
Components
Frequency
ACCESS AND CONVENIENCE
Duration
Follow-up
PEER SUPPORT
Appraisal support
Informational support
Emotional support
Instrumental support
Team composition
Other contacts
Patient characteristics
Built environment
Social support
PARTNER SUPPORT
SUPPORT FROM HEALTH PROFESSIONAL
Appraisal support
Informational support
Emotional support
Instrumental support
Adherence
Physical signs and symptoms (was biophysical markers)
Self-efficacy
Patient participation
Long-term symptom management)
Psychological status (was functional status)
Quality of life
ED visits
Rehospitalisations
Unplanned primary care office visits
Mortality
Costs
Patient confidentiality
Patient (non) participation
Missed appointments
ED, emergency department.
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Appendix 10 Criteria used in quality assessment
For quality assessment of RCTs we used the CASP checklist for RCTs44 and the Cochrane risk ofbias tables.45
For quality assessment of qualitative studies we used the CASP checklist for qualitative studies.46 There is
no qualitative equivalent of the Cochrane risk of bias tables. Indeed, the effect of bias on quantitative
research is currently unknown and requires further exploration.
l Was there a clear statement of the aims of the research?
l Is a qualitative methodology appropriate?
l Was the research design appropriate to address the aims of the research?
l Was the recruitment strategy appropriate to the aims of the research?
l Were the data collected in a way that addressed the research issue?
l Has the relationship between researcher and participants been adequately considered?
l Have ethical issues been taken into consideration?
l Was the data analysis sufficiently rigorous?
l Is there a clear statement of findings?
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